≈ 2089 relations sortantes
- en:muscular atrophy --
r_associated #0: 363 / 1 ->
médecine
n1=en:muscular atrophy | n2=médecine | rel=r_associated | relid=0 | w=363
- en:muscular atrophy --
r_associated #0: 296 / 0.815 ->
atrophie
n1=en:muscular atrophy | n2=atrophie | rel=r_associated | relid=0 | w=296
- en:muscular atrophy --
r_associated #0: 295 / 0.813 ->
atrophie musculaire neurogène
n1=en:muscular atrophy | n2=atrophie musculaire neurogène | rel=r_associated | relid=0 | w=295
- en:muscular atrophy --
r_associated #0: 290 / 0.799 ->
en:atrophy
n1=en:muscular atrophy | n2=en:atrophy | rel=r_associated | relid=0 | w=290
- en:muscular atrophy --
r_associated #0: 285 / 0.785 ->
amyotrophie de dénervation
n1=en:muscular atrophy | n2=amyotrophie de dénervation | rel=r_associated | relid=0 | w=285
- en:muscular atrophy --
r_associated #0: 281 / 0.774 ->
en:brain stem
n1=en:muscular atrophy | n2=en:brain stem | rel=r_associated | relid=0 | w=281
- en:muscular atrophy --
r_associated #0: 281 / 0.774 ->
en:pineal gland
n1=en:muscular atrophy | n2=en:pineal gland | rel=r_associated | relid=0 | w=281
- en:muscular atrophy --
r_associated #0: 280 / 0.771 ->
en:atrophy, neurogenic muscular
n1=en:muscular atrophy | n2=en:atrophy, neurogenic muscular | rel=r_associated | relid=0 | w=280
- en:muscular atrophy --
r_associated #0: 276 / 0.76 ->
en:brain
n1=en:muscular atrophy | n2=en:brain | rel=r_associated | relid=0 | w=276
- en:muscular atrophy --
r_associated #0: 276 / 0.76 ->
en:eye
n1=en:muscular atrophy | n2=en:eye | rel=r_associated | relid=0 | w=276
- en:muscular atrophy --
r_associated #0: 260 / 0.716 ->
musculaire
n1=en:muscular atrophy | n2=musculaire | rel=r_associated | relid=0 | w=260
- en:muscular atrophy --
r_associated #0: 255 / 0.702 ->
fonte
n1=en:muscular atrophy | n2=fonte | rel=r_associated | relid=0 | w=255
- en:muscular atrophy --
r_associated #0: 255 / 0.702 ->
muscles
n1=en:muscular atrophy | n2=muscles | rel=r_associated | relid=0 | w=255
- en:muscular atrophy --
r_associated #0: 245 / 0.675 ->
atrophie d'un groupe de fibres musculaires
n1=en:muscular atrophy | n2=atrophie d'un groupe de fibres musculaires | rel=r_associated | relid=0 | w=245
- en:muscular atrophy --
r_associated #0: 245 / 0.675 ->
atrophie musculaire de la sénescence
n1=en:muscular atrophy | n2=atrophie musculaire de la sénescence | rel=r_associated | relid=0 | w=245
- en:muscular atrophy --
r_associated #0: 245 / 0.675 ->
muscle
n1=en:muscular atrophy | n2=muscle | rel=r_associated | relid=0 | w=245
- en:muscular atrophy --
r_associated #0: 240 / 0.661 ->
en:hand
n1=en:muscular atrophy | n2=en:hand | rel=r_associated | relid=0 | w=240
- en:muscular atrophy --
r_associated #0: 240 / 0.661 ->
en:motor neuron/peripheral motor
n1=en:muscular atrophy | n2=en:motor neuron/peripheral motor | rel=r_associated | relid=0 | w=240
- en:muscular atrophy --
r_associated #0: 240 / 0.661 ->
en:muscle related signs and symptoms nec
n1=en:muscular atrophy | n2=en:muscle related signs and symptoms nec | rel=r_associated | relid=0 | w=240
- en:muscular atrophy --
r_associated #0: 240 / 0.661 ->
en:myositic disorders
n1=en:muscular atrophy | n2=en:myositic disorders | rel=r_associated | relid=0 | w=240
- en:muscular atrophy --
r_associated #0: 240 / 0.661 ->
en:neuromuscular disorders nec
n1=en:muscular atrophy | n2=en:neuromuscular disorders nec | rel=r_associated | relid=0 | w=240
- en:muscular atrophy --
r_associated #0: 240 / 0.661 ->
en:neuromuscular manifestations
n1=en:muscular atrophy | n2=en:neuromuscular manifestations | rel=r_associated | relid=0 | w=240
- en:muscular atrophy --
r_associated #0: 240 / 0.661 ->
processus pathologique
n1=en:muscular atrophy | n2=processus pathologique | rel=r_associated | relid=0 | w=240
- en:muscular atrophy --
r_associated #0: 235 / 0.647 ->
amyotrophies
n1=en:muscular atrophy | n2=amyotrophies | rel=r_associated | relid=0 | w=235
- en:muscular atrophy --
r_associated #0: 235 / 0.647 ->
consomption
n1=en:muscular atrophy | n2=consomption | rel=r_associated | relid=0 | w=235
- en:muscular atrophy --
r_associated #0: 235 / 0.647 ->
maladies
n1=en:muscular atrophy | n2=maladies | rel=r_associated | relid=0 | w=235
- en:muscular atrophy --
r_associated #0: 225 / 0.62 ->
en:muscle wasting (disuse)
n1=en:muscular atrophy | n2=en:muscle wasting (disuse) | rel=r_associated | relid=0 | w=225
- en:muscular atrophy --
r_associated #0: 225 / 0.62 ->
myatrophie
n1=en:muscular atrophy | n2=myatrophie | rel=r_associated | relid=0 | w=225
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:3-hydroxyacetyl-coenzyme a dehydrogenase deficiency
n1=en:muscular atrophy | n2=en:3-hydroxyacetyl-coenzyme a dehydrogenase deficiency | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:acute post asthmatic amyotrophy
n1=en:muscular atrophy | n2=en:acute post asthmatic amyotrophy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:age-related atrophy
n1=en:muscular atrophy | n2=en:age-related atrophy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:amyotrophy, monomelic
n1=en:muscular atrophy | n2=en:amyotrophy, monomelic | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:arnold stickler bourne syndrome
n1=en:muscular atrophy | n2=en:arnold stickler bourne syndrome | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:arthrogryposis
n1=en:muscular atrophy | n2=en:arthrogryposis | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:athetosis
n1=en:muscular atrophy | n2=en:athetosis | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:autoimmune necrotizing myopathy
n1=en:muscular atrophy | n2=en:autoimmune necrotizing myopathy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:bone mineral density
n1=en:muscular atrophy | n2=en:bone mineral density | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:bradykinesia
n1=en:muscular atrophy | n2=en:bradykinesia | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:cerebral atrophy
n1=en:muscular atrophy | n2=en:cerebral atrophy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:cerebrospinal fluid
n1=en:muscular atrophy | n2=en:cerebrospinal fluid | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:chills
n1=en:muscular atrophy | n2=en:chills | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:chronic fatigue syndrome
n1=en:muscular atrophy | n2=en:chronic fatigue syndrome | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:cns component
n1=en:muscular atrophy | n2=en:cns component | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:compartment syndrome
n1=en:muscular atrophy | n2=en:compartment syndrome | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:congenital fiber-type disproportion
n1=en:muscular atrophy | n2=en:congenital fiber-type disproportion | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:congenital structural myopathy
n1=en:muscular atrophy | n2=en:congenital structural myopathy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:cranial suture separation
n1=en:muscular atrophy | n2=en:cranial suture separation | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:detrusor and sphincter dyssynergia
n1=en:muscular atrophy | n2=en:detrusor and sphincter dyssynergia | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:diaphragmatic paresis
n1=en:muscular atrophy | n2=en:diaphragmatic paresis | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:disorder of extraocular muscle
n1=en:muscular atrophy | n2=en:disorder of extraocular muscle | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:disorder of muscle, unspecified; ankle and foot
n1=en:muscular atrophy | n2=en:disorder of muscle, unspecified; ankle and foot | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:disorder of muscle, unspecified; hand
n1=en:muscular atrophy | n2=en:disorder of muscle, unspecified; hand | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:disorder of muscle, unspecified; pelvic region and thigh
n1=en:muscular atrophy | n2=en:disorder of muscle, unspecified; pelvic region and thigh | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:disuse atrophy
n1=en:muscular atrophy | n2=en:disuse atrophy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:eosinophilia-myalgia syndrome
n1=en:muscular atrophy | n2=en:eosinophilia-myalgia syndrome | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:facial dysmorphism with multiple malformations
n1=en:muscular atrophy | n2=en:facial dysmorphism with multiple malformations | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:fasciculation
n1=en:muscular atrophy | n2=en:fasciculation | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:fibromyalgia
n1=en:muscular atrophy | n2=en:fibromyalgia | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:foot-drop
n1=en:muscular atrophy | n2=en:foot-drop | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:frontal bossing
n1=en:muscular atrophy | n2=en:frontal bossing | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:glycogen storage disease type ii
n1=en:muscular atrophy | n2=en:glycogen storage disease type ii | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:glycogen storage disease type v
n1=en:muscular atrophy | n2=en:glycogen storage disease type v | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:gray matter
n1=en:muscular atrophy | n2=en:gray matter | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:guillain-barre syndrome
n1=en:muscular atrophy | n2=en:guillain-barre syndrome | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:hereditary motor neuron disease
n1=en:muscular atrophy | n2=en:hereditary motor neuron disease | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:hyperkinesia
n1=en:muscular atrophy | n2=en:hyperkinesia | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:hypocalcemic tetany
n1=en:muscular atrophy | n2=en:hypocalcemic tetany | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:hypokinesia
n1=en:muscular atrophy | n2=en:hypokinesia | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:hypotonia
n1=en:muscular atrophy | n2=en:hypotonia | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:hypotonic-hyporesponsive episode
n1=en:muscular atrophy | n2=en:hypotonic-hyporesponsive episode | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:idiopathic inflammatory myopathy
n1=en:muscular atrophy | n2=en:idiopathic inflammatory myopathy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:increased bone density
n1=en:muscular atrophy | n2=en:increased bone density | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:involuntary muscle contraction
n1=en:muscular atrophy | n2=en:involuntary muscle contraction | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:joint immobility
n1=en:muscular atrophy | n2=en:joint immobility | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:joint swelling
n1=en:muscular atrophy | n2=en:joint swelling | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:leg cramp
n1=en:muscular atrophy | n2=en:leg cramp | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:lethal congenital contractural syndrome 3
n1=en:muscular atrophy | n2=en:lethal congenital contractural syndrome 3 | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:long-chain acyl-coa dehydrogenase deficiency
n1=en:muscular atrophy | n2=en:long-chain acyl-coa dehydrogenase deficiency | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:malunion of bone
n1=en:muscular atrophy | n2=en:malunion of bone | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:medial tibial stress syndrome
n1=en:muscular atrophy | n2=en:medial tibial stress syndrome | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:medium-chain acyl-coa dehydrogenase deficiency
n1=en:muscular atrophy | n2=en:medium-chain acyl-coa dehydrogenase deficiency | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:merrf syndrome
n1=en:muscular atrophy | n2=en:merrf syndrome | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:metacarpus
n1=en:muscular atrophy | n2=en:metacarpus | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:minicore (multicore) myopathy
n1=en:muscular atrophy | n2=en:minicore (multicore) myopathy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:mitochondrial encephalomyopathies
n1=en:muscular atrophy | n2=en:mitochondrial encephalomyopathies | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:mitochondrial myopathy acquired
n1=en:muscular atrophy | n2=en:mitochondrial myopathy acquired | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:miyoshi muscular dystrophy 2 (disorder)
n1=en:muscular atrophy | n2=en:miyoshi muscular dystrophy 2 (disorder) | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:motor deficit
n1=en:muscular atrophy | n2=en:motor deficit | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscle calcification or ossification nos
n1=en:muscular atrophy | n2=en:muscle calcification or ossification nos | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscle contracture
n1=en:muscular atrophy | n2=en:muscle contracture | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscle fibrosis
n1=en:muscular atrophy | n2=en:muscle fibrosis | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscle fibrosis atrophy
n1=en:muscular atrophy | n2=en:muscle fibrosis atrophy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscle hemorrhage
n1=en:muscular atrophy | n2=en:muscle hemorrhage | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscle hypertrophy
n1=en:muscular atrophy | n2=en:muscle hypertrophy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscle hypertrophy in response to stress
n1=en:muscular atrophy | n2=en:muscle hypertrophy in response to stress | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscle spasm
n1=en:muscular atrophy | n2=en:muscle spasm | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscle weakness
n1=en:muscular atrophy | n2=en:muscle weakness | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus
n1=en:muscular atrophy | n2=en:muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscular atrophy, malignant neurogenic
n1=en:muscular atrophy | n2=en:muscular atrophy, malignant neurogenic | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscular dystrophy
n1=en:muscular atrophy | n2=en:muscular dystrophy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscular rigidity
n1=en:muscular atrophy | n2=en:muscular rigidity | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:muscular wasting and disuse atrophy, nec in mdr18_1
n1=en:muscular atrophy | n2=en:muscular wasting and disuse atrophy, nec in mdr18_1 | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:musculoskeletal system disorder
n1=en:muscular atrophy | n2=en:musculoskeletal system disorder | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:myalgia
n1=en:muscular atrophy | n2=en:myalgia | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:myasthenias
n1=en:muscular atrophy | n2=en:myasthenias | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:myoglobinuria
n1=en:muscular atrophy | n2=en:myoglobinuria | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:myokymia
n1=en:muscular atrophy | n2=en:myokymia | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:myomatous neoplasm
n1=en:muscular atrophy | n2=en:myomatous neoplasm | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:myopathy
n1=en:muscular atrophy | n2=en:myopathy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:myosclerosis
n1=en:muscular atrophy | n2=en:myosclerosis | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:myositis
n1=en:muscular atrophy | n2=en:myositis | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:nathalie syndrome
n1=en:muscular atrophy | n2=en:nathalie syndrome | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:neuralgia
n1=en:muscular atrophy | n2=en:neuralgia | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:neuralgic amyotrophy
n1=en:muscular atrophy | n2=en:neuralgic amyotrophy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:neuromuscular diseases
n1=en:muscular atrophy | n2=en:neuromuscular diseases | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:neuromuscular toxicity
n1=en:muscular atrophy | n2=en:neuromuscular toxicity | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:neuropathy
n1=en:muscular atrophy | n2=en:neuropathy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:nocturnal myoclonus syndrome
n1=en:muscular atrophy | n2=en:nocturnal myoclonus syndrome | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:other disorders of muscle
n1=en:muscular atrophy | n2=en:other disorders of muscle | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:other specified disorders of muscle
n1=en:muscular atrophy | n2=en:other specified disorders of muscle | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:proximal myopathy
n1=en:muscular atrophy | n2=en:proximal myopathy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:psoas sign
n1=en:muscular atrophy | n2=en:psoas sign | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:respiratory muscle weakness
n1=en:muscular atrophy | n2=en:respiratory muscle weakness | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:rhabdomyolysis
n1=en:muscular atrophy | n2=en:rhabdomyolysis | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:sarcopenia
n1=en:muscular atrophy | n2=en:sarcopenia | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:satoyoshi syndrome
n1=en:muscular atrophy | n2=en:satoyoshi syndrome | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:skeletal myopathy
n1=en:muscular atrophy | n2=en:skeletal myopathy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:somatic dysfunction
n1=en:muscular atrophy | n2=en:somatic dysfunction | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:spinal cord
n1=en:muscular atrophy | n2=en:spinal cord | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:spinal muscular atrophy
n1=en:muscular atrophy | n2=en:spinal muscular atrophy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:strabismus
n1=en:muscular atrophy | n2=en:strabismus | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:striated muscle adaptation
n1=en:muscular atrophy | n2=en:striated muscle adaptation | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:structure of right hand
n1=en:muscular atrophy | n2=en:structure of right hand | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:swelling of skeletal muscle
n1=en:muscular atrophy | n2=en:swelling of skeletal muscle | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:symptomatic inflammatory myopathy associated with another disorder
n1=en:muscular atrophy | n2=en:symptomatic inflammatory myopathy associated with another disorder | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:temporomandibular joint dysfunction syndrome
n1=en:muscular atrophy | n2=en:temporomandibular joint dysfunction syndrome | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:tenesmus
n1=en:muscular atrophy | n2=en:tenesmus | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:tetany
n1=en:muscular atrophy | n2=en:tetany | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:thakker donnai syndrome
n1=en:muscular atrophy | n2=en:thakker donnai syndrome | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:toxic myopathy
n1=en:muscular atrophy | n2=en:toxic myopathy | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:trendelenburg's symptom
n1=en:muscular atrophy | n2=en:trendelenburg's symptom | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:uvular spasm
n1=en:muscular atrophy | n2=en:uvular spasm | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:werner syndrome
n1=en:muscular atrophy | n2=en:werner syndrome | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 220 / 0.606 ->
en:wristdrop
n1=en:muscular atrophy | n2=en:wristdrop | rel=r_associated | relid=0 | w=220
- en:muscular atrophy --
r_associated #0: 215 / 0.592 ->
atrophie musculaire
n1=en:muscular atrophy | n2=atrophie musculaire | rel=r_associated | relid=0 | w=215
- en:muscular atrophy --
r_associated #0: 215 / 0.592 ->
maladie
n1=en:muscular atrophy | n2=maladie | rel=r_associated | relid=0 | w=215
- en:muscular atrophy --
r_associated #0: 210 / 0.579 ->
atrophie des muscles
n1=en:muscular atrophy | n2=atrophie des muscles | rel=r_associated | relid=0 | w=210
- en:muscular atrophy --
r_associated #0: 205 / 0.565 ->
en:muscle atrophy
n1=en:muscular atrophy | n2=en:muscle atrophy | rel=r_associated | relid=0 | w=205
- en:muscular atrophy --
r_associated #0: 190 / 0.523 ->
fonte musculaire
n1=en:muscular atrophy | n2=fonte musculaire | rel=r_associated | relid=0 | w=190
- en:muscular atrophy --
r_associated #0: 185 / 0.51 ->
amyotrophie
n1=en:muscular atrophy | n2=amyotrophie | rel=r_associated | relid=0 | w=185
- en:muscular atrophy --
r_associated #0: 180 / 0.496 ->
amyotrophie neurogénique
n1=en:muscular atrophy | n2=amyotrophie neurogénique | rel=r_associated | relid=0 | w=180
- en:muscular atrophy --
r_associated #0: 180 / 0.496 ->
amyotrophique
n1=en:muscular atrophy | n2=amyotrophique | rel=r_associated | relid=0 | w=180
- en:muscular atrophy --
r_associated #0: 180 / 0.496 ->
atrophie musculaire neurogénique
n1=en:muscular atrophy | n2=atrophie musculaire neurogénique | rel=r_associated | relid=0 | w=180
- en:muscular atrophy --
r_associated #0: 125 / 0.344 ->
amyotrophie péronière de Charcot-Marie-Tooth combinée à l'ataxie de Friedreich
n1=en:muscular atrophy | n2=amyotrophie péronière de Charcot-Marie-Tooth combinée à l'ataxie de Friedreich | rel=r_associated | relid=0 | w=125
- en:muscular atrophy --
r_associated #0: 125 / 0.344 ->
maladie des muscles
n1=en:muscular atrophy | n2=maladie des muscles | rel=r_associated | relid=0 | w=125
- en:muscular atrophy --
r_associated #0: 117 / 0.322 ->
en:wasting
n1=en:muscular atrophy | n2=en:wasting | rel=r_associated | relid=0 | w=117
- en:muscular atrophy --
r_associated #0: 110 / 0.303 ->
en:alcoholic brain atrophy
n1=en:muscular atrophy | n2=en:alcoholic brain atrophy | rel=r_associated | relid=0 | w=110
- en:muscular atrophy --
r_associated #0: 110 / 0.303 ->
en:endocrine myopathy
n1=en:muscular atrophy | n2=en:endocrine myopathy | rel=r_associated | relid=0 | w=110
- en:muscular atrophy --
r_associated #0: 110 / 0.303 ->
en:epiphysiolysis
n1=en:muscular atrophy | n2=en:epiphysiolysis | rel=r_associated | relid=0 | w=110
- en:muscular atrophy --
r_associated #0: 110 / 0.303 ->
en:kearns-sayre syndrome
n1=en:muscular atrophy | n2=en:kearns-sayre syndrome | rel=r_associated | relid=0 | w=110
- en:muscular atrophy --
r_associated #0: 110 / 0.303 ->
en:muscle infections and inflammations
n1=en:muscular atrophy | n2=en:muscle infections and inflammations | rel=r_associated | relid=0 | w=110
- en:muscular atrophy --
r_associated #0: 110 / 0.303 ->
en:muscle tightness
n1=en:muscular atrophy | n2=en:muscle tightness | rel=r_associated | relid=0 | w=110
- en:muscular atrophy --
r_associated #0: 110 / 0.303 ->
en:myofascial spasm
n1=en:muscular atrophy | n2=en:myofascial spasm | rel=r_associated | relid=0 | w=110
- en:muscular atrophy --
r_associated #0: 110 / 0.303 ->
en:white matter
n1=en:muscular atrophy | n2=en:white matter | rel=r_associated | relid=0 | w=110
- en:muscular atrophy --
r_associated #0: 105 / 0.289 ->
en:dermatomyositis
n1=en:muscular atrophy | n2=en:dermatomyositis | rel=r_associated | relid=0 | w=105
- en:muscular atrophy --
r_associated #0: 105 / 0.289 ->
en:disorder of muscle, unspecified; site unspecified
n1=en:muscular atrophy | n2=en:disorder of muscle, unspecified; site unspecified | rel=r_associated | relid=0 | w=105
- en:muscular atrophy --
r_associated #0: 105 / 0.289 ->
en:muscle necrosis
n1=en:muscular atrophy | n2=en:muscle necrosis | rel=r_associated | relid=0 | w=105
- en:muscular atrophy --
r_associated #0: 105 / 0.289 ->
en:ptosis
n1=en:muscular atrophy | n2=en:ptosis | rel=r_associated | relid=0 | w=105
- en:muscular atrophy --
r_associated #0: 105 / 0.289 ->
en:twitching
n1=en:muscular atrophy | n2=en:twitching | rel=r_associated | relid=0 | w=105
- en:muscular atrophy --
r_associated #0: 100 / 0.275 ->
en:disorder of muscle, unspecified; multiple sites
n1=en:muscular atrophy | n2=en:disorder of muscle, unspecified; multiple sites | rel=r_associated | relid=0 | w=100
- en:muscular atrophy --
r_associated #0: 100 / 0.275 ->
en:finger
n1=en:muscular atrophy | n2=en:finger | rel=r_associated | relid=0 | w=100
- en:muscular atrophy --
r_associated #0: 100 / 0.275 ->
en:myotonic disorder
n1=en:muscular atrophy | n2=en:myotonic disorder | rel=r_associated | relid=0 | w=100
- en:muscular atrophy --
r_associated #0: 90 / 0.248 ->
en:amyotrophy (1 patient)
n1=en:muscular atrophy | n2=en:amyotrophy (1 patient) | rel=r_associated | relid=0 | w=90
- en:muscular atrophy --
r_associated #0: 90 / 0.248 ->
en:muscle wasting
n1=en:muscular atrophy | n2=en:muscle wasting | rel=r_associated | relid=0 | w=90
- en:muscular atrophy --
r_associated #0: 90 / 0.248 ->
sarcopénie
n1=en:muscular atrophy | n2=sarcopénie | rel=r_associated | relid=0 | w=90
- en:muscular atrophy --
r_associated #0: 80 / 0.22 ->
en:a subset of patients have aggravation on cold exposure ('cold paresis')
n1=en:muscular atrophy | n2=en:a subset of patients have aggravation on cold exposure ('cold paresis') | rel=r_associated | relid=0 | w=80
- en:muscular atrophy --
r_associated #0: 80 / 0.22 ->
en:ankle edema (finding)
n1=en:muscular atrophy | n2=en:ankle edema (finding) | rel=r_associated | relid=0 | w=80
- en:muscular atrophy --
r_associated #0: 80 / 0.22 ->
en:atrophic calf muscles
n1=en:muscular atrophy | n2=en:atrophic calf muscles | rel=r_associated | relid=0 | w=80
- en:muscular atrophy --
r_associated #0: 80 / 0.22 ->
en:atrophic muscle fibers
n1=en:muscular atrophy | n2=en:atrophic muscle fibers | rel=r_associated | relid=0 | w=80
- en:muscular atrophy --
r_associated #0: 80 / 0.22 ->
en:autophagic vacuoles seen on biopsy (in some patients)
n1=en:muscular atrophy | n2=en:autophagic vacuoles seen on biopsy (in some patients) | rel=r_associated | relid=0 | w=80
- en:muscular atrophy --
r_associated #0: 80 / 0.22 ->
en:autophagosome
n1=en:muscular atrophy | n2=en:autophagosome | rel=r_associated | relid=0 | w=80
- en:muscular atrophy --
r_associated #0: 80 / 0.22 ->
en:axial muscle hyperextension, episodic
n1=en:muscular atrophy | n2=en:axial muscle hyperextension, episodic | rel=r_associated | relid=0 | w=80
- en:muscular atrophy --
r_associated #0: 80 / 0.22 ->
en:axial weakness
n1=en:muscular atrophy | n2=en:axial weakness | rel=r_associated | relid=0 | w=80
- en:muscular atrophy --
r_associated #0: 77 / 0.212 ->
maladie
(médecine)
n1=en:muscular atrophy | n2=maladie (médecine) | rel=r_associated | relid=0 | w=77
- en:muscular atrophy --
r_associated #0: 71 / 0.196 ->
en:medicine
n1=en:muscular atrophy | n2=en:medicine | rel=r_associated | relid=0 | w=71
- en:muscular atrophy --
r_associated #0: 66 / 0.182 ->
atrophie musculaire, ataxie, rétinite pigmentaire et diabète sucré
n1=en:muscular atrophy | n2=atrophie musculaire, ataxie, rétinite pigmentaire et diabète sucré | rel=r_associated | relid=0 | w=66
- en:muscular atrophy --
r_associated #0: 66 / 0.182 ->
pathologie
n1=en:muscular atrophy | n2=pathologie | rel=r_associated | relid=0 | w=66
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:amyotrophy of the upper limbs (in some patients)
n1=en:muscular atrophy | n2=en:amyotrophy of the upper limbs (in some patients) | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:angioedema
n1=en:muscular atrophy | n2=en:angioedema | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:angulated atrophic fibers
n1=en:muscular atrophy | n2=en:angulated atrophic fibers | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:angulated fibers
n1=en:muscular atrophy | n2=en:angulated fibers | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:anterior tibial muscles first involved
n1=en:muscular atrophy | n2=en:anterior tibial muscles first involved | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:areflexia due to muscle weakness
n1=en:muscular atrophy | n2=en:areflexia due to muscle weakness | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:arm/shoulder muscle hypoplasia
n1=en:muscular atrophy | n2=en:arm/shoulder muscle hypoplasia | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:ascites (in some patients)
n1=en:muscular atrophy | n2=en:ascites (in some patients) | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:atrophy of ankle and toe extensor (dorsiflexor) muscles
n1=en:muscular atrophy | n2=en:atrophy of ankle and toe extensor (dorsiflexor) muscles | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:atrophy of neck muscles may occur later
n1=en:muscular atrophy | n2=en:atrophy of neck muscles may occur later | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:atrophy of the intrinsic foot and hand muscles
n1=en:muscular atrophy | n2=en:atrophy of the intrinsic foot and hand muscles | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:atrophy of the small muscles in the hands and feet
n1=en:muscular atrophy | n2=en:atrophy of the small muscles in the hands and feet | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:atrophy of type 1 and type 2 fibers
n1=en:muscular atrophy | n2=en:atrophy of type 1 and type 2 fibers | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:attacks last 4 to 24 hours
n1=en:muscular atrophy | n2=en:attacks last 4 to 24 hours | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:attacks of weakness
n1=en:muscular atrophy | n2=en:attacks of weakness | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise
n1=en:muscular atrophy | n2=en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:attacks precipitated by rest after exercise
n1=en:muscular atrophy | n2=en:attacks precipitated by rest after exercise | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:attacks usually decrease or disappear after age 40 years
n1=en:muscular atrophy | n2=en:attacks usually decrease or disappear after age 40 years | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:berardinelli-seip congenital lipodystrophy
n1=en:muscular atrophy | n2=en:berardinelli-seip congenital lipodystrophy | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:biceps brachii atrophy
n1=en:muscular atrophy | n2=en:biceps brachii atrophy | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:bilateral foot drop
n1=en:muscular atrophy | n2=en:bilateral foot drop | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:biopsy of adipose tissue shows reduced adipocyte size
n1=en:muscular atrophy | n2=en:biopsy of adipose tissue shows reduced adipocyte size | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:biopsy shows degenerative changes consistent with myopathy
n1=en:muscular atrophy | n2=en:biopsy shows degenerative changes consistent with myopathy | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:biopsy shows deposition of complement proteins c5b-9 of the membrane attack complex on muscle fibers or in vacuoles
n1=en:muscular atrophy | n2=en:biopsy shows deposition of complement proteins c5b-9 of the membrane attack complex on muscle fibers or in vacuoles | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:biopsy shows myopathic and dystrophic changes
n1=en:muscular atrophy | n2=en:biopsy shows myopathic and dystrophic changes | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:biopsy shows nonspecific myopathy without rimmed vacuoles
n1=en:muscular atrophy | n2=en:biopsy shows nonspecific myopathy without rimmed vacuoles | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:both type 1 and type 2 fiber predominance has been reported
n1=en:muscular atrophy | n2=en:both type 1 and type 2 fiber predominance has been reported | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:buffalo hump
n1=en:muscular atrophy | n2=en:buffalo hump | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:bulbar weakness
n1=en:muscular atrophy | n2=en:bulbar weakness | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:calcific tendinopathy, early-onset (in some patients)
n1=en:muscular atrophy | n2=en:calcific tendinopathy, early-onset (in some patients) | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:calf atrophy (later onset)
n1=en:muscular atrophy | n2=en:calf atrophy (later onset) | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:calf hypertrophy (in some patients)
n1=en:muscular atrophy | n2=en:calf hypertrophy (in some patients) | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:calf hypertrophy (reported in 1 family)
n1=en:muscular atrophy | n2=en:calf hypertrophy (reported in 1 family) | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:calf muscle discomfort
n1=en:muscular atrophy | n2=en:calf muscle discomfort | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:calf muscle hypertrophy
n1=en:muscular atrophy | n2=en:calf muscle hypertrophy | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:calf muscle pseudohypertrophy
n1=en:muscular atrophy | n2=en:calf muscle pseudohypertrophy | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:calf pseudohypertrophy rare
n1=en:muscular atrophy | n2=en:calf pseudohypertrophy rare | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:cardiomyopathy is not a feature
n1=en:muscular atrophy | n2=en:cardiomyopathy is not a feature | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:casq1-immunopositive inclusions
n1=en:muscular atrophy | n2=en:casq1-immunopositive inclusions | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:cellulitis or infection may occur
n1=en:muscular atrophy | n2=en:cellulitis or infection may occur | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:centralized nuclei, rare
n1=en:muscular atrophy | n2=en:centralized nuclei, rare | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 60 / 0.165 ->
en:centrally located nuclei seen on muscle biopsy
n1=en:muscular atrophy | n2=en:centrally located nuclei seen on muscle biopsy | rel=r_associated | relid=0 | w=60
- en:muscular atrophy --
r_associated #0: 55 / 0.152 ->
myo-
n1=en:muscular atrophy | n2=myo- | rel=r_associated | relid=0 | w=55
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:ambulation difficulty
n1=en:muscular atrophy | n2=en:ambulation difficulty | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:amyloid deposition in muscle fibers occurs rarely
n1=en:muscular atrophy | n2=en:amyloid deposition in muscle fibers occurs rarely | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:amyotrophy of the lower limbs (in some patients)
n1=en:muscular atrophy | n2=en:amyotrophy of the lower limbs (in some patients) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:anasarca
n1=en:muscular atrophy | n2=en:anasarca | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:angular atrophic fibers
n1=en:muscular atrophy | n2=en:angular atrophic fibers | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:angulated atrophic muscle fibers
n1=en:muscular atrophy | n2=en:angulated atrophic muscle fibers | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:apoptotic nuclei
n1=en:muscular atrophy | n2=en:apoptotic nuclei | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:areflexia of lower limbs
n1=en:muscular atrophy | n2=en:areflexia of lower limbs | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:ascending muscle weakness (beginning with feet and legs)
n1=en:muscular atrophy | n2=en:ascending muscle weakness (beginning with feet and legs) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:atrophy of anterior compartment tibial muscles
n1=en:muscular atrophy | n2=en:atrophy of anterior compartment tibial muscles | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:atrophy of shins
n1=en:muscular atrophy | n2=en:atrophy of shins | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:atrophy of the muscles in the anterior compartment of the lower leg
n1=en:muscular atrophy | n2=en:atrophy of the muscles in the anterior compartment of the lower leg | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:atrophy of the thenar and hypothenar muscles
n1=en:muscular atrophy | n2=en:atrophy of the thenar and hypothenar muscles | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:atrophy of upper girdle muscles
n1=en:muscular atrophy | n2=en:atrophy of upper girdle muscles | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:attacks may present during or after sleep
n1=en:muscular atrophy | n2=en:attacks may present during or after sleep | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:attacks precipitated by cold temperature
n1=en:muscular atrophy | n2=en:attacks precipitated by cold temperature | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:attacks precipitated by potassium
n1=en:muscular atrophy | n2=en:attacks precipitated by potassium | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:generalized muscle hypertrophy
n1=en:muscular atrophy | n2=en:generalized muscle hypertrophy | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:generalized muscle weakness
n1=en:muscular atrophy | n2=en:generalized muscle weakness | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:generalized muscle weakness (less common)
n1=en:muscular atrophy | n2=en:generalized muscle weakness (less common) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:generalized muscular appearance from birth
n1=en:muscular atrophy | n2=en:generalized muscular appearance from birth | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:giant granules in muscle cells
n1=en:muscular atrophy | n2=en:giant granules in muscle cells | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:global muscle weakness
n1=en:muscular atrophy | n2=en:global muscle weakness | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:gluteus maximus and thigh adductors most affected
n1=en:muscular atrophy | n2=en:gluteus maximus and thigh adductors most affected | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:glycogen accumulation seen on biopsy
n1=en:muscular atrophy | n2=en:glycogen accumulation seen on biopsy | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:glycogen depletion in skeletal muscle
n1=en:muscular atrophy | n2=en:glycogen depletion in skeletal muscle | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:gowers sign (in some patients)
n1=en:muscular atrophy | n2=en:gowers sign (in some patients) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:greater sartorius involvement than gracilis involvement seen on mri
n1=en:muscular atrophy | n2=en:greater sartorius involvement than gracilis involvement seen on mri | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:grip strength decreased
n1=en:muscular atrophy | n2=en:grip strength decreased | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:haemorrhage subcutaneous
n1=en:muscular atrophy | n2=en:haemorrhage subcutaneous | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:hamstring muscle affected
n1=en:muscular atrophy | n2=en:hamstring muscle affected | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:hand and foot weakness
n1=en:muscular atrophy | n2=en:hand and foot weakness | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:hand muscle atrophy
n1=en:muscular atrophy | n2=en:hand muscle atrophy | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:hang weakness
n1=en:muscular atrophy | n2=en:hang weakness | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:hematomas, recurrent large subcutaneous
n1=en:muscular atrophy | n2=en:hematomas, recurrent large subcutaneous | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:hip flexor weakness
n1=en:muscular atrophy | n2=en:hip flexor weakness | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:histochemically normal type-ii muscle fibers
n1=en:muscular atrophy | n2=en:histochemically normal type-ii muscle fibers | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:humeroperoneal weakness and atrophy
n1=en:muscular atrophy | n2=en:humeroperoneal weakness and atrophy | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:hyaline inclusion
n1=en:muscular atrophy | n2=en:hyaline inclusion | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:hyperactive deep tendon reflexes
n1=en:muscular atrophy | n2=en:hyperactive deep tendon reflexes | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neurologic regression following seizure onset
n1=en:muscular atrophy | n2=en:neurologic regression following seizure onset | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neurologic sequelae of stroke
n1=en:muscular atrophy | n2=en:neurologic sequelae of stroke | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuromuscular disturbances, progressive
n1=en:muscular atrophy | n2=en:neuromuscular disturbances, progressive | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuron loss
n1=en:muscular atrophy | n2=en:neuron loss | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuronal loss (patient a)
n1=en:muscular atrophy | n2=en:neuronal loss (patient a) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuronal loss and gliosis in the cerebral cortex
n1=en:muscular atrophy | n2=en:neuronal loss and gliosis in the cerebral cortex | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuronal loss and gliosis in the inferior olives
n1=en:muscular atrophy | n2=en:neuronal loss and gliosis in the inferior olives | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuronal loss in basal ganglia
n1=en:muscular atrophy | n2=en:neuronal loss in basal ganglia | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuronal loss in the brainstem
n1=en:muscular atrophy | n2=en:neuronal loss in the brainstem | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuronal loss in the cerebrum and cerebellum
n1=en:muscular atrophy | n2=en:neuronal loss in the cerebrum and cerebellum | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuronal loss in the hippocampus
n1=en:muscular atrophy | n2=en:neuronal loss in the hippocampus | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuronal loss in the locus ceruleus
n1=en:muscular atrophy | n2=en:neuronal loss in the locus ceruleus | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuronal loss in the striatum, cerebral cortex, and cerebellum (in some patients)
n1=en:muscular atrophy | n2=en:neuronal loss in the striatum, cerebral cortex, and cerebellum (in some patients) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuronal loss in the substantia nigra
n1=en:muscular atrophy | n2=en:neuronal loss in the substantia nigra | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuronal loss, diffuse
n1=en:muscular atrophy | n2=en:neuronal loss, diffuse | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuropathologic examination shows extensive spongiosis and gliosis
n1=en:muscular atrophy | n2=en:neuropathologic examination shows extensive spongiosis and gliosis | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuropathologic findings include leukoencephalopathy, predominantly in the upper corticospinal tract and cerebellar peduncles (initially)
n1=en:muscular atrophy | n2=en:neuropathologic findings include leukoencephalopathy, predominantly in the upper corticospinal tract and cerebellar peduncles (initially) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuropathology shows neuronal degeneration
n1=en:muscular atrophy | n2=en:neuropathology shows neuronal degeneration | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neuropathology shows severe neuronal loss in the inner granular layer of the cerebellum
n1=en:muscular atrophy | n2=en:neuropathology shows severe neuronal loss in the inner granular layer of the cerebellum | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neurophysiologic abnormalities (eeg, vep, sep)
n1=en:muscular atrophy | n2=en:neurophysiologic abnormalities (eeg, vep, sep) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:neurosarcoidosis (5-16% of patients)
n1=en:muscular atrophy | n2=en:neurosarcoidosis (5-16% of patients) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:never learn to walk (some patients)
n1=en:muscular atrophy | n2=en:never learn to walk (some patients) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:nocturnal occurrence
n1=en:muscular atrophy | n2=en:nocturnal occurrence | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:nocturnal seizures
n1=en:muscular atrophy | n2=en:nocturnal seizures | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:nocturnal sleep disruption
n1=en:muscular atrophy | n2=en:nocturnal sleep disruption | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:nodular heterotopia (less common)
n1=en:muscular atrophy | n2=en:nodular heterotopia (less common) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:nodular heterotopia of the grey matter
n1=en:muscular atrophy | n2=en:nodular heterotopia of the grey matter | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:non-purposeful arm movements, choreoathetoid-like
n1=en:muscular atrophy | n2=en:non-purposeful arm movements, choreoathetoid-like | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:nonspecific spongiform degeneration
n1=en:muscular atrophy | n2=en:nonspecific spongiform degeneration | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal cognition (reported in 1 patient who survived to age 20 years)
n1=en:muscular atrophy | n2=en:normal cognition (reported in 1 patient who survived to age 20 years) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal development (in 2 of 6 patients)
n1=en:muscular atrophy | n2=en:normal development (in 2 of 6 patients) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal development until 6-18 months
n1=en:muscular atrophy | n2=en:normal development until 6-18 months | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal early development, up to 8 to 15 months of age
n1=en:muscular atrophy | n2=en:normal early development, up to 8 to 15 months of age | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal early psychomotor development
n1=en:muscular atrophy | n2=en:normal early psychomotor development | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal initial psychomotor development
n1=en:muscular atrophy | n2=en:normal initial psychomotor development | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal intellectual function
n1=en:muscular atrophy | n2=en:normal intellectual function | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal intelligence (majority)
n1=en:muscular atrophy | n2=en:normal intelligence (majority) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal intelligence in iib
n1=en:muscular atrophy | n2=en:normal intelligence in iib | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal intelligence in most cases
n1=en:muscular atrophy | n2=en:normal intelligence in most cases | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal interictal eeg
n1=en:muscular atrophy | n2=en:normal interictal eeg | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal iq in infancy, then iq drops with age
n1=en:muscular atrophy | n2=en:normal iq in infancy, then iq drops with age | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal motor conduction studies (initially)
n1=en:muscular atrophy | n2=en:normal motor conduction studies (initially) | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal muscle strength
n1=en:muscular atrophy | n2=en:normal muscle strength | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal neurologic development in most cases
n1=en:muscular atrophy | n2=en:normal neurologic development in most cases | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:normal, timely language development
n1=en:muscular atrophy | n2=en:normal, timely language development | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 50 / 0.138 ->
en:pick's disease
n1=en:muscular atrophy | n2=en:pick's disease | rel=r_associated | relid=0 | w=50
- en:muscular atrophy --
r_associated #0: 45 / 0.124 ->
en:amyotrophy, neurogenic
n1=en:muscular atrophy | n2=en:amyotrophy, neurogenic | rel=r_associated | relid=0 | w=45
- en:muscular atrophy --
r_associated #0: 45 / 0.124 ->
en:attacks relieved by potassium administration
n1=en:muscular atrophy | n2=en:attacks relieved by potassium administration | rel=r_associated | relid=0 | w=45
- en:muscular atrophy --
r_associated #0: 45 / 0.124 ->
en:granular deposits in the sarcomeres
n1=en:muscular atrophy | n2=en:granular deposits in the sarcomeres | rel=r_associated | relid=0 | w=45
- en:muscular atrophy --
r_associated #0: 45 / 0.124 ->
en:hip girdle muscle weakness (usually presenting symptom)
n1=en:muscular atrophy | n2=en:hip girdle muscle weakness (usually presenting symptom) | rel=r_associated | relid=0 | w=45
- en:muscular atrophy --
r_associated #0: 45 / 0.124 ->
en:muscle
n1=en:muscular atrophy | n2=en:muscle | rel=r_associated | relid=0 | w=45
- en:muscular atrophy --
r_associated #0: 45 / 0.124 ->
en:myofibrosis
n1=en:muscular atrophy | n2=en:myofibrosis | rel=r_associated | relid=0 | w=45
- en:muscular atrophy --
r_associated #0: 45 / 0.124 ->
en:neuronal migration disorder
n1=en:muscular atrophy | n2=en:neuronal migration disorder | rel=r_associated | relid=0 | w=45
- en:muscular atrophy --
r_associated #0: 45 / 0.124 ->
en:normal cognition (1 patient)
n1=en:muscular atrophy | n2=en:normal cognition (1 patient) | rel=r_associated | relid=0 | w=45
- en:muscular atrophy --
r_associated #0: 45 / 0.124 ->
en:normal cognition and intellectual function
n1=en:muscular atrophy | n2=en:normal cognition and intellectual function | rel=r_associated | relid=0 | w=45
- en:muscular atrophy --
r_associated #0: 45 / 0.124 ->
en:norrie syndrome
n1=en:muscular atrophy | n2=en:norrie syndrome | rel=r_associated | relid=0 | w=45
- en:muscular atrophy --
r_associated #0: 45 / 0.124 ->
insuffisance
n1=en:muscular atrophy | n2=insuffisance | rel=r_associated | relid=0 | w=45
- en:muscular atrophy --
r_associated #0: 40 / 0.11 ->
en:albinism
n1=en:muscular atrophy | n2=en:albinism | rel=r_associated | relid=0 | w=40
- en:muscular atrophy --
r_associated #0: 40 / 0.11 ->
en:atrophia
n1=en:muscular atrophy | n2=en:atrophia | rel=r_associated | relid=0 | w=40
- en:muscular atrophy --
r_associated #0: 40 / 0.11 ->
en:macies
n1=en:muscular atrophy | n2=en:macies | rel=r_associated | relid=0 | w=40
- en:muscular atrophy --
r_associated #0: 40 / 0.11 ->
en:neuropathology shows diffuse demyelination of the cerebral white matter
n1=en:muscular atrophy | n2=en:neuropathology shows diffuse demyelination of the cerebral white matter | rel=r_associated | relid=0 | w=40
- en:muscular atrophy --
r_associated #0: 40 / 0.11 ->
en:neuropsychologic cognitive abnormalities
n1=en:muscular atrophy | n2=en:neuropsychologic cognitive abnormalities | rel=r_associated | relid=0 | w=40
- en:muscular atrophy --
r_associated #0: 35 / 0.096 ->
neuropathies diabétiques
n1=en:muscular atrophy | n2=neuropathies diabétiques | rel=r_associated | relid=0 | w=35
- en:muscular atrophy --
r_associated #0: 31 / 0.085 ->
en:deafness
n1=en:muscular atrophy | n2=en:deafness | rel=r_associated | relid=0 | w=31
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:amyotrophy
n1=en:muscular atrophy | n2=en:amyotrophy | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:bethlem myopathy 1
n1=en:muscular atrophy | n2=en:bethlem myopathy 1 | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:decreased cytochrome c oxidase activity
n1=en:muscular atrophy | n2=en:decreased cytochrome c oxidase activity | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:degenerative changes with increased connective tissue
n1=en:muscular atrophy | n2=en:degenerative changes with increased connective tissue | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:difficulty walking on heels occurs prior to difficulty walking on toes
n1=en:muscular atrophy | n2=en:difficulty walking on heels occurs prior to difficulty walking on toes | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:distal muscle weakness in lower limbs, severe
n1=en:muscular atrophy | n2=en:distal muscle weakness in lower limbs, severe | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:fiber necrosis
n1=en:muscular atrophy | n2=en:fiber necrosis | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:fiber size variation
n1=en:muscular atrophy | n2=en:fiber size variation | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:fiber type grouping
n1=en:muscular atrophy | n2=en:fiber type grouping | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:hypotonia, neonatal and later
n1=en:muscular atrophy | n2=en:hypotonia, neonatal and later | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:muscle atrophy later in the disease
n1=en:muscular atrophy | n2=en:muscle atrophy later in the disease | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:muscle atrophy restricted to the upper limb
n1=en:muscular atrophy | n2=en:muscle atrophy restricted to the upper limb | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:muscle biopsy shows fibrosis and increased connective tissue
n1=en:muscular atrophy | n2=en:muscle biopsy shows fibrosis and increased connective tissue | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:muscle weakness (in some patients)
n1=en:muscular atrophy | n2=en:muscle weakness (in some patients) | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:muscle weakness, lower limbs, during exercise
n1=en:muscular atrophy | n2=en:muscle weakness, lower limbs, during exercise | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:poor exercise tolerance
n1=en:muscular atrophy | n2=en:poor exercise tolerance | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:rectus fascia separation
n1=en:muscular atrophy | n2=en:rectus fascia separation | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:small but structurally normal cerebral cortex
n1=en:muscular atrophy | n2=en:small but structurally normal cerebral cortex | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:small cerebellum (especially vermis)
n1=en:muscular atrophy | n2=en:small cerebellum (especially vermis) | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:small rotary component may be present
n1=en:muscular atrophy | n2=en:small rotary component may be present | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:specific visual spatial processing defect
n1=en:muscular atrophy | n2=en:specific visual spatial processing defect | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:speech absent or delayed
n1=en:muscular atrophy | n2=en:speech absent or delayed | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:speech delay (1 patient)
n1=en:muscular atrophy | n2=en:speech delay (1 patient) | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:speech disability
n1=en:muscular atrophy | n2=en:speech disability | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:speech never acquired
n1=en:muscular atrophy | n2=en:speech never acquired | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:spinal neurofibromas (64%)
n1=en:muscular atrophy | n2=en:spinal neurofibromas (64%) | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:spinocerebellar tract disease in lower limbs (in adulthood)
n1=en:muscular atrophy | n2=en:spinocerebellar tract disease in lower limbs (in adulthood) | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:spongiform degeneration
n1=en:muscular atrophy | n2=en:spongiform degeneration | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:stimulation sensitive generalized myoclonus (stage 3)
n1=en:muscular atrophy | n2=en:stimulation sensitive generalized myoclonus (stage 3) | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:stoke-like lesions
n1=en:muscular atrophy | n2=en:stoke-like lesions | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:strokes due to coagulopathy
n1=en:muscular atrophy | n2=en:strokes due to coagulopathy | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:structural brain abnormalities
n1=en:muscular atrophy | n2=en:structural brain abnormalities | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:triceps weakness
n1=en:muscular atrophy | n2=en:triceps weakness | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 30 / 0.083 ->
en:vacuoles are autophagocytic
n1=en:muscular atrophy | n2=en:vacuoles are autophagocytic | rel=r_associated | relid=0 | w=30
- en:muscular atrophy --
r_associated #0: 29 / 0.08 ->
dystrophie musculaire oculopharyngée récessive
n1=en:muscular atrophy | n2=dystrophie musculaire oculopharyngée récessive | rel=r_associated | relid=0 | w=29
- en:muscular atrophy --
r_associated #0: 29 / 0.08 ->
mental
n1=en:muscular atrophy | n2=mental | rel=r_associated | relid=0 | w=29
- en:muscular atrophy --
r_associated #0: 26 / 0.072 ->
ataxie
n1=en:muscular atrophy | n2=ataxie | rel=r_associated | relid=0 | w=26
- en:muscular atrophy --
r_associated #0: 26 / 0.072 ->
diabète sucré
n1=en:muscular atrophy | n2=diabète sucré | rel=r_associated | relid=0 | w=26
- en:muscular atrophy --
r_associated #0: 26 / 0.072 ->
pigmentaire
n1=en:muscular atrophy | n2=pigmentaire | rel=r_associated | relid=0 | w=26
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
atrophie musculaire spinale de la mi-enfance et de l'adolescence
n1=en:muscular atrophy | n2=atrophie musculaire spinale de la mi-enfance et de l'adolescence | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:a subset of patients develop bilateral weakness
n1=en:muscular atrophy | n2=en:a subset of patients develop bilateral weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:abdominal muscle hypoplasia
n1=en:muscular atrophy | n2=en:abdominal muscle hypoplasia | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:abdominal wall muscle weakness (later onset)
n1=en:muscular atrophy | n2=en:abdominal wall muscle weakness (later onset) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:abnormal aggregation of mitochondria
n1=en:muscular atrophy | n2=en:abnormal aggregation of mitochondria | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:abnormal changes in the organization of the sarcolemma and the subsarcolemmal membrane cytoskeleton
n1=en:muscular atrophy | n2=en:abnormal changes in the organization of the sarcolemma and the subsarcolemmal membrane cytoskeleton | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:abnormal distribution of subcutaneous fat
n1=en:muscular atrophy | n2=en:abnormal distribution of subcutaneous fat | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:abnormal iron deposition in mitochondria
n1=en:muscular atrophy | n2=en:abnormal iron deposition in mitochondria | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:abnormal irregular myofibrillar network
n1=en:muscular atrophy | n2=en:abnormal irregular myofibrillar network | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:abnormal mitochondria
n1=en:muscular atrophy | n2=en:abnormal mitochondria | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:abnormal mitochondria in skeletal muscle biopsy
n1=en:muscular atrophy | n2=en:abnormal mitochondria in skeletal muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:abnormal mitochondria with loss of cristae
n1=en:muscular atrophy | n2=en:abnormal mitochondria with loss of cristae | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:abnormal muscle fibers with amorphous, granular, or hyaline deposits
n1=en:muscular atrophy | n2=en:abnormal muscle fibers with amorphous, granular, or hyaline deposits | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:abnormalities in myofibril organization
n1=en:muscular atrophy | n2=en:abnormalities in myofibril organization | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:absence of gamma-sarcoglycan protein
n1=en:muscular atrophy | n2=en:absence of gamma-sarcoglycan protein | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:absence of laminin alpha-2 chain in muscle
n1=en:muscular atrophy | n2=en:absence of laminin alpha-2 chain in muscle | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:absence of merosin in muscle
n1=en:muscular atrophy | n2=en:absence of merosin in muscle | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:absence of myotonia in infancy (congenital form)
n1=en:muscular atrophy | n2=en:absence of myotonia in infancy (congenital form) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:absence of necrosis
n1=en:muscular atrophy | n2=en:absence of necrosis | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:absence of spontaneous activity at birth (severe form)
n1=en:muscular atrophy | n2=en:absence of spontaneous activity at birth (severe form) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:absence of telethonin protein
n1=en:muscular atrophy | n2=en:absence of telethonin protein | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:accumulation of intrasarcoplasmic granulofilamentous aggregates that are immunoreactive to desmin and alpha-beta-crystallin
n1=en:muscular atrophy | n2=en:accumulation of intrasarcoplasmic granulofilamentous aggregates that are immunoreactive to desmin and alpha-beta-crystallin | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:acetazolamide may worsen symptoms
n1=en:muscular atrophy | n2=en:acetazolamide may worsen symptoms | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:acquire ability to walk and jump in childhood, but motor regression occurs later
n1=en:muscular atrophy | n2=en:acquire ability to walk and jump in childhood, but motor regression occurs later | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:affected muscles show atrophy
n1=en:muscular atrophy | n2=en:affected muscles show atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:amyotrophy, distal, upper and lower limbs
n1=en:muscular atrophy | n2=en:amyotrophy, distal, upper and lower limbs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:asymmetric muscle involvement
n1=en:muscular atrophy | n2=en:asymmetric muscle involvement | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:atrophic fibers
n1=en:muscular atrophy | n2=en:atrophic fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:atrophic muscle fiber on biopsy
n1=en:muscular atrophy | n2=en:atrophic muscle fiber on biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:autophagic rimmed vacuoles
n1=en:muscular atrophy | n2=en:autophagic rimmed vacuoles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:autophagic vacuoles with multilamellar structures seen on electron microscopy
n1=en:muscular atrophy | n2=en:autophagic vacuoles with multilamellar structures seen on electron microscopy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:bilateral facial weakness (congenital form)
n1=en:muscular atrophy | n2=en:bilateral facial weakness (congenital form) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:biopsy shows defects in pyruvate oxidation
n1=en:muscular atrophy | n2=en:biopsy shows defects in pyruvate oxidation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:biopsy shows dystrophic changes
n1=en:muscular atrophy | n2=en:biopsy shows dystrophic changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size
n1=en:muscular atrophy | n2=en:biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:by fourth decade, many patients need help with ambulation
n1=en:muscular atrophy | n2=en:by fourth decade, many patients need help with ambulation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:calf hypertrophy (early in the disease)
n1=en:muscular atrophy | n2=en:calf hypertrophy (early in the disease) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:calf hypertrophy (less common)
n1=en:muscular atrophy | n2=en:calf hypertrophy (less common) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:calf hypertrophy (uncommon)
n1=en:muscular atrophy | n2=en:calf hypertrophy (uncommon) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:centralized myonuclei
n1=en:muscular atrophy | n2=en:centralized myonuclei | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:centralized nuclei may be seen
n1=en:muscular atrophy | n2=en:centralized nuclei may be seen | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:changes in sarcoplasmic reticulum and t-tubules
n1=en:muscular atrophy | n2=en:changes in sarcoplasmic reticulum and t-tubules | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:congenital absence of gluteal muscles
n1=en:muscular atrophy | n2=en:congenital absence of gluteal muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:congenital myasthenic syndrome (reported in 1 patient who survived to age 20 years)
n1=en:muscular atrophy | n2=en:congenital myasthenic syndrome (reported in 1 patient who survived to age 20 years) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:congenital, nonprogressive myopathy
n1=en:muscular atrophy | n2=en:congenital, nonprogressive myopathy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:congophilic amyloid material
n1=en:muscular atrophy | n2=en:congophilic amyloid material | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:congophilic deposits
n1=en:muscular atrophy | n2=en:congophilic deposits | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:congophilic inclusions
n1=en:muscular atrophy | n2=en:congophilic inclusions | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:congophilic staining
n1=en:muscular atrophy | n2=en:congophilic staining | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:cores contain densely packed myofilaments
n1=en:muscular atrophy | n2=en:cores contain densely packed myofilaments | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:cores extend along length of muscle fiber
n1=en:muscular atrophy | n2=en:cores extend along length of muscle fiber | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:cores have abrupt borders within normal regions of the muscle fiber
n1=en:muscular atrophy | n2=en:cores have abrupt borders within normal regions of the muscle fiber | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:cores or minicores
n1=en:muscular atrophy | n2=en:cores or minicores | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:cores with lack of oxidative activity and mitochondrial depletion may also be found and extend along length of fiber
n1=en:muscular atrophy | n2=en:cores with lack of oxidative activity and mitochondrial depletion may also be found and extend along length of fiber | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:cranial muscles spared
n1=en:muscular atrophy | n2=en:cranial muscles spared | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:cytochrome c oxidase-negative fibers
n1=en:muscular atrophy | n2=en:cytochrome c oxidase-negative fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:cytoplasmic inclusion bodies (finding)
n1=en:muscular atrophy | n2=en:cytoplasmic inclusion bodies (finding) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased ability to run
n1=en:muscular atrophy | n2=en:decreased ability to run | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased activities of mitochondrial-encoded respiratory chain complexes
n1=en:muscular atrophy | n2=en:decreased activities of mitochondrial-encoded respiratory chain complexes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased activity of cytochrome c oxidase in most cases seen on muscle biopsy
n1=en:muscular atrophy | n2=en:decreased activity of cytochrome c oxidase in most cases seen on muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased activity of cytochrome c oxidase seen on muscle biopsy
n1=en:muscular atrophy | n2=en:decreased activity of cytochrome c oxidase seen on muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased activity of multiple mitochondrial respiratory complex enzymes
n1=en:muscular atrophy | n2=en:decreased activity of multiple mitochondrial respiratory complex enzymes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased adipose tissue around neck
n1=en:muscular atrophy | n2=en:decreased adipose tissue around neck | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased caveolae in muscle tissue
n1=en:muscular atrophy | n2=en:decreased caveolae in muscle tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased caveolin-3 expression on muscle biopsy
n1=en:muscular atrophy | n2=en:decreased caveolin-3 expression on muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased caveolin-3 expression seen on muscle biopsy
n1=en:muscular atrophy | n2=en:decreased caveolin-3 expression seen on muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased cytochrome c oxidase staining
n1=en:muscular atrophy | n2=en:decreased cytochrome c oxidase staining | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased distal reflexes
n1=en:muscular atrophy | n2=en:decreased distal reflexes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased endplate potential and amplitudes
n1=en:muscular atrophy | n2=en:decreased endplate potential and amplitudes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased glutamate oxidation (about 63% of normal)
n1=en:muscular atrophy | n2=en:decreased glutamate oxidation (about 63% of normal) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased glycosylation of alpha-dystroglycan
n1=en:muscular atrophy | n2=en:decreased glycosylation of alpha-dystroglycan | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased hand grip strength
n1=en:muscular atrophy | n2=en:decreased hand grip strength | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased immunostaining for alpha-sarcoglycan
n1=en:muscular atrophy | n2=en:decreased immunostaining for alpha-sarcoglycan | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased lactate clearance from muscle after exercise (reported in 1 patient)
n1=en:muscular atrophy | n2=en:decreased lactate clearance from muscle after exercise (reported in 1 patient) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased lipoic acid
n1=en:muscular atrophy | n2=en:decreased lipoic acid | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased mitochondria
n1=en:muscular atrophy | n2=en:decreased mitochondria | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased muscle action potential after warming affected muscle
n1=en:muscular atrophy | n2=en:decreased muscle action potential after warming affected muscle | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased muscle bulk
n1=en:muscular atrophy | n2=en:decreased muscle bulk | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased muscle density on imaging
n1=en:muscular atrophy | n2=en:decreased muscle density on imaging | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased muscle mass
n1=en:muscular atrophy | n2=en:decreased muscle mass | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased muscle mass (especially in lower limbs)
n1=en:muscular atrophy | n2=en:decreased muscle mass (especially in lower limbs) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased muscle mitochondrial aconitase
n1=en:muscular atrophy | n2=en:decreased muscle mitochondrial aconitase | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased muscle succinate dehydrogenase
n1=en:muscular atrophy | n2=en:decreased muscle succinate dehydrogenase | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased or patchy amounts of alpha-dystrobrevin and beta-2-syntrophin at the sarcolemma
n1=en:muscular atrophy | n2=en:decreased or patchy amounts of alpha-dystrobrevin and beta-2-syntrophin at the sarcolemma | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased postsynaptic length
n1=en:muscular atrophy | n2=en:decreased postsynaptic length | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased shank muscle mass
n1=en:muscular atrophy | n2=en:decreased shank muscle mass | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decreased thiamine pyrophosphate
n1=en:muscular atrophy | n2=en:decreased thiamine pyrophosphate | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:decremental response to repetitive stimulation at neuromuscular junction
n1=en:muscular atrophy | n2=en:decremental response to repetitive stimulation at neuromuscular junction | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:deep finger muscle weakness
n1=en:muscular atrophy | n2=en:deep finger muscle weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:defective mitochondrial oxidative phosphorylation of multiple enzymes
n1=en:muscular atrophy | n2=en:defective mitochondrial oxidative phosphorylation of multiple enzymes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:degenerating fibers
n1=en:muscular atrophy | n2=en:degenerating fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:degenerating nerve terminals
n1=en:muscular atrophy | n2=en:degenerating nerve terminals | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:deltoid muscle hypoplasia
n1=en:muscular atrophy | n2=en:deltoid muscle hypoplasia | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:dense membranous structure surrounding nuclei on electron microscopy
n1=en:muscular atrophy | n2=en:dense membranous structure surrounding nuclei on electron microscopy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:denuded postsynaptic regions
n1=en:muscular atrophy | n2=en:denuded postsynaptic regions | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:dependent edema after excess fat has been present for several years
n1=en:muscular atrophy | n2=en:dependent edema after excess fat has been present for several years | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:deposits immunoreactive to beta-amyloid protein
n1=en:muscular atrophy | n2=en:deposits immunoreactive to beta-amyloid protein | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:difficulty climbing stairs, jumping, running
n1=en:muscular atrophy | n2=en:difficulty climbing stairs, jumping, running | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:difficulty in toe walking
n1=en:muscular atrophy | n2=en:difficulty in toe walking | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:difficulty rising from a squatting position
n1=en:muscular atrophy | n2=en:difficulty rising from a squatting position | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:difficulty rising from chair
n1=en:muscular atrophy | n2=en:difficulty rising from chair | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:difficulty running or inability to run
n1=en:muscular atrophy | n2=en:difficulty running or inability to run | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:difficulty walking, running, climbing stairs
n1=en:muscular atrophy | n2=en:difficulty walking, running, climbing stairs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:disorganization of the myofibrillar pattern
n1=en:muscular atrophy | n2=en:disorganization of the myofibrillar pattern | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:disorganization of the neuromuscular junction
n1=en:muscular atrophy | n2=en:disorganization of the neuromuscular junction | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal atrophy of the legs
n1=en:muscular atrophy | n2=en:distal atrophy of the legs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal leg muscle atrophy
n1=en:muscular atrophy | n2=en:distal leg muscle atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal limb muscle atrophy (less common)
n1=en:muscular atrophy | n2=en:distal limb muscle atrophy (less common) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal limb muscle weakness (less common)
n1=en:muscular atrophy | n2=en:distal limb muscle weakness (less common) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal limb muscle weakness and atrophy
n1=en:muscular atrophy | n2=en:distal limb muscle weakness and atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal limb muscle weakness occurs later
n1=en:muscular atrophy | n2=en:distal limb muscle weakness occurs later | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal lower limb amyotrophy
n1=en:muscular atrophy | n2=en:distal lower limb amyotrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal lower limb muscle weakness and atrophy
n1=en:muscular atrophy | n2=en:distal lower limb muscle weakness and atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle atrophy (lower limbs more affected than upper limbs)
n1=en:muscular atrophy | n2=en:distal muscle atrophy (lower limbs more affected than upper limbs) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle atrophy due to denervation
n1=en:muscular atrophy | n2=en:distal muscle atrophy due to denervation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle atrophy due to neurologic disease
n1=en:muscular atrophy | n2=en:distal muscle atrophy due to neurologic disease | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle atrophy due to neuropathy
n1=en:muscular atrophy | n2=en:distal muscle atrophy due to neuropathy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle atrophy, affecting the lower limbs
n1=en:muscular atrophy | n2=en:distal muscle atrophy, affecting the lower limbs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle weakness (first affects anterior leg muscles, then posterior leg muscles)
n1=en:muscular atrophy | n2=en:distal muscle weakness (first affects anterior leg muscles, then posterior leg muscles) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle weakness and atrophy
n1=en:muscular atrophy | n2=en:distal muscle weakness and atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle weakness and atrophy may occur, upper and lower limbs affected
n1=en:muscular atrophy | n2=en:distal muscle weakness and atrophy may occur, upper and lower limbs affected | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle weakness due to neuropathy
n1=en:muscular atrophy | n2=en:distal muscle weakness due to neuropathy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle weakness may occur
n1=en:muscular atrophy | n2=en:distal muscle weakness may occur | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle weakness occurs later
n1=en:muscular atrophy | n2=en:distal muscle weakness occurs later | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle weakness, affecting the lower limbs
n1=en:muscular atrophy | n2=en:distal muscle weakness, affecting the lower limbs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle weakness, mild
n1=en:muscular atrophy | n2=en:distal muscle weakness, mild | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscle weakness, occurs initially
n1=en:muscular atrophy | n2=en:distal muscle weakness, occurs initially | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal muscles may be affected
n1=en:muscular atrophy | n2=en:distal muscles may be affected | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:distal weakness, upper and lower limbs (variable)
n1=en:muscular atrophy | n2=en:distal weakness, upper and lower limbs (variable) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:dorsal and flexor muscles of the forearm are involved
n1=en:muscular atrophy | n2=en:dorsal and flexor muscles of the forearm are involved | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:dystrophic changes
n1=en:muscular atrophy | n2=en:dystrophic changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:dystrophic changes may be present
n1=en:muscular atrophy | n2=en:dystrophic changes may be present | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:dystrophic changes occur later
n1=en:muscular atrophy | n2=en:dystrophic changes occur later | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:dystrophic changes on biopsy
n1=en:muscular atrophy | n2=en:dystrophic changes on biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:dystrophic changes seen on muscle biopsy
n1=en:muscular atrophy | n2=en:dystrophic changes seen on muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:dystrophic changes seen on skeletal muscle biopsy
n1=en:muscular atrophy | n2=en:dystrophic changes seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:dystrophic features
n1=en:muscular atrophy | n2=en:dystrophic features | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:easy bruisability of lower extremities
n1=en:muscular atrophy | n2=en:easy bruisability of lower extremities | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:edema (hands and feet)
n1=en:muscular atrophy | n2=en:edema (hands and feet) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:edema at birth
n1=en:muscular atrophy | n2=en:edema at birth | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:edema is present at birth and then slowly decreases
n1=en:muscular atrophy | n2=en:edema is present at birth and then slowly decreases | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:edema reoccurs with infections
n1=en:muscular atrophy | n2=en:edema reoccurs with infections | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:edema, subcutaneous, generalized
n1=en:muscular atrophy | n2=en:edema, subcutaneous, generalized | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:electromyographic decrements in some muscles
n1=en:muscular atrophy | n2=en:electromyographic decrements in some muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:electromyography shows myotonic discharges
n1=en:muscular atrophy | n2=en:electromyography shows myotonic discharges | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:electron microscopy shows abnormal mitochondria with disorganized and vacuolated cristae
n1=en:muscular atrophy | n2=en:electron microscopy shows abnormal mitochondria with disorganized and vacuolated cristae | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:electron microscopy shows subsarcolemmal accumulations of abnormally shaped mitochondria
n1=en:muscular atrophy | n2=en:electron microscopy shows subsarcolemmal accumulations of abnormally shaped mitochondria | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:endomysial fibrosis
n1=en:muscular atrophy | n2=en:endomysial fibrosis | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:enlarged mitochondria
n1=en:muscular atrophy | n2=en:enlarged mitochondria | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:eosinophilic inclusions
n1=en:muscular atrophy | n2=en:eosinophilic inclusions | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:episodic weakness may or may not occur independent of myotonia
n1=en:muscular atrophy | n2=en:episodic weakness may or may not occur independent of myotonia | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:episodic, nonpruritic, nonurticarial, nonpitting edema
n1=en:muscular atrophy | n2=en:episodic, nonpruritic, nonurticarial, nonpitting edema | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:excess fat, symmetrically located in buttocks and lower extremities to ankles
n1=en:muscular atrophy | n2=en:excess fat, symmetrically located in buttocks and lower extremities to ankles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:exercise intolerance (also seen in some heterozygotes)
n1=en:muscular atrophy | n2=en:exercise intolerance (also seen in some heterozygotes) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:exercise intolerance (less common)
n1=en:muscular atrophy | n2=en:exercise intolerance (less common) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:exercise-induced muscle fatigue
n1=en:muscular atrophy | n2=en:exercise-induced muscle fatigue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:exercise-induced muscle stiffness
n1=en:muscular atrophy | n2=en:exercise-induced muscle stiffness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:exercise-induced weakness
n1=en:muscular atrophy | n2=en:exercise-induced weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:exertional fatigue
n1=en:muscular atrophy | n2=en:exertional fatigue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:extensor muscle weakness more severe than flexor muscle weakness
n1=en:muscular atrophy | n2=en:extensor muscle weakness more severe than flexor muscle weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:facial muscle weakness and atrophy, progressive
n1=en:muscular atrophy | n2=en:facial muscle weakness and atrophy, progressive | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:fasciculations (less common)
n1=en:muscular atrophy | n2=en:fasciculations (less common) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:fat pad anterior to malleolus
n1=en:muscular atrophy | n2=en:fat pad anterior to malleolus | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:fatty infiltration of affected muscles
n1=en:muscular atrophy | n2=en:fatty infiltration of affected muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:fatty replacement
n1=en:muscular atrophy | n2=en:fatty replacement | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:fiber size variation seen on muscle biopsy
n1=en:muscular atrophy | n2=en:fiber size variation seen on muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:fibrillations in affected muscles
n1=en:muscular atrophy | n2=en:fibrillations in affected muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:finger and wrist extensor weakness
n1=en:muscular atrophy | n2=en:finger and wrist extensor weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:firm muscles
n1=en:muscular atrophy | n2=en:firm muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:flaccid weakness or paralysis, episodic attacks
n1=en:muscular atrophy | n2=en:flaccid weakness or paralysis, episodic attacks | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:foot dorsiflexor weakness
n1=en:muscular atrophy | n2=en:foot dorsiflexor weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:foot extensor muscle weakness (later onset)
n1=en:muscular atrophy | n2=en:foot extensor muscle weakness (later onset) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:gait abnormalities (occurs later)
n1=en:muscular atrophy | n2=en:gait abnormalities (occurs later) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:gastrocnemius and soleus muscles most affected
n1=en:muscular atrophy | n2=en:gastrocnemius and soleus muscles most affected | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:generalized amyoplasia
n1=en:muscular atrophy | n2=en:generalized amyoplasia | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:generalized limb muscle atrophy
n1=en:muscular atrophy | n2=en:generalized limb muscle atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:generalized muscle wasting
n1=en:muscular atrophy | n2=en:generalized muscle wasting | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:generalized muscle weakness, proximal and distal
n1=en:muscular atrophy | n2=en:generalized muscle weakness, proximal and distal | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:generalized neonatal hypotonia
n1=en:muscular atrophy | n2=en:generalized neonatal hypotonia | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:gluteal hypoplasia
n1=en:muscular atrophy | n2=en:gluteal hypoplasia | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:glycogenosis of skeletal muscle, mild (in some patients)
n1=en:muscular atrophy | n2=en:glycogenosis of skeletal muscle, mild (in some patients) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hamstring and quadriceps muscles mildly affected
n1=en:muscular atrophy | n2=en:hamstring and quadriceps muscles mildly affected | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:handgrip myotonia
n1=en:muscular atrophy | n2=en:handgrip myotonia | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hangrip myotonia
n1=en:muscular atrophy | n2=en:hangrip myotonia | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:heterotopic bone formation in subcutaneous fat
n1=en:muscular atrophy | n2=en:heterotopic bone formation in subcutaneous fat | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hip abductor weakness and atrophy
n1=en:muscular atrophy | n2=en:hip abductor weakness and atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hip girdle muscle atrophy
n1=en:muscular atrophy | n2=en:hip girdle muscle atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hyaline plaques with absent oxidative activity
n1=en:muscular atrophy | n2=en:hyaline plaques with absent oxidative activity | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypertonia at birth
n1=en:muscular atrophy | n2=en:hypertonia at birth | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypertrophy of calves (in 3 of 6 patients)
n1=en:muscular atrophy | n2=en:hypertrophy of calves (in 3 of 6 patients) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypertrophy of the extensor digitorum brevis muscles
n1=en:muscular atrophy | n2=en:hypertrophy of the extensor digitorum brevis muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypoglycosylation of alpha-dystroglycan seen on muscle biopsy
n1=en:muscular atrophy | n2=en:hypoglycosylation of alpha-dystroglycan seen on muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypoplasia of cervical paravertebral muscles
n1=en:muscular atrophy | n2=en:hypoplasia of cervical paravertebral muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypoplasia of serratus anterior muscle
n1=en:muscular atrophy | n2=en:hypoplasia of serratus anterior muscle | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypoplasia of supraspinatus muscle
n1=en:muscular atrophy | n2=en:hypoplasia of supraspinatus muscle | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypoplasia of the hand muscles (29%)
n1=en:muscular atrophy | n2=en:hypoplasia of the hand muscles (29%) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hyporeflexia in affected muscles
n1=en:muscular atrophy | n2=en:hyporeflexia in affected muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypothenar muscle atrophy
n1=en:muscular atrophy | n2=en:hypothenar muscle atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypotonia (2 patients)
n1=en:muscular atrophy | n2=en:hypotonia (2 patients) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypotonia (45%)
n1=en:muscular atrophy | n2=en:hypotonia (45%) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypotonia (untreated hypothyroidism)
n1=en:muscular atrophy | n2=en:hypotonia (untreated hypothyroidism) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypotonia, truncal and appendicular
n1=en:muscular atrophy | n2=en:hypotonia, truncal and appendicular | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:hypotrophy of type 1 fibers
n1=en:muscular atrophy | n2=en:hypotrophy of type 1 fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:imaging shows muscle atrophy and fatty replacement
n1=en:muscular atrophy | n2=en:imaging shows muscle atrophy and fatty replacement | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:imaging shows progressive fatty infiltration of muscle
n1=en:muscular atrophy | n2=en:imaging shows progressive fatty infiltration of muscle | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:inability to jump or squat
n1=en:muscular atrophy | n2=en:inability to jump or squat | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:inability to stand on tiptoes
n1=en:muscular atrophy | n2=en:inability to stand on tiptoes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:inclusion body myopathy
n1=en:muscular atrophy | n2=en:inclusion body myopathy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased adipose fibrosis
n1=en:muscular atrophy | n2=en:increased adipose fibrosis | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased central nucleation
n1=en:muscular atrophy | n2=en:increased central nucleation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased centralized internal nuclei
n1=en:muscular atrophy | n2=en:increased centralized internal nuclei | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased connective tissue
n1=en:muscular atrophy | n2=en:increased connective tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased connective tissue and fat in muscles
n1=en:muscular atrophy | n2=en:increased connective tissue and fat in muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased endo- and perimysial connective tissue
n1=en:muscular atrophy | n2=en:increased endo- and perimysial connective tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased endomysial connective tissue around muscle fibers
n1=en:muscular atrophy | n2=en:increased endomysial connective tissue around muscle fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased fatigue
n1=en:muscular atrophy | n2=en:increased fatigue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased fatty and connective tissue in skeletal muscle
n1=en:muscular atrophy | n2=en:increased fatty and connective tissue in skeletal muscle | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased fatty infiltration
n1=en:muscular atrophy | n2=en:increased fatty infiltration | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased glycogen
n1=en:muscular atrophy | n2=en:increased glycogen | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased internal nuclei
n1=en:muscular atrophy | n2=en:increased internal nuclei | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased internal nuclei in skeletal muscle fibers
n1=en:muscular atrophy | n2=en:increased internal nuclei in skeletal muscle fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased intraabdominal fat
n1=en:muscular atrophy | n2=en:increased intraabdominal fat | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased intramuscular fat
n1=en:muscular atrophy | n2=en:increased intramuscular fat | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased lipid droplets and abnormal mitochondria
n1=en:muscular atrophy | n2=en:increased lipid droplets and abnormal mitochondria | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased lysosomal glycogen
n1=en:muscular atrophy | n2=en:increased lysosomal glycogen | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased muscle glycogen content
n1=en:muscular atrophy | n2=en:increased muscle glycogen content | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased muscle lipid content
n1=en:muscular atrophy | n2=en:increased muscle lipid content | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased numbers of type 1 fibers
n1=en:muscular atrophy | n2=en:increased numbers of type 1 fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased perisarcolemmal calcium deposition
n1=en:muscular atrophy | n2=en:increased perisarcolemmal calcium deposition | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased staining for myotilin, dystrophin, desmin
n1=en:muscular atrophy | n2=en:increased staining for myotilin, dystrophin, desmin | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased subcutaneous truncal adipose tissue
n1=en:muscular atrophy | n2=en:increased subcutaneous truncal adipose tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased variability in muscle fiber diameter
n1=en:muscular atrophy | n2=en:increased variability in muscle fiber diameter | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased variation in fiber size seen on muscle biopsy
n1=en:muscular atrophy | n2=en:increased variation in fiber size seen on muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:increased variation in muscle fiber diameter
n1=en:muscular atrophy | n2=en:increased variation in muscle fiber diameter | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:indentations or folds of the sarcolemma are connected to the membranes enclosing the vacuoles
n1=en:muscular atrophy | n2=en:indentations or folds of the sarcolemma are connected to the membranes enclosing the vacuoles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:independent walking may not be achieved
n1=en:muscular atrophy | n2=en:independent walking may not be achieved | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:inflammatory cells absent
n1=en:muscular atrophy | n2=en:inflammatory cells absent | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:interfibrillar and subsarcolemmal vacuoles
n1=en:muscular atrophy | n2=en:interfibrillar and subsarcolemmal vacuoles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:intermyofibrillar and subsarcolemmal granulofilamentous protein aggregates
n1=en:muscular atrophy | n2=en:intermyofibrillar and subsarcolemmal granulofilamentous protein aggregates | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:internal nuclei
n1=en:muscular atrophy | n2=en:internal nuclei | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:interosseus muscles involved
n1=en:muscular atrophy | n2=en:interosseus muscles involved | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:intrasarcoplasmic dense granulofilamentous aggregates that are immunoreactive with desmin
n1=en:muscular atrophy | n2=en:intrasarcoplasmic dense granulofilamentous aggregates that are immunoreactive with desmin | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:involves upper and lower proximal muscles
n1=en:muscular atrophy | n2=en:involves upper and lower proximal muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:large hypertrophied fibers
n1=en:muscular atrophy | n2=en:large hypertrophied fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:large lipid droplets
n1=en:muscular atrophy | n2=en:large lipid droplets | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:leg cramps may occur with exercise
n1=en:muscular atrophy | n2=en:leg cramps may occur with exercise | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:levator palpebrae superioris atrophy
n1=en:muscular atrophy | n2=en:levator palpebrae superioris atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:limb muscle weakness, proximal, upper and lower
n1=en:muscular atrophy | n2=en:limb muscle weakness, proximal, upper and lower | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:limb weakness and atrophy
n1=en:muscular atrophy | n2=en:limb weakness and atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:limb-girdle muscle atrophy
n1=en:muscular atrophy | n2=en:limb-girdle muscle atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:limb-girdle muscle weakness, proximal, upper greater than lower
n1=en:muscular atrophy | n2=en:limb-girdle muscle weakness, proximal, upper greater than lower | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:limb-girdle myopathy
n1=en:muscular atrophy | n2=en:limb-girdle myopathy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lipid droplet accumulation
n1=en:muscular atrophy | n2=en:lipid droplet accumulation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lipoatrophy (lower face, upper limb, buttock)
n1=en:muscular atrophy | n2=en:lipoatrophy (lower face, upper limb, buttock) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lipoatrophy of trunk
n1=en:muscular atrophy | n2=en:lipoatrophy of trunk | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lipoatrophy, generalized
n1=en:muscular atrophy | n2=en:lipoatrophy, generalized | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lipodystrophy (in some patients)
n1=en:muscular atrophy | n2=en:lipodystrophy (in some patients) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lipodystrophy, generalized, panniculitis-induced (in some)
n1=en:muscular atrophy | n2=en:lipodystrophy, generalized, panniculitis-induced (in some) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lipohypoplasia, regional
n1=en:muscular atrophy | n2=en:lipohypoplasia, regional | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lipomas or lipomatous masses (most cases)
n1=en:muscular atrophy | n2=en:lipomas or lipomatous masses (most cases) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:loss of ability to walk in early childhood
n1=en:muscular atrophy | n2=en:loss of ability to walk in early childhood | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:loss of adipose tissue occurs around puberty
n1=en:muscular atrophy | n2=en:loss of adipose tissue occurs around puberty | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:loss of ambulation between third and sixth decade
n1=en:muscular atrophy | n2=en:loss of ambulation between third and sixth decade | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:loss of antigravity strength
n1=en:muscular atrophy | n2=en:loss of antigravity strength | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:loss of gluteal adipose tissue
n1=en:muscular atrophy | n2=en:loss of gluteal adipose tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:loss of independent ambulation around age 12 years
n1=en:muscular atrophy | n2=en:loss of independent ambulation around age 12 years | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:loss of subcutaneous adipose tissue from gluteal region
n1=en:muscular atrophy | n2=en:loss of subcutaneous adipose tissue from gluteal region | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:loss of subcutaneous adipose tissue from upper limbs and trunk
n1=en:muscular atrophy | n2=en:loss of subcutaneous adipose tissue from upper limbs and trunk | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:loss of subcutaneous adipose tissue in limbs
n1=en:muscular atrophy | n2=en:loss of subcutaneous adipose tissue in limbs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:loss of subcutaneous adipose tissue primarily in gluteal region and lower limbs
n1=en:muscular atrophy | n2=en:loss of subcutaneous adipose tissue primarily in gluteal region and lower limbs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:loss of subcutaneous fat, generalized
n1=en:muscular atrophy | n2=en:loss of subcutaneous fat, generalized | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:loss of truncal subcutaneous adipose tissue
n1=en:muscular atrophy | n2=en:loss of truncal subcutaneous adipose tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:low muscle mass
n1=en:muscular atrophy | n2=en:low muscle mass | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lymphangitis, episodic
n1=en:muscular atrophy | n2=en:lymphangitis, episodic | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lymphedema (lower limb)
n1=en:muscular atrophy | n2=en:lymphedema (lower limb) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lymphedema of the extremities
n1=en:muscular atrophy | n2=en:lymphedema of the extremities | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lymphedema of the hands (in some patients)
n1=en:muscular atrophy | n2=en:lymphedema of the hands (in some patients) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lymphedema of the lower limbs (swelling is confined to below the knees)
n1=en:muscular atrophy | n2=en:lymphedema of the lower limbs (swelling is confined to below the knees) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lymphedema, dorsa of feet
n1=en:muscular atrophy | n2=en:lymphedema, dorsa of feet | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lymphedema, hands (rare)
n1=en:muscular atrophy | n2=en:lymphedema, hands (rare) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lymphedema, of upper and/or lower extremity (rare)
n1=en:muscular atrophy | n2=en:lymphedema, of upper and/or lower extremity (rare) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lymphography shows hypoplasia of lymphatic vessels
n1=en:muscular atrophy | n2=en:lymphography shows hypoplasia of lymphatic vessels | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:lymphography shows increased number of dilated lymphatic vessels (hyperplasia)
n1=en:muscular atrophy | n2=en:lymphography shows increased number of dilated lymphatic vessels (hyperplasia) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:mallory-like bodies
n1=en:muscular atrophy | n2=en:mallory-like bodies | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:marked lack of adipose tissue
n1=en:muscular atrophy | n2=en:marked lack of adipose tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:marked loss of subcutaneous fat in the limbs, face, and sometimes chest
n1=en:muscular atrophy | n2=en:marked loss of subcutaneous fat in the limbs, face, and sometimes chest | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:marked muscular hypertrophy
n1=en:muscular atrophy | n2=en:marked muscular hypertrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:marked predominance of slow-twitch, oxidative (type 1) muscle fibers
n1=en:muscular atrophy | n2=en:marked predominance of slow-twitch, oxidative (type 1) muscle fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:merosin-positive biopsy
n1=en:muscular atrophy | n2=en:merosin-positive biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:mild muscle atrophy in forearm muscles
n1=en:muscular atrophy | n2=en:mild muscle atrophy in forearm muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:mild variability in muscle fiber size
n1=en:muscular atrophy | n2=en:mild variability in muscle fiber size | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:mild weakness
n1=en:muscular atrophy | n2=en:mild weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:mild weakness of the small hand muscles
n1=en:muscular atrophy | n2=en:mild weakness of the small hand muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:minicore regions are poorly defined and do not extend through entire fiber length
n1=en:muscular atrophy | n2=en:minicore regions are poorly defined and do not extend through entire fiber length | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:minicore-like lesions with mitochondrial depletion and sarcomeric disorganization
n1=en:muscular atrophy | n2=en:minicore-like lesions with mitochondrial depletion and sarcomeric disorganization | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:minicores extend full fiber diameter
n1=en:muscular atrophy | n2=en:minicores extend full fiber diameter | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:minimal subcutaneous fat
n1=en:muscular atrophy | n2=en:minimal subcutaneous fat | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:minipolymyoclonus
n1=en:muscular atrophy | n2=en:minipolymyoclonus | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:mitochondria are placed at the periphery of muscle fibers
n1=en:muscular atrophy | n2=en:mitochondria are placed at the periphery of muscle fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:mitochondria show paracrystalline inclusions
n1=en:muscular atrophy | n2=en:mitochondria show paracrystalline inclusions | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:mitochondrial paracrystalline inclusion bodies
n1=en:muscular atrophy | n2=en:mitochondrial paracrystalline inclusion bodies | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:mitochondrial proliferation
n1=en:muscular atrophy | n2=en:mitochondrial proliferation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:motor clumsiness
n1=en:muscular atrophy | n2=en:motor clumsiness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle aches, intermittent
n1=en:muscular atrophy | n2=en:muscle aches, intermittent | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle atrophy (variable)
n1=en:muscular atrophy | n2=en:muscle atrophy (variable) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle atrophy affecting the upper back and neck muscles
n1=en:muscular atrophy | n2=en:muscle atrophy affecting the upper back and neck muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle atrophy appears later in disease course
n1=en:muscular atrophy | n2=en:muscle atrophy appears later in disease course | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle atrophy in the limbs
n1=en:muscular atrophy | n2=en:muscle atrophy in the limbs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle atrophy, especially quadriceps and forearm muscles
n1=en:muscular atrophy | n2=en:muscle atrophy, especially quadriceps and forearm muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle atrophy, limb-girdle and proximal
n1=en:muscular atrophy | n2=en:muscle atrophy, limb-girdle and proximal | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle atrophy, mild, more proximal than distal
n1=en:muscular atrophy | n2=en:muscle atrophy, mild, more proximal than distal | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle atrophy, progressive
n1=en:muscular atrophy | n2=en:muscle atrophy, progressive | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy in acute stage shows increased numbers of abnormal mitochondria
n1=en:muscular atrophy | n2=en:muscle biopsy in acute stage shows increased numbers of abnormal mitochondria | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy is immunopositive for merosin (156225)
n1=en:muscular atrophy | n2=en:muscle biopsy is immunopositive for merosin (156225) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy may show inflammatory changes
n1=en:muscular atrophy | n2=en:muscle biopsy may show inflammatory changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows 60-80-nm tubular aggregates arranged in hexagonal arrays in type 2 fibers
n1=en:muscular atrophy | n2=en:muscle biopsy shows 60-80-nm tubular aggregates arranged in hexagonal arrays in type 2 fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows abnormal fiber size and variation
n1=en:muscular atrophy | n2=en:muscle biopsy shows abnormal fiber size and variation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows abnormal mitochondria
n1=en:muscular atrophy | n2=en:muscle biopsy shows abnormal mitochondria | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows centralized nuclei
n1=en:muscular atrophy | n2=en:muscle biopsy shows centralized nuclei | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows chronic and active denervation
n1=en:muscular atrophy | n2=en:muscle biopsy shows chronic and active denervation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows core-like regions devoid of oxidative activity
n1=en:muscular atrophy | n2=en:muscle biopsy shows core-like regions devoid of oxidative activity | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows decrease or absence of cytochrome c oxidase
n1=en:muscular atrophy | n2=en:muscle biopsy shows decrease or absence of cytochrome c oxidase | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows decreased activity of cytochrome c oxidase
n1=en:muscular atrophy | n2=en:muscle biopsy shows decreased activity of cytochrome c oxidase | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows decreased muscle-specific phosphorylase kinase activity
n1=en:muscular atrophy | n2=en:muscle biopsy shows decreased muscle-specific phosphorylase kinase activity | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows decreased or absent dysferlin staining
n1=en:muscular atrophy | n2=en:muscle biopsy shows decreased or absent dysferlin staining | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows degenerating endplates and junctional folds
n1=en:muscular atrophy | n2=en:muscle biopsy shows degenerating endplates and junctional folds | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows degeneration of muscle fibers, variation in fiber size, fiber splitting, rimmed vacuoles, and central myonuclei
n1=en:muscular atrophy | n2=en:muscle biopsy shows degeneration of muscle fibers, variation in fiber size, fiber splitting, rimmed vacuoles, and central myonuclei | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows disruption of the sarcolemmal membrane
n1=en:muscular atrophy | n2=en:muscle biopsy shows disruption of the sarcolemmal membrane | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows dystrophic changes
n1=en:muscular atrophy | n2=en:muscle biopsy shows dystrophic changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows dystrophic features
n1=en:muscular atrophy | n2=en:muscle biopsy shows dystrophic features | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows dystrophic pattern
n1=en:muscular atrophy | n2=en:muscle biopsy shows dystrophic pattern | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows fiber type disproportion
n1=en:muscular atrophy | n2=en:muscle biopsy shows fiber type disproportion | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows glycogen accumulation in myofibrils and lysosomes
n1=en:muscular atrophy | n2=en:muscle biopsy shows glycogen accumulation in myofibrils and lysosomes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows glycogen storage
n1=en:muscular atrophy | n2=en:muscle biopsy shows glycogen storage | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows hypotrophy of type 1 muscle fibers
n1=en:muscular atrophy | n2=en:muscle biopsy shows hypotrophy of type 1 muscle fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows increased subsarcolemmal vacuolar glycogen accumulation
n1=en:muscular atrophy | n2=en:muscle biopsy shows increased subsarcolemmal vacuolar glycogen accumulation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows increased variation in fiber size
n1=en:muscular atrophy | n2=en:muscle biopsy shows increased variation in fiber size | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows intranuclear tubulofilamentous inclusions
n1=en:muscular atrophy | n2=en:muscle biopsy shows intranuclear tubulofilamentous inclusions | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows lipid deposition
n1=en:muscular atrophy | n2=en:muscle biopsy shows lipid deposition | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows loss of myofibrillar organization
n1=en:muscular atrophy | n2=en:muscle biopsy shows loss of myofibrillar organization | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows merosin (156225)-positive muscle fibers
n1=en:muscular atrophy | n2=en:muscle biopsy shows merosin (156225)-positive muscle fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows mild dystrophic changes
n1=en:muscular atrophy | n2=en:muscle biopsy shows mild dystrophic changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows mitochondrial paracrystalline inclusions
n1=en:muscular atrophy | n2=en:muscle biopsy shows mitochondrial paracrystalline inclusions | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows myodegenerative changes with beta-amyloid and phosphorylated tau deposits
n1=en:muscular atrophy | n2=en:muscle biopsy shows myodegenerative changes with beta-amyloid and phosphorylated tau deposits | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows myofiber degeneration
n1=en:muscular atrophy | n2=en:muscle biopsy shows myofiber degeneration | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows myofibrillar changes
n1=en:muscular atrophy | n2=en:muscle biopsy shows myofibrillar changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows myofibrillar disruption
n1=en:muscular atrophy | n2=en:muscle biopsy shows myofibrillar disruption | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows myofibrillar myopathy
n1=en:muscular atrophy | n2=en:muscle biopsy shows myofibrillar myopathy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows myopathic changes
n1=en:muscular atrophy | n2=en:muscle biopsy shows myopathic changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows myopathic or dystrophic changes
n1=en:muscular atrophy | n2=en:muscle biopsy shows myopathic or dystrophic changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows necrotic and atrophic fibers with centralized nuclei
n1=en:muscular atrophy | n2=en:muscle biopsy shows necrotic and atrophic fibers with centralized nuclei | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows necrotic and regenerating fibers
n1=en:muscular atrophy | n2=en:muscle biopsy shows necrotic and regenerating fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows neurogenic atrophy
n1=en:muscular atrophy | n2=en:muscle biopsy shows neurogenic atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows no dystrophic changes
n1=en:muscular atrophy | n2=en:muscle biopsy shows no dystrophic changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows nonspecific myopathic changes
n1=en:muscular atrophy | n2=en:muscle biopsy shows nonspecific myopathic changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows nonspecific myopathic changes without dystrophic or inflammatory changes
n1=en:muscular atrophy | n2=en:muscle biopsy shows nonspecific myopathic changes without dystrophic or inflammatory changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows ragged red fibers
n1=en:muscular atrophy | n2=en:muscle biopsy shows ragged red fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows rimmed vacuoles
n1=en:muscular atrophy | n2=en:muscle biopsy shows rimmed vacuoles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows small fibers with central nuclei and accumulation of mitochondria in the central part of the fibers
n1=en:muscular atrophy | n2=en:muscle biopsy shows small fibers with central nuclei and accumulation of mitochondria in the central part of the fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows small rounded fibers
n1=en:muscular atrophy | n2=en:muscle biopsy shows small rounded fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows small, membrane-bound vacuoles predominantly in type 2 fibers
n1=en:muscular atrophy | n2=en:muscle biopsy shows small, membrane-bound vacuoles predominantly in type 2 fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows type 1 fiber predominance
n1=en:muscular atrophy | n2=en:muscle biopsy shows type 1 fiber predominance | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows type 1 fiber predominance and hypertrophy
n1=en:muscular atrophy | n2=en:muscle biopsy shows type 1 fiber predominance and hypertrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows type 2 fiber atrophy
n1=en:muscular atrophy | n2=en:muscle biopsy shows type 2 fiber atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle biopsy shows variation in fiber size
n1=en:muscular atrophy | n2=en:muscle biopsy shows variation in fiber size | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle cramps (also seen in some heterozygotes)
n1=en:muscular atrophy | n2=en:muscle cramps (also seen in some heterozygotes) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle cramps affect the upper and lower limbs
n1=en:muscular atrophy | n2=en:muscle cramps affect the upper and lower limbs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle cramps during exercise
n1=en:muscular atrophy | n2=en:muscle cramps during exercise | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle cramps may affect jaw muscles
n1=en:muscular atrophy | n2=en:muscle cramps may affect jaw muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle cramps, painful, recurrent
n1=en:muscular atrophy | n2=en:muscle cramps, painful, recurrent | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle fiber atrophy, profound (rare)
n1=en:muscular atrophy | n2=en:muscle fiber atrophy, profound (rare) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle fiber necrosis
n1=en:muscular atrophy | n2=en:muscle fiber necrosis | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle fiber regeneration
n1=en:muscular atrophy | n2=en:muscle fiber regeneration | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle fiber splitting
n1=en:muscular atrophy | n2=en:muscle fiber splitting | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle fiber splitting and fibrosis seen on muscle biopsy
n1=en:muscular atrophy | n2=en:muscle fiber splitting and fibrosis seen on muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle fibers appear as fetal myotubules
n1=en:muscular atrophy | n2=en:muscle fibers appear as fetal myotubules | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle fibers are immunoreactive for desmin and vimentin
n1=en:muscular atrophy | n2=en:muscle fibers are immunoreactive for desmin and vimentin | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle fibers may contain abnormal polysaccharide
n1=en:muscular atrophy | n2=en:muscle fibers may contain abnormal polysaccharide | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle hyperirritability
n1=en:muscular atrophy | n2=en:muscle hyperirritability | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle hypertrophy of the lower extremities
n1=en:muscular atrophy | n2=en:muscle hypertrophy of the lower extremities | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle mitochondria normal by histochemical analysis
n1=en:muscular atrophy | n2=en:muscle mitochondria normal by histochemical analysis | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle mounding
n1=en:muscular atrophy | n2=en:muscle mounding | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle pain (less common)
n1=en:muscular atrophy | n2=en:muscle pain (less common) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle pain and cramps following exercise
n1=en:muscular atrophy | n2=en:muscle pain and cramps following exercise | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle pain with exercise (in older patients)
n1=en:muscular atrophy | n2=en:muscle pain with exercise (in older patients) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle shows lipid accumulation
n1=en:muscular atrophy | n2=en:muscle shows lipid accumulation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle stiffness (in older patients)
n1=en:muscular atrophy | n2=en:muscle stiffness (in older patients) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle stiffness or aching
n1=en:muscular atrophy | n2=en:muscle stiffness or aching | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle wasting due to chronic denervation
n1=en:muscular atrophy | n2=en:muscle wasting due to chronic denervation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle wasting in lower limbs
n1=en:muscular atrophy | n2=en:muscle wasting in lower limbs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness after cooling or on warming affected muscle
n1=en:muscular atrophy | n2=en:muscle weakness after cooling or on warming affected muscle | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness and atrophy may be asymmetric
n1=en:muscular atrophy | n2=en:muscle weakness and atrophy may be asymmetric | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness and atrophy, proximal
n1=en:muscular atrophy | n2=en:muscle weakness and atrophy, proximal | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness associated with fasting or infection
n1=en:muscular atrophy | n2=en:muscle weakness associated with fasting or infection | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness in forearm muscles
n1=en:muscular atrophy | n2=en:muscle weakness in forearm muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness is not a feature
n1=en:muscular atrophy | n2=en:muscle weakness is not a feature | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness is predominantly of extremities and tongue
n1=en:muscular atrophy | n2=en:muscle weakness is predominantly of extremities and tongue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness of the face and neck, mild to moderate
n1=en:muscular atrophy | n2=en:muscle weakness of the face and neck, mild to moderate | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness restricted to the upper limb
n1=en:muscular atrophy | n2=en:muscle weakness restricted to the upper limb | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness usually does not occur
n1=en:muscular atrophy | n2=en:muscle weakness usually does not occur | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness, congenital
n1=en:muscular atrophy | n2=en:muscle weakness, congenital | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness, distal, particularly affecting the hands
n1=en:muscular atrophy | n2=en:muscle weakness, distal, particularly affecting the hands | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness, mild, proximal and distal
n1=en:muscular atrophy | n2=en:muscle weakness, mild, proximal and distal | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness, predominantly proximal
n1=en:muscular atrophy | n2=en:muscle weakness, predominantly proximal | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness, proximal and distal
n1=en:muscular atrophy | n2=en:muscle weakness, proximal and distal | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness, proximal greater than distal
n1=en:muscular atrophy | n2=en:muscle weakness, proximal greater than distal | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness, proximal limb muscle, mild to moderate
n1=en:muscular atrophy | n2=en:muscle weakness, proximal limb muscle, mild to moderate | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness, proximal, limb-girdle
n1=en:muscular atrophy | n2=en:muscle weakness, proximal, limb-girdle | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness, proximal, slowly progressive
n1=en:muscular atrophy | n2=en:muscle weakness, proximal, slowly progressive | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness, severe, diffuse
n1=en:muscular atrophy | n2=en:muscle weakness, severe, diffuse | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscle weakness, upper and lower limbs
n1=en:muscular atrophy | n2=en:muscle weakness, upper and lower limbs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscles become hard and tender during exercise
n1=en:muscular atrophy | n2=en:muscles become hard and tender during exercise | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscles have a woody consistency on palpation
n1=en:muscular atrophy | n2=en:muscles have a woody consistency on palpation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:muscular appearance
n1=en:muscular atrophy | n2=en:muscular appearance | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myalgia (in some patients)
n1=en:muscular atrophy | n2=en:myalgia (in some patients) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myalgia, episodic
n1=en:muscular atrophy | n2=en:myalgia, episodic | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myofibrillar disintegration
n1=en:muscular atrophy | n2=en:myofibrillar disintegration | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myofibrillar disorganization
n1=en:muscular atrophy | n2=en:myofibrillar disorganization | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myofibrillar lesions
n1=en:muscular atrophy | n2=en:myofibrillar lesions | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myopathic changes on pathology
n1=en:muscular atrophy | n2=en:myopathic changes on pathology | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myopathic episodes triggered by exercise, fasting, infection, cold temperatures
n1=en:muscular atrophy | n2=en:myopathic episodes triggered by exercise, fasting, infection, cold temperatures | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myopathic findings on biopsy have been occasionally reported
n1=en:muscular atrophy | n2=en:myopathic findings on biopsy have been occasionally reported | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myopathy (rare)
n1=en:muscular atrophy | n2=en:myopathy (rare) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myopathy in approximately 45% of patients
n1=en:muscular atrophy | n2=en:myopathy in approximately 45% of patients | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myopathy, mild to severe
n1=en:muscular atrophy | n2=en:myopathy, mild to severe | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myopathy, nonprogressive
n1=en:muscular atrophy | n2=en:myopathy, nonprogressive | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myotonia (usually occurs during rapid voluntary muscle movements after a period of rest)
n1=en:muscular atrophy | n2=en:myotonia (usually occurs during rapid voluntary muscle movements after a period of rest) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myotonia improves with continued activity ('warm-up phenomenon')
n1=en:muscular atrophy | n2=en:myotonia improves with continued activity ('warm-up phenomenon') | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myotonia is most pronounced in the extremities
n1=en:muscular atrophy | n2=en:myotonia is most pronounced in the extremities | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myotonia is present in majority of cases
n1=en:muscular atrophy | n2=en:myotonia is present in majority of cases | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myotonia is usually not seen
n1=en:muscular atrophy | n2=en:myotonia is usually not seen | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myotonia, cold-sensitive, predominantly of face, tongue, forearm, and hand precipitated by muscle cooling or cold exposure or rest after exercise
n1=en:muscular atrophy | n2=en:myotonia, cold-sensitive, predominantly of face, tongue, forearm, and hand precipitated by muscle cooling or cold exposure or rest after exercise | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myotonia, potassium-sensitive (may be responsive to acetazolamide)
n1=en:muscular atrophy | n2=en:myotonia, potassium-sensitive (may be responsive to acetazolamide) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myotonic discharges
n1=en:muscular atrophy | n2=en:myotonic discharges | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:myxedematous appearance
n1=en:muscular atrophy | n2=en:myxedematous appearance | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:nearly complete absence of mechanical adipose tissue (joints, orbits, palms, soles)
n1=en:muscular atrophy | n2=en:nearly complete absence of mechanical adipose tissue (joints, orbits, palms, soles) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:nearly complete absence of metabolically active adipose tissue (subcutaneous, intraabdominal, intrathoracic)
n1=en:muscular atrophy | n2=en:nearly complete absence of metabolically active adipose tissue (subcutaneous, intraabdominal, intrathoracic) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:neck and proximal limb muscle myopathy
n1=en:muscular atrophy | n2=en:neck and proximal limb muscle myopathy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:neck flexor weakness
n1=en:muscular atrophy | n2=en:neck flexor weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:necrotic and atrophic fibers with centralized nuclei seen on muscle biopsy
n1=en:muscular atrophy | n2=en:necrotic and atrophic fibers with centralized nuclei seen on muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:necrotic and regenerating muscle fibers
n1=en:muscular atrophy | n2=en:necrotic and regenerating muscle fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:necrotic fibers
n1=en:muscular atrophy | n2=en:necrotic fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:nemaline bodies are rarely intranuclear
n1=en:muscular atrophy | n2=en:nemaline bodies are rarely intranuclear | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:nemaline bodies are usually subsarcolemmal or sarcoplasmic
n1=en:muscular atrophy | n2=en:nemaline bodies are usually subsarcolemmal or sarcoplasmic | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:nemaline bodies occur in type 1 fibers
n1=en:muscular atrophy | n2=en:nemaline bodies occur in type 1 fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:nemaline rod formation
n1=en:muscular atrophy | n2=en:nemaline rod formation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:neurogenic atrophy seen on muscle biopsy
n1=en:muscular atrophy | n2=en:neurogenic atrophy seen on muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:no dystrophic changes
n1=en:muscular atrophy | n2=en:no dystrophic changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:no facial muscle involvement
n1=en:muscular atrophy | n2=en:no facial muscle involvement | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:no lipodystrophy in face and neck
n1=en:muscular atrophy | n2=en:no lipodystrophy in face and neck | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:no muscle fiber necrosis
n1=en:muscular atrophy | n2=en:no muscle fiber necrosis | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:no muscle weakness
n1=en:muscular atrophy | n2=en:no muscle weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:no ragged-red fibers
n1=en:muscular atrophy | n2=en:no ragged-red fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:no rods
n1=en:muscular atrophy | n2=en:no rods | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:no staining for oxidative enzymes
n1=en:muscular atrophy | n2=en:no staining for oxidative enzymes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:non-pitting edema
n1=en:muscular atrophy | n2=en:non-pitting edema | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:nonspecific muscle fiber atrophy
n1=en:muscular atrophy | n2=en:nonspecific muscle fiber atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:nonspecific myopathy
n1=en:muscular atrophy | n2=en:nonspecific myopathy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:normal dystrophin immunostaining
n1=en:muscular atrophy | n2=en:normal dystrophin immunostaining | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:normal mitochondrial morphology (1 patient)
n1=en:muscular atrophy | n2=en:normal mitochondrial morphology (1 patient) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:normal neonatal period may occur before weakness is apparent
n1=en:muscular atrophy | n2=en:normal neonatal period may occur before weakness is apparent | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:normal or decreased facial and neck adipose tissue
n1=en:muscular atrophy | n2=en:normal or decreased facial and neck adipose tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:normal or increased abdominal adipose tissue
n1=en:muscular atrophy | n2=en:normal or increased abdominal adipose tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:normal or increased adipose tissue around the neck
n1=en:muscular atrophy | n2=en:normal or increased adipose tissue around the neck | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:normal or increased facial and neck adipose tissue
n1=en:muscular atrophy | n2=en:normal or increased facial and neck adipose tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:normal or increased truncal adipose tissue
n1=en:muscular atrophy | n2=en:normal or increased truncal adipose tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:nuclear clumps
n1=en:muscular atrophy | n2=en:nuclear clumps | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:onset of lymphedema around puberty
n1=en:muscular atrophy | n2=en:onset of lymphedema around puberty | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:onset of weakness in hands and feet
n1=en:muscular atrophy | n2=en:onset of weakness in hands and feet | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:other mitochondrial complex enzyme activities may also be decreased
n1=en:muscular atrophy | n2=en:other mitochondrial complex enzyme activities may also be decreased | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:pain or cramping during sustained manual activity
n1=en:muscular atrophy | n2=en:pain or cramping during sustained manual activity | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:painful muscle cramps
n1=en:muscular atrophy | n2=en:painful muscle cramps | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:painful swelling in fasciae
n1=en:muscular atrophy | n2=en:painful swelling in fasciae | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:paradoxical myotonia (myotonia increases with exercise)
n1=en:muscular atrophy | n2=en:paradoxical myotonia (myotonia increases with exercise) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:paralysis of the lower limbs (later)
n1=en:muscular atrophy | n2=en:paralysis of the lower limbs (later) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:partial lipodystrophy (abnormal distribution of adipose tissue)
n1=en:muscular atrophy | n2=en:partial lipodystrophy (abnormal distribution of adipose tissue) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:partial lipodystrophy (abnormal distribution of subcutaneous adipose tissue)
n1=en:muscular atrophy | n2=en:partial lipodystrophy (abnormal distribution of subcutaneous adipose tissue) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:patchy muscle fiber degeneration
n1=en:muscular atrophy | n2=en:patchy muscle fiber degeneration | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:patients achieve independent ambulation, but may lose it
n1=en:muscular atrophy | n2=en:patients achieve independent ambulation, but may lose it | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:patients may have distal or proximal muscle weakness, or both
n1=en:muscular atrophy | n2=en:patients may have distal or proximal muscle weakness, or both | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:pectoralis hypoplasia
n1=en:muscular atrophy | n2=en:pectoralis hypoplasia | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:pectoralis major hypoplasia
n1=en:muscular atrophy | n2=en:pectoralis major hypoplasia | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:pectoralis muscles may be less involved, leading to inward shrugging posture
n1=en:muscular atrophy | n2=en:pectoralis muscles may be less involved, leading to inward shrugging posture | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:pelvic girdle muscle weakness (occurs earlier)
n1=en:muscular atrophy | n2=en:pelvic girdle muscle weakness (occurs earlier) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:pelvic girdle weakness and atrophy
n1=en:muscular atrophy | n2=en:pelvic girdle weakness and atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:pelvic muscle involvement occurs later
n1=en:muscular atrophy | n2=en:pelvic muscle involvement occurs later | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:percussion-induced muscle mounding (muscle rippling)
n1=en:muscular atrophy | n2=en:percussion-induced muscle mounding (muscle rippling) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:peroneal muscle atrophy
n1=en:muscular atrophy | n2=en:peroneal muscle atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:phagocytic vacuoles with degraded membranous material
n1=en:muscular atrophy | n2=en:phagocytic vacuoles with degraded membranous material | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:plaques immunoreactive for desmin and alpha-beta-crystallin
n1=en:muscular atrophy | n2=en:plaques immunoreactive for desmin and alpha-beta-crystallin | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:poor head control in infancy
n1=en:muscular atrophy | n2=en:poor head control in infancy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:poor muscle build
n1=en:muscular atrophy | n2=en:poor muscle build | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:poor muscle bulk
n1=en:muscular atrophy | n2=en:poor muscle bulk | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:poor musculature
n1=en:muscular atrophy | n2=en:poor musculature | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:positive staining for slow myosin heavy chain
n1=en:muscular atrophy | n2=en:positive staining for slow myosin heavy chain | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:potassium sensitivity has been reported
n1=en:muscular atrophy | n2=en:potassium sensitivity has been reported | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:premature exertional muscle weakness
n1=en:muscular atrophy | n2=en:premature exertional muscle weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:primarily affects lower limbs
n1=en:muscular atrophy | n2=en:primarily affects lower limbs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:progression to proximal muscle weakness
n1=en:muscular atrophy | n2=en:progression to proximal muscle weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:progression to wheelchair in fourth decade
n1=en:muscular atrophy | n2=en:progression to wheelchair in fourth decade | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:progressive distal and proximal symmetric limb weakness
n1=en:muscular atrophy | n2=en:progressive distal and proximal symmetric limb weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:progressive distal muscle weakness
n1=en:muscular atrophy | n2=en:progressive distal muscle weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:progressive ectopic ossification (neck, dorsal trunk, proximal limbs, sternocleidomastoid, masseters)
n1=en:muscular atrophy | n2=en:progressive ectopic ossification (neck, dorsal trunk, proximal limbs, sternocleidomastoid, masseters) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:progressive interictal weakness is common
n1=en:muscular atrophy | n2=en:progressive interictal weakness is common | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:progressive loss of facial adipose tissue
n1=en:muscular atrophy | n2=en:progressive loss of facial adipose tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:progressive proximal muscle weakness
n1=en:muscular atrophy | n2=en:progressive proximal muscle weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proliferation of fatty tissue in muscle (in some patients)
n1=en:muscular atrophy | n2=en:proliferation of fatty tissue in muscle (in some patients) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:prominent involvement of the biceps brachii muscles
n1=en:muscular atrophy | n2=en:prominent involvement of the biceps brachii muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:prominent involvement of the quadriceps femoris muscles
n1=en:muscular atrophy | n2=en:prominent involvement of the quadriceps femoris muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:prominent muscular appearance
n1=en:muscular atrophy | n2=en:prominent muscular appearance | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:prominent musculature
n1=en:muscular atrophy | n2=en:prominent musculature | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal and distal muscle atrophy
n1=en:muscular atrophy | n2=en:proximal and distal muscle atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal and distal muscle atrophy in lower limbs
n1=en:muscular atrophy | n2=en:proximal and distal muscle atrophy in lower limbs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal limb muscle weakness (occurs later)
n1=en:muscular atrophy | n2=en:proximal limb muscle weakness (occurs later) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal limb muscle weakness initially
n1=en:muscular atrophy | n2=en:proximal limb muscle weakness initially | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal lower limb amyotrophy
n1=en:muscular atrophy | n2=en:proximal lower limb amyotrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal lower limb muscle weakness, upper and lower (later onset)
n1=en:muscular atrophy | n2=en:proximal lower limb muscle weakness, upper and lower (later onset) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal muscle weakness (85% of patients)
n1=en:muscular atrophy | n2=en:proximal muscle weakness (85% of patients) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal muscle weakness (occasional)
n1=en:muscular atrophy | n2=en:proximal muscle weakness (occasional) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal muscle weakness in upper limbs
n1=en:muscular atrophy | n2=en:proximal muscle weakness in upper limbs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal muscle weakness more severe than distal muscle weakness
n1=en:muscular atrophy | n2=en:proximal muscle weakness more severe than distal muscle weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal muscle weakness occurs later
n1=en:muscular atrophy | n2=en:proximal muscle weakness occurs later | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal muscle weakness, mild
n1=en:muscular atrophy | n2=en:proximal muscle weakness, mild | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal upper limb amyotrophy
n1=en:muscular atrophy | n2=en:proximal upper limb amyotrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal weakness
n1=en:muscular atrophy | n2=en:proximal weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:proximal weakness of the lower limbs with longer disease duration
n1=en:muscular atrophy | n2=en:proximal weakness of the lower limbs with longer disease duration | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:pseudoathletic appearance with prominent muscles before disease onset
n1=en:muscular atrophy | n2=en:pseudoathletic appearance with prominent muscles before disease onset | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:pyruvate oxidation defect
n1=en:muscular atrophy | n2=en:pyruvate oxidation defect | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:quadriceps atrophy
n1=en:muscular atrophy | n2=en:quadriceps atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:quadriceps atrophy (later onset)
n1=en:muscular atrophy | n2=en:quadriceps atrophy (later onset) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:quadriceps muscle spared
n1=en:muscular atrophy | n2=en:quadriceps muscle spared | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:ragged-red fibers on muscle biopsy
n1=en:muscular atrophy | n2=en:ragged-red fibers on muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:ragged-red fibers seen on muscle biopsy
n1=en:muscular atrophy | n2=en:ragged-red fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:ragged-red muscle fibers
n1=en:muscular atrophy | n2=en:ragged-red muscle fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:rectus abdominis muscle separation
n1=en:muscular atrophy | n2=en:rectus abdominis muscle separation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:rectus medial atrophy
n1=en:muscular atrophy | n2=en:rectus medial atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:red-ragged fibers (2p21del)
n1=en:muscular atrophy | n2=en:red-ragged fibers (2p21del) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:reduced ankle dorsiflexion
n1=en:muscular atrophy | n2=en:reduced ankle dorsiflexion | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:reduced muscle bulk
n1=en:muscular atrophy | n2=en:reduced muscle bulk | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:reduced muscle mass
n1=en:muscular atrophy | n2=en:reduced muscle mass | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:replacement of affected muscle tissue with fatty tissue
n1=en:muscular atrophy | n2=en:replacement of affected muscle tissue with fatty tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:respiratory distress (congenital form)
n1=en:muscular atrophy | n2=en:respiratory distress (congenital form) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:respiratory muscles may be involved (more common in juvenile-onset)
n1=en:muscular atrophy | n2=en:respiratory muscles may be involved (more common in juvenile-onset) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:retain some mechanical adipose tissue (joints, orbits, palms, soles)
n1=en:muscular atrophy | n2=en:retain some mechanical adipose tissue (joints, orbits, palms, soles) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:retinitis pigmentosa
n1=en:muscular atrophy | n2=en:retinitis pigmentosa | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:retroperitoneal fibrosis (rare)
n1=en:muscular atrophy | n2=en:retroperitoneal fibrosis (rare) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:rhabdomyolysis may occur
n1=en:muscular atrophy | n2=en:rhabdomyolysis may occur | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:rhabdomyolysis with exercise (in older patients)
n1=en:muscular atrophy | n2=en:rhabdomyolysis with exercise (in older patients) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:rhabdomyolysis, episodic
n1=en:muscular atrophy | n2=en:rhabdomyolysis, episodic | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:rhabdomyolysis, episodic and recurrent
n1=en:muscular atrophy | n2=en:rhabdomyolysis, episodic and recurrent | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:rimmed vacuoles on biopsy
n1=en:muscular atrophy | n2=en:rimmed vacuoles on biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:rimmed vacuoles with basophilic granular material
n1=en:muscular atrophy | n2=en:rimmed vacuoles with basophilic granular material | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:sarcoplasmic inclusions
n1=en:muscular atrophy | n2=en:sarcoplasmic inclusions | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:scapuloperoneal amyotrophy
n1=en:muscular atrophy | n2=en:scapuloperoneal amyotrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:scapuloperoneal muscular atrophy due to denervation
n1=en:muscular atrophy | n2=en:scapuloperoneal muscular atrophy due to denervation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:secondary loss of sarcolemmal caveolin-3
n1=en:muscular atrophy | n2=en:secondary loss of sarcolemmal caveolin-3 | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:secondary myopathic features
n1=en:muscular atrophy | n2=en:secondary myopathic features | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:severe disability within 20 years of onset
n1=en:muscular atrophy | n2=en:severe disability within 20 years of onset | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:severe form shows absence of spontaneous activity at birth
n1=en:muscular atrophy | n2=en:severe form shows absence of spontaneous activity at birth | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:severe muscle hypotonia at birth
n1=en:muscular atrophy | n2=en:severe muscle hypotonia at birth | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:shortening of flexor profundus muscle-tendon unit
n1=en:muscular atrophy | n2=en:shortening of flexor profundus muscle-tendon unit | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:shortening of various muscle-tendon groups in feet
n1=en:muscular atrophy | n2=en:shortening of various muscle-tendon groups in feet | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:shoulder girdle muscle atrophy
n1=en:muscular atrophy | n2=en:shoulder girdle muscle atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:shoulder muscle hypoplasia
n1=en:muscular atrophy | n2=en:shoulder muscle hypoplasia | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:shoulder weakness
n1=en:muscular atrophy | n2=en:shoulder weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:shoulder weakness and atrophy
n1=en:muscular atrophy | n2=en:shoulder weakness and atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:skeletal muscle biopsy shows dystrophic changes
n1=en:muscular atrophy | n2=en:skeletal muscle biopsy shows dystrophic changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:skeletal muscle biopsy shows hypertrophy of type 1 and 2 muscle fibers
n1=en:muscular atrophy | n2=en:skeletal muscle biopsy shows hypertrophy of type 1 and 2 muscle fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:skeletal muscle biopsy shows impaired respiratory oxidation
n1=en:muscular atrophy | n2=en:skeletal muscle biopsy shows impaired respiratory oxidation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:skeletal muscle biopsy shows minor variation in fiber size
n1=en:muscular atrophy | n2=en:skeletal muscle biopsy shows minor variation in fiber size | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:skeletal muscle shows decreased sarcoglycan proteins
n1=en:muscular atrophy | n2=en:skeletal muscle shows decreased sarcoglycan proteins | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:skeletal muscle shows dystrophic changes
n1=en:muscular atrophy | n2=en:skeletal muscle shows dystrophic changes | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:slow motor responses to sudden events (i.e., falling)
n1=en:muscular atrophy | n2=en:slow motor responses to sudden events (i.e., falling) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:slowly progressive limb-girdle myopathy
n1=en:muscular atrophy | n2=en:slowly progressive limb-girdle myopathy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:slurred speech, episodic
n1=en:muscular atrophy | n2=en:slurred speech, episodic | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:small and incompletely fused muscle fibers seen on biopsy
n1=en:muscular atrophy | n2=en:small and incompletely fused muscle fibers seen on biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:smooth muscle may also become involved
n1=en:muscular atrophy | n2=en:smooth muscle may also become involved | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:soft fleshy palms (50%)
n1=en:muscular atrophy | n2=en:soft fleshy palms (50%) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:soft tissue or tendinous calcinosis may occur
n1=en:muscular atrophy | n2=en:soft tissue or tendinous calcinosis may occur | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:soft tissue vascular malformations
n1=en:muscular atrophy | n2=en:soft tissue vascular malformations | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:some patients become wheelchair-dependent
n1=en:muscular atrophy | n2=en:some patients become wheelchair-dependent | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:some patients never achieve ambulation
n1=en:muscular atrophy | n2=en:some patients never achieve ambulation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:some subcutaneous adipose tissue may remain on upper arms
n1=en:muscular atrophy | n2=en:some subcutaneous adipose tissue may remain on upper arms | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:sparing of anterior tibialis muscle
n1=en:muscular atrophy | n2=en:sparing of anterior tibialis muscle | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:sparing of small hand and finger muscles
n1=en:muscular atrophy | n2=en:sparing of small hand and finger muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:sparing of the anterior tibial compartment
n1=en:muscular atrophy | n2=en:sparing of the anterior tibial compartment | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:sparing of the brachioradialis muscle (gives appearance of 'oblique amyotrophy')
n1=en:muscular atrophy | n2=en:sparing of the brachioradialis muscle (gives appearance of 'oblique amyotrophy') | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:speech delay (in all patients)
n1=en:muscular atrophy | n2=en:speech delay (in all patients) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:speech deterioration
n1=en:muscular atrophy | n2=en:speech deterioration | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:spinocerebellar ataxia (in some patients)
n1=en:muscular atrophy | n2=en:spinocerebellar ataxia (in some patients) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:spongy gliosis
n1=en:muscular atrophy | n2=en:spongy gliosis | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:status epilepticus (in some)
n1=en:muscular atrophy | n2=en:status epilepticus (in some) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:stroke (rare)
n1=en:muscular atrophy | n2=en:stroke (rare) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:subsarcolemmal accumulation of enlarged mitochondria with variably sized rectangular or elongated rhomboidal paracrystalline inclusions
n1=en:muscular atrophy | n2=en:subsarcolemmal accumulation of enlarged mitochondria with variably sized rectangular or elongated rhomboidal paracrystalline inclusions | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:subsarcolemmal accumulations of abnormally shaped mitochondria (on electron microscopy)
n1=en:muscular atrophy | n2=en:subsarcolemmal accumulations of abnormally shaped mitochondria (on electron microscopy) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:subsarcolemmal accumulations of abnormally shaped mitochondria seen on electron microscopy
n1=en:muscular atrophy | n2=en:subsarcolemmal accumulations of abnormally shaped mitochondria seen on electron microscopy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:subsarcolemmal accumulations of abnormally shaped mitochondria seen with electronmicroscopy
n1=en:muscular atrophy | n2=en:subsarcolemmal accumulations of abnormally shaped mitochondria seen with electronmicroscopy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:subsarcolemmal hyaline bodies in type 1 fibers only
n1=en:muscular atrophy | n2=en:subsarcolemmal hyaline bodies in type 1 fibers only | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:subsarcolemmal mitochondrial accumulation
n1=en:muscular atrophy | n2=en:subsarcolemmal mitochondrial accumulation | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:superior rectus atrophy
n1=en:muscular atrophy | n2=en:superior rectus atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:swelling of the affected areas
n1=en:muscular atrophy | n2=en:swelling of the affected areas | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:swelling of the extremities, episodic
n1=en:muscular atrophy | n2=en:swelling of the extremities, episodic | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:symptoms are progressive for a few years, and then become stationary
n1=en:muscular atrophy | n2=en:symptoms are progressive for a few years, and then become stationary | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:symptoms may be induced by heat
n1=en:muscular atrophy | n2=en:symptoms may be induced by heat | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:tenderness of lower extremities
n1=en:muscular atrophy | n2=en:tenderness of lower extremities | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:tendinous and tuberous xanthoma
n1=en:muscular atrophy | n2=en:tendinous and tuberous xanthoma | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:tendon tears
n1=en:muscular atrophy | n2=en:tendon tears | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:tetanus-like muscle contractions
n1=en:muscular atrophy | n2=en:tetanus-like muscle contractions | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:thenar amyotrophy (rare)
n1=en:muscular atrophy | n2=en:thenar amyotrophy (rare) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:thickened subcutaneous tissue
n1=en:muscular atrophy | n2=en:thickened subcutaneous tissue | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:thickening of the fascial structures of the palm and fingers
n1=en:muscular atrophy | n2=en:thickening of the fascial structures of the palm and fingers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:transient muscle weakness occur in 75% of patients, particularly in the arms and hands
n1=en:muscular atrophy | n2=en:transient muscle weakness occur in 75% of patients, particularly in the arms and hands | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:transient neonatal hypotonia (less common)
n1=en:muscular atrophy | n2=en:transient neonatal hypotonia (less common) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:tremor at birth, involving most skeletal muscle groups, especially jaw muscles and lower limb muscles
n1=en:muscular atrophy | n2=en:tremor at birth, involving most skeletal muscle groups, especially jaw muscles and lower limb muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:tremors subside over the first 2 to 3 months of life
n1=en:muscular atrophy | n2=en:tremors subside over the first 2 to 3 months of life | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:tubular aggregates in muscle fibers may occur
n1=en:muscular atrophy | n2=en:tubular aggregates in muscle fibers may occur | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:tubular aggregates in type 2 skeletal muscle fibers
n1=en:muscular atrophy | n2=en:tubular aggregates in type 2 skeletal muscle fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:tubulofilamentous inclusions
n1=en:muscular atrophy | n2=en:tubulofilamentous inclusions | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:tubulofilamentous nuclear or cytoplasmic inclusions on biopsy
n1=en:muscular atrophy | n2=en:tubulofilamentous nuclear or cytoplasmic inclusions on biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:type 1 and type 2 muscle fibers with 'minicore' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria
n1=en:muscular atrophy | n2=en:type 1 and type 2 muscle fibers with 'minicore' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:type 1 fiber atrophy
n1=en:muscular atrophy | n2=en:type 1 fiber atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:type 1 fiber predominance
n1=en:muscular atrophy | n2=en:type 1 fiber predominance | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:type 1 fibers are at least 12% smaller than type 2 fibers
n1=en:muscular atrophy | n2=en:type 1 fibers are at least 12% smaller than type 2 fibers | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:type 1 muscle fiber predominance
n1=en:muscular atrophy | n2=en:type 1 muscle fiber predominance | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:type 1 muscle fibers with clearly demarcated central 'core' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria
n1=en:muscular atrophy | n2=en:type 1 muscle fibers with clearly demarcated central 'core' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:type 2 fiber hypertrophy
n1=en:muscular atrophy | n2=en:type 2 fiber hypertrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:type 2 muscle fiber atrophy
n1=en:muscular atrophy | n2=en:type 2 muscle fiber atrophy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:type 2 muscle fiber predominance
n1=en:muscular atrophy | n2=en:type 2 muscle fiber predominance | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:upper arm and pelvic muscle weakness and atrophy (later onset)
n1=en:muscular atrophy | n2=en:upper arm and pelvic muscle weakness and atrophy (later onset) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:upper limb involvement and distal muscle involvement may occur later in disease course (often by second decade)
n1=en:muscular atrophy | n2=en:upper limb involvement and distal muscle involvement may occur later in disease course (often by second decade) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:upper limb involvement occurs later or not at all
n1=en:muscular atrophy | n2=en:upper limb involvement occurs later or not at all | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:upper limb muscle hypoplasia
n1=en:muscular atrophy | n2=en:upper limb muscle hypoplasia | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:upper limb weakness
n1=en:muscular atrophy | n2=en:upper limb weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:usually a unilateral disorder
n1=en:muscular atrophy | n2=en:usually a unilateral disorder | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:usually no myopathic changes on biopsy
n1=en:muscular atrophy | n2=en:usually no myopathic changes on biopsy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:uterine muscle may be stiff during pregnancy
n1=en:muscular atrophy | n2=en:uterine muscle may be stiff during pregnancy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:vacuolar degeneration
n1=en:muscular atrophy | n2=en:vacuolar degeneration | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:vacuolar membranes immunostain with sarcolemmal proteins
n1=en:muscular atrophy | n2=en:vacuolar membranes immunostain with sarcolemmal proteins | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:vacuolar myopathy
n1=en:muscular atrophy | n2=en:vacuolar myopathy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:vacuolar myopathy may occur
n1=en:muscular atrophy | n2=en:vacuolar myopathy may occur | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:vacuolated muscle fibers show reduplication of the basement membrane
n1=en:muscular atrophy | n2=en:vacuolated muscle fibers show reduplication of the basement membrane | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:vacuoles appear to be exocytosing material at the cell surface
n1=en:muscular atrophy | n2=en:vacuoles appear to be exocytosing material at the cell surface | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:vacuoles are autophagocytic and contain granular and membranous cellular debris
n1=en:muscular atrophy | n2=en:vacuoles are autophagocytic and contain granular and membranous cellular debris | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:variable fiber size
n1=en:muscular atrophy | n2=en:variable fiber size | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:variation of fiber size and shape
n1=en:muscular atrophy | n2=en:variation of fiber size and shape | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:variation of myofiber diameter
n1=en:muscular atrophy | n2=en:variation of myofiber diameter | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:velopharyngeal muscle weakness
n1=en:muscular atrophy | n2=en:velopharyngeal muscle weakness | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:walking may be limited
n1=en:muscular atrophy | n2=en:walking may be limited | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:wasting, especially temporal, neck, and facial muscles
n1=en:muscular atrophy | n2=en:wasting, especially temporal, neck, and facial muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:weakness and wasting of the lower limbs
n1=en:muscular atrophy | n2=en:weakness and wasting of the lower limbs | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:weakness of ankle and toe extensor (dorsiflexor) muscles
n1=en:muscular atrophy | n2=en:weakness of ankle and toe extensor (dorsiflexor) muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:weakness of ankle plantar flexion
n1=en:muscular atrophy | n2=en:weakness of ankle plantar flexion | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:weakness of anterior compartment tibial muscles
n1=en:muscular atrophy | n2=en:weakness of anterior compartment tibial muscles | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:weakness of long finger extensor muscles (occurs later)
n1=en:muscular atrophy | n2=en:weakness of long finger extensor muscles (occurs later) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:weakness of neck muscles may occur later
n1=en:muscular atrophy | n2=en:weakness of neck muscles may occur later | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle)
n1=en:muscular atrophy | n2=en:weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle) | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:wheelchair dependency in 20% of patients by age 40
n1=en:muscular atrophy | n2=en:wheelchair dependency in 20% of patients by age 40 | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:z-band streaming
n1=en:muscular atrophy | n2=en:z-band streaming | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:z-disk degeneration
n1=en:muscular atrophy | n2=en:z-disk degeneration | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:z-disk streaming
n1=en:muscular atrophy | n2=en:z-disk streaming | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:z-disks with abnormal homogeneous material
n1=en:muscular atrophy | n2=en:z-disks with abnormal homogeneous material | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
en:z-line streaming see on electron microscopy
n1=en:muscular atrophy | n2=en:z-line streaming see on electron microscopy | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
faiblesse musculaire
n1=en:muscular atrophy | n2=faiblesse musculaire | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
retard
n1=en:muscular atrophy | n2=retard | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
surdité
n1=en:muscular atrophy | n2=surdité | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 25 / 0.069 ->
syndrome de Laurence-Moon
n1=en:muscular atrophy | n2=syndrome de Laurence-Moon | rel=r_associated | relid=0 | w=25
- en:muscular atrophy --
r_associated #0: 23 / 0.063 ->
rétinite
n1=en:muscular atrophy | n2=rétinite | rel=r_associated | relid=0 | w=23
- en:muscular atrophy --
r_associated #0: 22 / 0.061 ->
en:and diabetes mellitus
n1=en:muscular atrophy | n2=en:and diabetes mellitus | rel=r_associated | relid=0 | w=22
- en:muscular atrophy --
r_associated #0: 21 / 0.058 ->
en:ataxia
n1=en:muscular atrophy | n2=en:ataxia | rel=r_associated | relid=0 | w=21
- en:muscular atrophy --
r_associated #0: 21 / 0.058 ->
Refsum (maladie de)
n1=en:muscular atrophy | n2=Refsum (maladie de) | rel=r_associated | relid=0 | w=21
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
altération cavitaire
n1=en:muscular atrophy | n2=altération cavitaire | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
amyotrophies spinales
n1=en:muscular atrophy | n2=amyotrophies spinales | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
atrophie musculaire spinale
n1=en:muscular atrophy | n2=atrophie musculaire spinale | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
atrophie musculaire spinale (I-II ou III)
n1=en:muscular atrophy | n2=atrophie musculaire spinale (I-II ou III) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
dégénérescence cavitaire
n1=en:muscular atrophy | n2=dégénérescence cavitaire | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
dégénérescence vacuolaire
n1=en:muscular atrophy | n2=dégénérescence vacuolaire | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:abnormal fat pad, buttocks and upper thighs (in some patients)
n1=en:muscular atrophy | n2=en:abnormal fat pad, buttocks and upper thighs (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:abnormal fatigue
n1=en:muscular atrophy | n2=en:abnormal fatigue | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:abnormal fiber size variation
n1=en:muscular atrophy | n2=en:abnormal fiber size variation | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:abnormal size and shape of synaptic endplates
n1=en:muscular atrophy | n2=en:abnormal size and shape of synaptic endplates | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:abnormal variation in fiber type seen on muscle biopsy
n1=en:muscular atrophy | n2=en:abnormal variation in fiber type seen on muscle biopsy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:absence of immunostaining for alpha- and beta-dystroglycan (family b)
n1=en:muscular atrophy | n2=en:absence of immunostaining for alpha- and beta-dystroglycan (family b) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:absent moro response
n1=en:muscular atrophy | n2=en:absent moro response | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:accelerated decay of the synaptic current
n1=en:muscular atrophy | n2=en:accelerated decay of the synaptic current | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:angina co-occurrent and due to arteriosclerosis of coronary artery bypass graft
n1=en:muscular atrophy | n2=en:angina co-occurrent and due to arteriosclerosis of coronary artery bypass graft | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:angular fibers (in some patients)
n1=en:muscular atrophy | n2=en:angular fibers (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:atrophy of soft tissue of orbit
n1=en:muscular atrophy | n2=en:atrophy of soft tissue of orbit | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:atrophy of the lower leg muscles
n1=en:muscular atrophy | n2=en:atrophy of the lower leg muscles | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:auditory auras
n1=en:muscular atrophy | n2=en:auditory auras | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:axial hypertonia
n1=en:muscular atrophy | n2=en:axial hypertonia | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:bifrontal subdural hygroma
n1=en:muscular atrophy | n2=en:bifrontal subdural hygroma | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:cerebellar tonsilar ectopia (in some patients)
n1=en:muscular atrophy | n2=en:cerebellar tonsilar ectopia (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:chronic neurogenic changes seen on emg
n1=en:muscular atrophy | n2=en:chronic neurogenic changes seen on emg | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decreased achr
n1=en:muscular atrophy | n2=en:decreased achr | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decreased atp production
n1=en:muscular atrophy | n2=en:decreased atp production | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decreased distal strength (in some patients)
n1=en:muscular atrophy | n2=en:decreased distal strength (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decreased miniature endplate potential (mepp) and current (mepc)
n1=en:muscular atrophy | n2=en:decreased miniature endplate potential (mepp) and current (mepc) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decreased muscle bulk (in one patient)
n1=en:muscular atrophy | n2=en:decreased muscle bulk (in one patient) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decreased numbers of acetylcholine receptors (achr) in the postsynaptic membrane (less than 50% of normal)
n1=en:muscular atrophy | n2=en:decreased numbers of acetylcholine receptors (achr) in the postsynaptic membrane (less than 50% of normal) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decreased numbers of achr seen on muscle biopsy
n1=en:muscular atrophy | n2=en:decreased numbers of achr seen on muscle biopsy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decreased numbers of postsynaptic nerve terminals at the neuromuscular junction
n1=en:muscular atrophy | n2=en:decreased numbers of postsynaptic nerve terminals at the neuromuscular junction | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decreased quantal release
n1=en:muscular atrophy | n2=en:decreased quantal release | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decreased spontaneous miniature endplate potentials (mepp)
n1=en:muscular atrophy | n2=en:decreased spontaneous miniature endplate potentials (mepp) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decremental cmap response to repetitive nerve stimulation
n1=en:muscular atrophy | n2=en:decremental cmap response to repetitive nerve stimulation | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decremental cmap response to repetitive nerve stimulation seen on emg
n1=en:muscular atrophy | n2=en:decremental cmap response to repetitive nerve stimulation seen on emg | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decremental compound muscle action potential (cmap) in response to repetitive nerve stimulation seen on emg
n1=en:muscular atrophy | n2=en:decremental compound muscle action potential (cmap) in response to repetitive nerve stimulation seen on emg | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:decremental compound muscle action potential on repetitive stimulation
n1=en:muscular atrophy | n2=en:decremental compound muscle action potential on repetitive stimulation | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:degenerating junctional folds
n1=en:muscular atrophy | n2=en:degenerating junctional folds | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:degeneration of junctional folds
n1=en:muscular atrophy | n2=en:degeneration of junctional folds | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:delayed myelination (patient c)
n1=en:muscular atrophy | n2=en:delayed myelination (patient c) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:delayed myelination (patients a and c)
n1=en:muscular atrophy | n2=en:delayed myelination (patients a and c) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:delayed myelination endocrine : gonadotropin-dependent precocious puberty (1 patient)
n1=en:muscular atrophy | n2=en:delayed myelination endocrine : gonadotropin-dependent precocious puberty (1 patient) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:difficulty walking and climbing stairs (patient a)
n1=en:muscular atrophy | n2=en:difficulty walking and climbing stairs (patient a) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:diffuse signal hyperintensity of white matter seen on mri
n1=en:muscular atrophy | n2=en:diffuse signal hyperintensity of white matter seen on mri | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:diffuse slow background activity seen on eeg
n1=en:muscular atrophy | n2=en:diffuse slow background activity seen on eeg | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:disarray of mitochondrial cristae seen on muscle biopsy
n1=en:muscular atrophy | n2=en:disarray of mitochondrial cristae seen on muscle biopsy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:distal muscle weakness due to peripheral neuropathy, lower limbs more affected than upper limbs
n1=en:muscular atrophy | n2=en:distal muscle weakness due to peripheral neuropathy, lower limbs more affected than upper limbs | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:distal muscle weakness of the lower limbs secondary to peripheral neuropathy
n1=en:muscular atrophy | n2=en:distal muscle weakness of the lower limbs secondary to peripheral neuropathy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:distal muscle weakness, lower legs
n1=en:muscular atrophy | n2=en:distal muscle weakness, lower legs | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:dystonic movements (in some patients)
n1=en:muscular atrophy | n2=en:dystonic movements (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:endplate myopathy
n1=en:muscular atrophy | n2=en:endplate myopathy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:extrapyramidal symptoms (patient a)
n1=en:muscular atrophy | n2=en:extrapyramidal symptoms (patient a) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:fat droplets in sarcoplasm and mitochondria seen on skeletal muscle biopsy
n1=en:muscular atrophy | n2=en:fat droplets in sarcoplasm and mitochondria seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:feebleness
n1=en:muscular atrophy | n2=en:feebleness | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:few spontaneous movements
n1=en:muscular atrophy | n2=en:few spontaneous movements | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:fiber type variation
n1=en:muscular atrophy | n2=en:fiber type variation | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:focal loss of cross striations seen on muscle biopsy
n1=en:muscular atrophy | n2=en:focal loss of cross striations seen on muscle biopsy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:frittering
n1=en:muscular atrophy | n2=en:frittering | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:furukawa takagi nakao syndrome
n1=en:muscular atrophy | n2=en:furukawa takagi nakao syndrome | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:generalized lack of subcutaneous fat
n1=en:muscular atrophy | n2=en:generalized lack of subcutaneous fat | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:generalized muscle weakness, severe
n1=en:muscular atrophy | n2=en:generalized muscle weakness, severe | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:hypertrophy of orbicularis oculi muscle
n1=en:muscular atrophy | n2=en:hypertrophy of orbicularis oculi muscle | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:hypotonia (families a and b)
n1=en:muscular atrophy | n2=en:hypotonia (families a and b) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:hypotonia (patients a and c)
n1=en:muscular atrophy | n2=en:hypotonia (patients a and c) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:hypotonia, generalized, severe
n1=en:muscular atrophy | n2=en:hypotonia, generalized, severe | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:hypotonia, neonatal, severe (hcs)
n1=en:muscular atrophy | n2=en:hypotonia, neonatal, severe (hcs) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:hypotonia, profound
n1=en:muscular atrophy | n2=en:hypotonia, profound | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:inability to stand or walk (in severe cases)
n1=en:muscular atrophy | n2=en:inability to stand or walk (in severe cases) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:inability to walk (in some patients)
n1=en:muscular atrophy | n2=en:inability to walk (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:increased connective tissue and fat
n1=en:muscular atrophy | n2=en:increased connective tissue and fat | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:increased fibrosis (family a)
n1=en:muscular atrophy | n2=en:increased fibrosis (family a) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:increased fibrosis (in some patients)
n1=en:muscular atrophy | n2=en:increased fibrosis (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:increased glycogen in muscle (but to a lesser extent than in the heart)
n1=en:muscular atrophy | n2=en:increased glycogen in muscle (but to a lesser extent than in the heart) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:increased internal nuclei (in some patients)
n1=en:muscular atrophy | n2=en:increased internal nuclei (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:increased length of endplate regions seen on muscle biopsy
n1=en:muscular atrophy | n2=en:increased length of endplate regions seen on muscle biopsy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:increased variation in fiber size (in some patients)
n1=en:muscular atrophy | n2=en:increased variation in fiber size (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:increased white matter signal
n1=en:muscular atrophy | n2=en:increased white matter signal | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:internal nuclei (in some patients)
n1=en:muscular atrophy | n2=en:internal nuclei (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:lack of antigravity movements (patient b)
n1=en:muscular atrophy | n2=en:lack of antigravity movements (patient b) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:lafora bodies (accumulation of polyglucosan) seen on skeletal muscle biopsy
n1=en:muscular atrophy | n2=en:lafora bodies (accumulation of polyglucosan) seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:lavishing
n1=en:muscular atrophy | n2=en:lavishing | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:limited walking ability
n1=en:muscular atrophy | n2=en:limited walking ability | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:lipid storage, mainly in type i fibers
n1=en:muscular atrophy | n2=en:lipid storage, mainly in type i fibers | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:loss of ambulation
n1=en:muscular atrophy | n2=en:loss of ambulation | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:lymphedema (primarily in lower limbs, but also arms in some patients)
n1=en:muscular atrophy | n2=en:lymphedema (primarily in lower limbs, but also arms in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:mental retardation, mild to severe (iq <35 in some patients)
n1=en:muscular atrophy | n2=en:mental retardation, mild to severe (iq <35 in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:mild endplate myopathy
n1=en:muscular atrophy | n2=en:mild endplate myopathy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:mild kinetic abnormalities of the achr (in some patients)
n1=en:muscular atrophy | n2=en:mild kinetic abnormalities of the achr (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy
n1=en:muscular atrophy | n2=en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:mildly increased mtdna
n1=en:muscular atrophy | n2=en:mildly increased mtdna | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:minimal muscle mass
n1=en:muscular atrophy | n2=en:minimal muscle mass | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:miyoshi myopathy
n1=en:muscular atrophy | n2=en:miyoshi myopathy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:mlasa syndrome
n1=en:muscular atrophy | n2=en:mlasa syndrome | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:molar tooth sign seen on brain imaging
n1=en:muscular atrophy | n2=en:molar tooth sign seen on brain imaging | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:motor deficits (in some patients)
n1=en:muscular atrophy | n2=en:motor deficits (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:motor disability
n1=en:muscular atrophy | n2=en:motor disability | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:motor handicap
n1=en:muscular atrophy | n2=en:motor handicap | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:muscle atrophy, lower limbs more affected than upper limbs
n1=en:muscular atrophy | n2=en:muscle atrophy, lower limbs more affected than upper limbs | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:muscle atrophy, upper and lower limbs
n1=en:muscular atrophy | n2=en:muscle atrophy, upper and lower limbs | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:muscle biopsy shows loss of type 2a fibers
n1=en:muscular atrophy | n2=en:muscle biopsy shows loss of type 2a fibers | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:muscle biopsy shows neurogenic atrophy (1 patient)
n1=en:muscular atrophy | n2=en:muscle biopsy shows neurogenic atrophy (1 patient) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:muscle hyperplasia
n1=en:muscular atrophy | n2=en:muscle hyperplasia | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:muscle weakness (hcs)
n1=en:muscular atrophy | n2=en:muscle weakness (hcs) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:muscle weakness, lower limbs (patient a)
n1=en:muscular atrophy | n2=en:muscle weakness, lower limbs (patient a) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:muscle weakness, particularly of the lower limbs
n1=en:muscular atrophy | n2=en:muscle weakness, particularly of the lower limbs | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:muscles do not contract upon electrical stimulation
n1=en:muscular atrophy | n2=en:muscles do not contract upon electrical stimulation | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:muscular dystrophy (in 1 of 3 patients)
n1=en:muscular atrophy | n2=en:muscular dystrophy (in 1 of 3 patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:myofibril destruction (in some patients)
n1=en:muscular atrophy | n2=en:myofibril destruction (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:myopathic features seen on emg
n1=en:muscular atrophy | n2=en:myopathic features seen on emg | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:myopathy due to magnesium deficiency
n1=en:muscular atrophy | n2=en:myopathy due to magnesium deficiency | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:nemaline myopathy 8
n1=en:muscular atrophy | n2=en:nemaline myopathy 8 | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:neonatal edema (in some patients)
n1=en:muscular atrophy | n2=en:neonatal edema (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:neurogenic atrophy
n1=en:muscular atrophy | n2=en:neurogenic atrophy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:neurogenic atrophy of muscle fibers seen on biopsy (in some patients)
n1=en:muscular atrophy | n2=en:neurogenic atrophy of muscle fibers seen on biopsy (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:nonspecific myopathy seen on biopsy
n1=en:muscular atrophy | n2=en:nonspecific myopathy seen on biopsy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:opisthotonus (patient b)
n1=en:muscular atrophy | n2=en:opisthotonus (patient b) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:periventricular calcifications (patient c)
n1=en:muscular atrophy | n2=en:periventricular calcifications (patient c) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:plasma membrane discontinuities
n1=en:muscular atrophy | n2=en:plasma membrane discontinuities | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:positive regulation of muscle atrophy
n1=en:muscular atrophy | n2=en:positive regulation of muscle atrophy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:preserved junctional folds
n1=en:muscular atrophy | n2=en:preserved junctional folds | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:preserved junctional structure seen on muscle biopsy
n1=en:muscular atrophy | n2=en:preserved junctional structure seen on muscle biopsy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:primrose syndrome
n1=en:muscular atrophy | n2=en:primrose syndrome | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:Primrose syndrome
n1=en:muscular atrophy | n2=en:Primrose syndrome | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:prolonged endplate potentials
n1=en:muscular atrophy | n2=en:prolonged endplate potentials | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:proximal muscle weakness, upper and lower limbs, due to peripheral neuropathy, later in disease course
n1=en:muscular atrophy | n2=en:proximal muscle weakness, upper and lower limbs, due to peripheral neuropathy, later in disease course | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:ragged red fibers seen on skeletal muscle biopsy
n1=en:muscular atrophy | n2=en:ragged red fibers seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:ragged red fibers, mainly in type i fibers seen on skeletal muscle biopsy
n1=en:muscular atrophy | n2=en:ragged red fibers, mainly in type i fibers seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:reduced muscle tone
n1=en:muscular atrophy | n2=en:reduced muscle tone | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:reduced postsynaptic cleft area
n1=en:muscular atrophy | n2=en:reduced postsynaptic cleft area | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:repetitive action potentials in response to single nerve stimulation
n1=en:muscular atrophy | n2=en:repetitive action potentials in response to single nerve stimulation | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:repetitive compound muscle action potentials (cmap) in response to single stimulus
n1=en:muscular atrophy | n2=en:repetitive compound muscle action potentials (cmap) in response to single stimulus | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:repetitive response to single nerve stimulation
n1=en:muscular atrophy | n2=en:repetitive response to single nerve stimulation | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:repetitive response to single nerve stimulus
n1=en:muscular atrophy | n2=en:repetitive response to single nerve stimulus | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:rounded, atrophic fibers (family a)
n1=en:muscular atrophy | n2=en:rounded, atrophic fibers (family a) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:scattered necrotic fibers
n1=en:muscular atrophy | n2=en:scattered necrotic fibers | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:secondarily decreased activities of mitochondrial respiratory enzymes (in some patients)
n1=en:muscular atrophy | n2=en:secondarily decreased activities of mitochondrial respiratory enzymes (in some patients) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:shortened open channel duration
n1=en:muscular atrophy | n2=en:shortened open channel duration | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:small nerve terminals
n1=en:muscular atrophy | n2=en:small nerve terminals | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:smooth brain surface
n1=en:muscular atrophy | n2=en:smooth brain surface | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:smooth muscle adaptation
n1=en:muscular atrophy | n2=en:smooth muscle adaptation | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:somatosensory evoked potentials show prolonged latency
n1=en:muscular atrophy | n2=en:somatosensory evoked potentials show prolonged latency | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:some patients do not achieve ability to walk
n1=en:muscular atrophy | n2=en:some patients do not achieve ability to walk | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:some patients have neurologic involvement
n1=en:muscular atrophy | n2=en:some patients have neurologic involvement | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:some patients have no structural brain abnormalities
n1=en:muscular atrophy | n2=en:some patients have no structural brain abnormalities | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:some patients may develop afebrile seizures later in life
n1=en:muscular atrophy | n2=en:some patients may develop afebrile seizures later in life | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:spastic diplegia, symmetric
n1=en:muscular atrophy | n2=en:spastic diplegia, symmetric | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:spastic paraplegia, slowly progressive
n1=en:muscular atrophy | n2=en:spastic paraplegia, slowly progressive | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:spastic-ataxic gait
n1=en:muscular atrophy | n2=en:spastic-ataxic gait | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:spastic-ataxic tetraparesis
n1=en:muscular atrophy | n2=en:spastic-ataxic tetraparesis | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:spasticity (later onset)
n1=en:muscular atrophy | n2=en:spasticity (later onset) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:spasticity (reported in 1 patient)
n1=en:muscular atrophy | n2=en:spasticity (reported in 1 patient) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:spasticity may be present
n1=en:muscular atrophy | n2=en:spasticity may be present | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:spasticity may occur
n1=en:muscular atrophy | n2=en:spasticity may occur | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:spasticity of lower and upper limbs
n1=en:muscular atrophy | n2=en:spasticity of lower and upper limbs | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:spasticity, mainly in the lower limbs
n1=en:muscular atrophy | n2=en:spasticity, mainly in the lower limbs | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:spike-wave discharges
n1=en:muscular atrophy | n2=en:spike-wave discharges | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:sporadic adult-onset ataxia of unknown etiology
n1=en:muscular atrophy | n2=en:sporadic adult-onset ataxia of unknown etiology | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:subsarcolemmal aggregates of abnormal mitochondria with concentric lamellar membranes
n1=en:muscular atrophy | n2=en:subsarcolemmal aggregates of abnormal mitochondria with concentric lamellar membranes | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:superficial rerouting of lymph through the skin
n1=en:muscular atrophy | n2=en:superficial rerouting of lymph through the skin | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:vacuoles in the myofiber cytoplasm
n1=en:muscular atrophy | n2=en:vacuoles in the myofiber cytoplasm | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:variable decreases in mitochondrial respiratory complex enzyme activities
n1=en:muscular atrophy | n2=en:variable decreases in mitochondrial respiratory complex enzyme activities | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:variation in fibrodiameter seen on muscle biopsy
n1=en:muscular atrophy | n2=en:variation in fibrodiameter seen on muscle biopsy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:variation in skeletal muscle fiber diameter
n1=en:muscular atrophy | n2=en:variation in skeletal muscle fiber diameter | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:waste of money
n1=en:muscular atrophy | n2=en:waste of money | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:wastefulness
n1=en:muscular atrophy | n2=en:wastefulness | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:wasting of calf muscles (rare)
n1=en:muscular atrophy | n2=en:wasting of calf muscles (rare) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:weakness worsened by activity
n1=en:muscular atrophy | n2=en:weakness worsened by activity | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:white matter rarefaction
n1=en:muscular atrophy | n2=en:white matter rarefaction | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
en:widening of the synaptic cleft
n1=en:muscular atrophy | n2=en:widening of the synaptic cleft | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
gaspi
n1=en:muscular atrophy | n2=gaspi | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
gaspillage
n1=en:muscular atrophy | n2=gaspillage | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
handicap moteur
n1=en:muscular atrophy | n2=handicap moteur | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
hypoplasie glutéale
n1=en:muscular atrophy | n2=hypoplasie glutéale | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 20 / 0.055 ->
Werdnig-Hoffmann (amyotrophie spinale de)
n1=en:muscular atrophy | n2=Werdnig-Hoffmann (amyotrophie spinale de) | rel=r_associated | relid=0 | w=20
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
amyotrophie péronière de Charcot-Marie-Tooth liée au sexe
n1=en:muscular atrophy | n2=amyotrophie péronière de Charcot-Marie-Tooth liée au sexe | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
amyotrophie spinale de Werdnig-Hoffmann
n1=en:muscular atrophy | n2=amyotrophie spinale de Werdnig-Hoffmann | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
amyotrophie spinale distale de Silver
n1=en:muscular atrophy | n2=amyotrophie spinale distale de Silver | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
atrophie musculaire progressive
n1=en:muscular atrophy | n2=atrophie musculaire progressive | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
atrophie optique
n1=en:muscular atrophy | n2=atrophie optique | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
dystrophie
n1=en:muscular atrophy | n2=dystrophie | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:abnormal axons with sprouting and swelling
n1=en:muscular atrophy | n2=en:abnormal axons with sprouting and swelling | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:abnormal fat accumulation below the triceps (in some patients)
n1=en:muscular atrophy | n2=en:abnormal fat accumulation below the triceps (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:abnormal fat accumulation in axillae (in some patients)
n1=en:muscular atrophy | n2=en:abnormal fat accumulation in axillae (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:abnormal fat accumulation in the back (in some patients)
n1=en:muscular atrophy | n2=en:abnormal fat accumulation in the back (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:abnormal fat distribution
n1=en:muscular atrophy | n2=en:abnormal fat distribution | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:abnormal fiber size variation seen on muscle biopsy
n1=en:muscular atrophy | n2=en:abnormal fiber size variation seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:abnormal glycosylation of alpha-dystroglycan seen on muscle biopsy
n1=en:muscular atrophy | n2=en:abnormal glycosylation of alpha-dystroglycan seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:abnormal mitochondria with paracrystalline inclusions seen on muscle biopsy
n1=en:muscular atrophy | n2=en:abnormal mitochondria with paracrystalline inclusions seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:abnormal mitochondrial morphology
n1=en:muscular atrophy | n2=en:abnormal mitochondrial morphology | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:abnormal mitochondrial proliferation
n1=en:muscular atrophy | n2=en:abnormal mitochondrial proliferation | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:abnormal sarcoplasmic reticulum elements
n1=en:muscular atrophy | n2=en:abnormal sarcoplasmic reticulum elements | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:abnormal subcutaneous fat tissue distribution
n1=en:muscular atrophy | n2=en:abnormal subcutaneous fat tissue distribution | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:absence of some scapular muscles (less common)
n1=en:muscular atrophy | n2=en:absence of some scapular muscles (less common) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:accumulated lipid droplets seen on muscle biopsy
n1=en:muscular atrophy | n2=en:accumulated lipid droplets seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:accumulation of abnormal mitochondria
n1=en:muscular atrophy | n2=en:accumulation of abnormal mitochondria | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:acute rhabdomyolysis
n1=en:muscular atrophy | n2=en:acute rhabdomyolysis | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:adhalin deficiency seen on muscle biopsy
n1=en:muscular atrophy | n2=en:adhalin deficiency seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:adipose tissue shows many adipocytes with multiple small lipid droplets rather than a normal single lipid droplet
n1=en:muscular atrophy | n2=en:adipose tissue shows many adipocytes with multiple small lipid droplets rather than a normal single lipid droplet | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:aggregates contain granular electron-dense material
n1=en:muscular atrophy | n2=en:aggregates contain granular electron-dense material | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:alimentary edema
n1=en:muscular atrophy | n2=en:alimentary edema | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:ankle reflex absent
n1=en:muscular atrophy | n2=en:ankle reflex absent | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:atrophic muscular disorder
n1=en:muscular atrophy | n2=en:atrophic muscular disorder | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:atrophy, mild (in some cases)
n1=en:muscular atrophy | n2=en:atrophy, mild (in some cases) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:axial hypotonia (in some patients)
n1=en:muscular atrophy | n2=en:axial hypotonia (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:axial muscle weakness
n1=en:muscular atrophy | n2=en:axial muscle weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:benign soft tissue developmental anomalies
n1=en:muscular atrophy | n2=en:benign soft tissue developmental anomalies | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:biceps aplasia
n1=en:muscular atrophy | n2=en:biceps aplasia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:biopsy muscle normal
n1=en:muscular atrophy | n2=en:biopsy muscle normal | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:biopsy shows myopathy without vacuoles
n1=en:muscular atrophy | n2=en:biopsy shows myopathy without vacuoles | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:broad-based gait
n1=en:muscular atrophy | n2=en:broad-based gait | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:buffalo hump (rare)
n1=en:muscular atrophy | n2=en:buffalo hump (rare) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:calf and thigh cramping muscle pains
n1=en:muscular atrophy | n2=en:calf and thigh cramping muscle pains | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:calf muscle enlargement
n1=en:muscular atrophy | n2=en:calf muscle enlargement | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:calf muscle hypoplasia
n1=en:muscular atrophy | n2=en:calf muscle hypoplasia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:carpopedal spasm
n1=en:muscular atrophy | n2=en:carpopedal spasm | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:central cores seen on muscle biopsy
n1=en:muscular atrophy | n2=en:central cores seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:central nuclei
n1=en:muscular atrophy | n2=en:central nuclei | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:chronic denervation seen on skeletal muscle biopsy
n1=en:muscular atrophy | n2=en:chronic denervation seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:chronic weakness
n1=en:muscular atrophy | n2=en:chronic weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:clumsiness
n1=en:muscular atrophy | n2=en:clumsiness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:combined mitochondrial respiratory chain deficiency (in most patients)
n1=en:muscular atrophy | n2=en:combined mitochondrial respiratory chain deficiency (in most patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:congophilic eosinophilic inclusions
n1=en:muscular atrophy | n2=en:congophilic eosinophilic inclusions | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:contractures of distal lower limbs
n1=en:muscular atrophy | n2=en:contractures of distal lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:contractures of upper limbs (in some patients)
n1=en:muscular atrophy | n2=en:contractures of upper limbs (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:cox-negative fibers seen on muscle biopsy
n1=en:muscular atrophy | n2=en:cox-negative fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:cytochrome-c oxidase deficiency
n1=en:muscular atrophy | n2=en:cytochrome-c oxidase deficiency | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:deafferentation
n1=en:muscular atrophy | n2=en:deafferentation | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:decreased activities of several mitochondrial respiratory enzymes
n1=en:muscular atrophy | n2=en:decreased activities of several mitochondrial respiratory enzymes | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:decreased activity of cytochrome c oxidase (in most cases)
n1=en:muscular atrophy | n2=en:decreased activity of cytochrome c oxidase (in most cases) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:decreased activity of mitochondrial complex i
n1=en:muscular atrophy | n2=en:decreased activity of mitochondrial complex i | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:decreased density of calcium release units
n1=en:muscular atrophy | n2=en:decreased density of calcium release units | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:decreased exercise tolerance
n1=en:muscular atrophy | n2=en:decreased exercise tolerance | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:decreased glycosylation of alpha-dystroglycan seen on muscle biopsy
n1=en:muscular atrophy | n2=en:decreased glycosylation of alpha-dystroglycan seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:decreased mitochondrial respiratory activities (in some patients)
n1=en:muscular atrophy | n2=en:decreased mitochondrial respiratory activities (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:decreased muscle mass (especially of limbs)
n1=en:muscular atrophy | n2=en:decreased muscle mass (especially of limbs) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:decreased muscle mass (predominantly in lower extremities)
n1=en:muscular atrophy | n2=en:decreased muscle mass (predominantly in lower extremities) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:decreased muscle mass, especially distally
n1=en:muscular atrophy | n2=en:decreased muscle mass, especially distally | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:decreased postsynaptic folding at the neuromuscular junction
n1=en:muscular atrophy | n2=en:decreased postsynaptic folding at the neuromuscular junction | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:decrement of the compound muscle action potential on repetitive stimulation
n1=en:muscular atrophy | n2=en:decrement of the compound muscle action potential on repetitive stimulation | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:decremental response of compound muscle action potential on repetitive nerve stimulation
n1=en:muscular atrophy | n2=en:decremental response of compound muscle action potential on repetitive nerve stimulation | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:defect in glycosylation of alpha-dystroglycan seen on skeletal muscle biopsy
n1=en:muscular atrophy | n2=en:defect in glycosylation of alpha-dystroglycan seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:defective glycosylation of alpha-dystroglycan seen on biopsy
n1=en:muscular atrophy | n2=en:defective glycosylation of alpha-dystroglycan seen on biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:defects in lipoate-containing mitochondrial enzyme complexes
n1=en:muscular atrophy | n2=en:defects in lipoate-containing mitochondrial enzyme complexes | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:deficiency of mitochondrial respiratory enzymes seen on muscle biopsy
n1=en:muscular atrophy | n2=en:deficiency of mitochondrial respiratory enzymes seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:degrading mitochondria
n1=en:muscular atrophy | n2=en:degrading mitochondria | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:denervation of skeletal muscles
n1=en:muscular atrophy | n2=en:denervation of skeletal muscles | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:dermal or subcutaneous infiltrate of spindle-shaped cells arranged in a whorled pattern seen on histology
n1=en:muscular atrophy | n2=en:dermal or subcutaneous infiltrate of spindle-shaped cells arranged in a whorled pattern seen on histology | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:diabetic amyotrophy
n1=en:muscular atrophy | n2=en:diabetic amyotrophy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:difficulty raising arms
n1=en:muscular atrophy | n2=en:difficulty raising arms | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:difficulty running and jumping
n1=en:muscular atrophy | n2=en:difficulty running and jumping | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:difficulty standing
n1=en:muscular atrophy | n2=en:difficulty standing | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:difficulty walking up stairs
n1=en:muscular atrophy | n2=en:difficulty walking up stairs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:disorganized myofilaments seen on muscle biopsy
n1=en:muscular atrophy | n2=en:disorganized myofilaments seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:disruption in the basal lamina seen on skeletal muscle biopsy
n1=en:muscular atrophy | n2=en:disruption in the basal lamina seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:disruption of the sarcolemmal membrane seen on muscle biopsy
n1=en:muscular atrophy | n2=en:disruption of the sarcolemmal membrane seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:disruption plasma membrane (in some patients)
n1=en:muscular atrophy | n2=en:disruption plasma membrane (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal amyotrophy (hands and feet)
n1=en:muscular atrophy | n2=en:distal amyotrophy (hands and feet) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal limb atrophy (upper and lower)
n1=en:muscular atrophy | n2=en:distal limb atrophy (upper and lower) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal limb muscle atrophy due to peripheral neuropathy (lower limbs are more affected than upper limbs)
n1=en:muscular atrophy | n2=en:distal limb muscle atrophy due to peripheral neuropathy (lower limbs are more affected than upper limbs) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal limb muscle atrophy, lower more than upper
n1=en:muscular atrophy | n2=en:distal limb muscle atrophy, lower more than upper | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal limb muscle weakness due to peripheral neuropathy (lower limbs are more affected than upper limbs)
n1=en:muscular atrophy | n2=en:distal limb muscle weakness due to peripheral neuropathy (lower limbs are more affected than upper limbs) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal limb muscle weakness, lower more than upper
n1=en:muscular atrophy | n2=en:distal limb muscle weakness, lower more than upper | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal lower limb anterior compartment weakness
n1=en:muscular atrophy | n2=en:distal lower limb anterior compartment weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal lower limb muscle weakness
n1=en:muscular atrophy | n2=en:distal lower limb muscle weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal muscle atrophy (1 patient)
n1=en:muscular atrophy | n2=en:distal muscle atrophy (1 patient) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal muscle atrophy, lower limbs more severely affected than upper limbs
n1=en:muscular atrophy | n2=en:distal muscle atrophy, lower limbs more severely affected than upper limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal muscle atrophy, predominantly affecting the lower limbs
n1=en:muscular atrophy | n2=en:distal muscle atrophy, predominantly affecting the lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal muscle atrophy, predominantly lower limbs
n1=en:muscular atrophy | n2=en:distal muscle atrophy, predominantly lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal muscle wasting, mild
n1=en:muscular atrophy | n2=en:distal muscle wasting, mild | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal muscle weakness and atrophy of upper and lower limbs due to peripheral neuropathy
n1=en:muscular atrophy | n2=en:distal muscle weakness and atrophy of upper and lower limbs due to peripheral neuropathy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal muscle weakness and atrophy, upper and lower limbs
n1=en:muscular atrophy | n2=en:distal muscle weakness and atrophy, upper and lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal muscle weakness, lower limbs more severely affected than upper limbs
n1=en:muscular atrophy | n2=en:distal muscle weakness, lower limbs more severely affected than upper limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal muscle weakness, predominantly affecting the lower limbs
n1=en:muscular atrophy | n2=en:distal muscle weakness, predominantly affecting the lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal muscle weakness, predominantly lower limbs
n1=en:muscular atrophy | n2=en:distal muscle weakness, predominantly lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal muscular atrophy due to peripheral neuropathy
n1=en:muscular atrophy | n2=en:distal muscular atrophy due to peripheral neuropathy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal myopathy (in 1 family)
n1=en:muscular atrophy | n2=en:distal myopathy (in 1 family) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:distal skeletal muscle atrophy (after long disease duration)
n1=en:muscular atrophy | n2=en:distal skeletal muscle atrophy (after long disease duration) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:dysphagia
n1=en:muscular atrophy | n2=en:dysphagia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:dystrophic changes, mild, seen on muscle biopsy
n1=en:muscular atrophy | n2=en:dystrophic changes, mild, seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:dystrophic features and atrophic fibers seen on muscle biopsy
n1=en:muscular atrophy | n2=en:dystrophic features and atrophic fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:dystrophic features seen on muscle biopsy
n1=en:muscular atrophy | n2=en:dystrophic features seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:easy fatigability with exercise
n1=en:muscular atrophy | n2=en:easy fatigability with exercise | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:easy fatigue
n1=en:muscular atrophy | n2=en:easy fatigue | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:edema
n1=en:muscular atrophy | n2=en:edema | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:edema limbs
n1=en:muscular atrophy | n2=en:edema limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:edematous hands and feet (1 patient)
n1=en:muscular atrophy | n2=en:edematous hands and feet (1 patient) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:enlarged nuclei with central pallor
n1=en:muscular atrophy | n2=en:enlarged nuclei with central pallor | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:enlarged terminal cisternae of the sarcoplasmic reticulum
n1=en:muscular atrophy | n2=en:enlarged terminal cisternae of the sarcoplasmic reticulum | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:enlarged vesicles of sarcoplasmic reticulum origin
n1=en:muscular atrophy | n2=en:enlarged vesicles of sarcoplasmic reticulum origin | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:enteroviral dermatomyositis syndrome
n1=en:muscular atrophy | n2=en:enteroviral dermatomyositis syndrome | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:episodic, nonerythematous, nonpruritic, nontender edema, episodic
n1=en:muscular atrophy | n2=en:episodic, nonerythematous, nonpruritic, nontender edema, episodic | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:evidence of lymphatic rerouting
n1=en:muscular atrophy | n2=en:evidence of lymphatic rerouting | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:exercise capacity decreased
n1=en:muscular atrophy | n2=en:exercise capacity decreased | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:exercise-induced myalgia
n1=en:muscular atrophy | n2=en:exercise-induced myalgia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:exertional leg pain
n1=en:muscular atrophy | n2=en:exertional leg pain | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:extensive fatty infiltration on biopsy
n1=en:muscular atrophy | n2=en:extensive fatty infiltration on biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:face edema
n1=en:muscular atrophy | n2=en:face edema | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:facial muscle atrophy of involved side
n1=en:muscular atrophy | n2=en:facial muscle atrophy of involved side | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:fasciculations (in some patients)
n1=en:muscular atrophy | n2=en:fasciculations (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:fat accumulation in the suprabuttock area
n1=en:muscular atrophy | n2=en:fat accumulation in the suprabuttock area | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:fat pads on the hands and feet
n1=en:muscular atrophy | n2=en:fat pads on the hands and feet | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:fatigue
n1=en:muscular atrophy | n2=en:fatigue | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:fatty deposition
n1=en:muscular atrophy | n2=en:fatty deposition | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:fatty infiltration seen on muscle biopsy
n1=en:muscular atrophy | n2=en:fatty infiltration seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:fiber type variation seen on biopsy
n1=en:muscular atrophy | n2=en:fiber type variation seen on biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:fiber-type grouping pattern
n1=en:muscular atrophy | n2=en:fiber-type grouping pattern | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:fiber-type variability
n1=en:muscular atrophy | n2=en:fiber-type variability | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:fibrillation
n1=en:muscular atrophy | n2=en:fibrillation | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:fibrous dysplasia (rare)
n1=en:muscular atrophy | n2=en:fibrous dysplasia (rare) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:filamentous inclusions in muscle fibers
n1=en:muscular atrophy | n2=en:filamentous inclusions in muscle fibers | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:floppy infant
n1=en:muscular atrophy | n2=en:floppy infant | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:focal lymphocytic and macrophage infiltrates on biopsy
n1=en:muscular atrophy | n2=en:focal lymphocytic and macrophage infiltrates on biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:fragmentation of the neuromuscular junction with pre- and postsynaptic defects
n1=en:muscular atrophy | n2=en:fragmentation of the neuromuscular junction with pre- and postsynaptic defects | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:fragmented mitochondrial network
n1=en:muscular atrophy | n2=en:fragmented mitochondrial network | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:gait disturbance
n1=en:muscular atrophy | n2=en:gait disturbance | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:gait unsteady
n1=en:muscular atrophy | n2=en:gait unsteady | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:gait, drop foot
n1=en:muscular atrophy | n2=en:gait, drop foot | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:generalized hypotonia
n1=en:muscular atrophy | n2=en:generalized hypotonia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:generalized muscle contractions, episodic
n1=en:muscular atrophy | n2=en:generalized muscle contractions, episodic | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:generalized muscle weakness also seen in symptomatic carrier females
n1=en:muscular atrophy | n2=en:generalized muscle weakness also seen in symptomatic carrier females | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:generalized weakness (adult-onset)
n1=en:muscular atrophy | n2=en:generalized weakness (adult-onset) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:glycogen deficiency in muscle fibers
n1=en:muscular atrophy | n2=en:glycogen deficiency in muscle fibers | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:head drop due to neck muscle weakness
n1=en:muscular atrophy | n2=en:head drop due to neck muscle weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:hypertonia
n1=en:muscular atrophy | n2=en:hypertonia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:hypertonicity (uncommon)
n1=en:muscular atrophy | n2=en:hypertonicity (uncommon) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:hypertonicity of the lower limbs
n1=en:muscular atrophy | n2=en:hypertonicity of the lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:hypoactive gag reflex
n1=en:muscular atrophy | n2=en:hypoactive gag reflex | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:hypoglycosylation of alpha-dystroglycan
n1=en:muscular atrophy | n2=en:hypoglycosylation of alpha-dystroglycan | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:hypoplasia of latissimus dorsi muscle
n1=en:muscular atrophy | n2=en:hypoplasia of latissimus dorsi muscle | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:hypoplasia of muscle
n1=en:muscular atrophy | n2=en:hypoplasia of muscle | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:hyporeflexia
n1=en:muscular atrophy | n2=en:hyporeflexia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:hyporeflexia of lower limbs
n1=en:muscular atrophy | n2=en:hyporeflexia of lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:hypotonia, generalized (in some patients)
n1=en:muscular atrophy | n2=en:hypotonia, generalized (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:hypotonia, infantile, severe
n1=en:muscular atrophy | n2=en:hypotonia, infantile, severe | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:hypotonia, mild (1 patient)
n1=en:muscular atrophy | n2=en:hypotonia, mild (1 patient) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:hypotonia, severe, neonatal
n1=en:muscular atrophy | n2=en:hypotonia, severe, neonatal | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:impaired heel-walking
n1=en:muscular atrophy | n2=en:impaired heel-walking | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:impaired mitochondrial respiration
n1=en:muscular atrophy | n2=en:impaired mitochondrial respiration | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:impaired toe-walking
n1=en:muscular atrophy | n2=en:impaired toe-walking | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:inability to sit or hold head up
n1=en:muscular atrophy | n2=en:inability to sit or hold head up | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:inclusions form a lobulated structure seen on electron microscopy
n1=en:muscular atrophy | n2=en:inclusions form a lobulated structure seen on electron microscopy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased centralized nuclei
n1=en:muscular atrophy | n2=en:increased centralized nuclei | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased connective tissue (in some patients)
n1=en:muscular atrophy | n2=en:increased connective tissue (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased endomysial fibrosis
n1=en:muscular atrophy | n2=en:increased endomysial fibrosis | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased fat and fibrous tissue
n1=en:muscular atrophy | n2=en:increased fat and fibrous tissue | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased fiber size variability
n1=en:muscular atrophy | n2=en:increased fiber size variability | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased focal mitochondrial density
n1=en:muscular atrophy | n2=en:increased focal mitochondrial density | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased glycogen in muscle
n1=en:muscular atrophy | n2=en:increased glycogen in muscle | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased intermyofibrillar and subsarcolemmal glycogen
n1=en:muscular atrophy | n2=en:increased intermyofibrillar and subsarcolemmal glycogen | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased lipid
n1=en:muscular atrophy | n2=en:increased lipid | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased mitochondria seen on muscle biopsy
n1=en:muscular atrophy | n2=en:increased mitochondria seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased mitochondria with abnormal cristae
n1=en:muscular atrophy | n2=en:increased mitochondria with abnormal cristae | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased mitochondria with rare paracrystalline inclusions
n1=en:muscular atrophy | n2=en:increased mitochondria with rare paracrystalline inclusions | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased muscle tone (early in life)
n1=en:muscular atrophy | n2=en:increased muscle tone (early in life) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased muscle tone at birth
n1=en:muscular atrophy | n2=en:increased muscle tone at birth | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased numbers of abnormally-shaped mitochondria in subsarcolemmal areas
n1=en:muscular atrophy | n2=en:increased numbers of abnormally-shaped mitochondria in subsarcolemmal areas | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:increased variability of fiber size seen on muscle biopsy
n1=en:muscular atrophy | n2=en:increased variability of fiber size seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:infantile axial hypotonia
n1=en:muscular atrophy | n2=en:infantile axial hypotonia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:intermyofibrillar and subsarcolemmal accumulation of electron-dense material (in some patients)
n1=en:muscular atrophy | n2=en:intermyofibrillar and subsarcolemmal accumulation of electron-dense material (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:internal nuclei seen on biopsy (in some patients)
n1=en:muscular atrophy | n2=en:internal nuclei seen on biopsy (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:internal nuclei seen on muscle biopsy
n1=en:muscular atrophy | n2=en:internal nuclei seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:jitter
n1=en:muscular atrophy | n2=en:jitter | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:knee and hip flexor weakness due to peripheral neuropathy
n1=en:muscular atrophy | n2=en:knee and hip flexor weakness due to peripheral neuropathy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lack of adipose tissue on limbs and femorogluteal regions
n1=en:muscular atrophy | n2=en:lack of adipose tissue on limbs and femorogluteal regions | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lack of integrin alpha-7 staining
n1=en:muscular atrophy | n2=en:lack of integrin alpha-7 staining | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:leg edema
n1=en:muscular atrophy | n2=en:leg edema | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:limb lymphedema (in some patients)
n1=en:muscular atrophy | n2=en:limb lymphedema (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:limb muscle weakness and atrophy, distal, neurogenic
n1=en:muscular atrophy | n2=en:limb muscle weakness and atrophy, distal, neurogenic | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:limb muscular atrophy
n1=en:muscular atrophy | n2=en:limb muscular atrophy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:limb weakness, proximal followed by distal
n1=en:muscular atrophy | n2=en:limb weakness, proximal followed by distal | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:limb-girdle muscle weakness (2 families)
n1=en:muscular atrophy | n2=en:limb-girdle muscle weakness (2 families) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lipid accumulation in muscle tissue
n1=en:muscular atrophy | n2=en:lipid accumulation in muscle tissue | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lipid and glycogen accumulation
n1=en:muscular atrophy | n2=en:lipid and glycogen accumulation | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lipid droplets seen on muscle biopsy
n1=en:muscular atrophy | n2=en:lipid droplets seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lipoatrophic appearance
n1=en:muscular atrophy | n2=en:lipoatrophic appearance | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lipoma
n1=en:muscular atrophy | n2=en:lipoma | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:loss of ambulation (in some patients)
n1=en:muscular atrophy | n2=en:loss of ambulation (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:loss of lower-limb tendon reflexes
n1=en:muscular atrophy | n2=en:loss of lower-limb tendon reflexes | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:loss of sarcomeric striations
n1=en:muscular atrophy | n2=en:loss of sarcomeric striations | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:loss of subcutaneous and visceral adipose tissue, mild
n1=en:muscular atrophy | n2=en:loss of subcutaneous and visceral adipose tissue, mild | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:loss of subcutaneous fat, particularly affecting the limbs
n1=en:muscular atrophy | n2=en:loss of subcutaneous fat, particularly affecting the limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:low maximum workload on exercise testing
n1=en:muscular atrophy | n2=en:low maximum workload on exercise testing | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lower and upper limbs affected
n1=en:muscular atrophy | n2=en:lower and upper limbs affected | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lower limb muscle atrophy (in 2 of 3 families)
n1=en:muscular atrophy | n2=en:lower limb muscle atrophy (in 2 of 3 families) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lower limb muscle hypotrophy
n1=en:muscular atrophy | n2=en:lower limb muscle hypotrophy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lower limb muscle weakness (in 2 of 3 families)
n1=en:muscular atrophy | n2=en:lower limb muscle weakness (in 2 of 3 families) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lower limbs more often affected
n1=en:muscular atrophy | n2=en:lower limbs more often affected | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lymphangiectasia
n1=en:muscular atrophy | n2=en:lymphangiectasia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lymphedema of lower limbs (in some patients)
n1=en:muscular atrophy | n2=en:lymphedema of lower limbs (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lymphedema of upper and/or lower limbs (in some patients)
n1=en:muscular atrophy | n2=en:lymphedema of upper and/or lower limbs (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:lymphoscintigraphy shows impaired lymphatic uptake and drainage
n1=en:muscular atrophy | n2=en:lymphoscintigraphy shows impaired lymphatic uptake and drainage | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:macroglossia
n1=en:muscular atrophy | n2=en:macroglossia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:many fibers with internal nuclei
n1=en:muscular atrophy | n2=en:many fibers with internal nuclei | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:marked variability of fiber size
n1=en:muscular atrophy | n2=en:marked variability of fiber size | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:mild atrophy of the proximal lower limbs
n1=en:muscular atrophy | n2=en:mild atrophy of the proximal lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:mild decrease in mitochondrial respiratory chain activity
n1=en:muscular atrophy | n2=en:mild decrease in mitochondrial respiratory chain activity | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:mild distal muscle atrophy
n1=en:muscular atrophy | n2=en:mild distal muscle atrophy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:mild proximal muscle weakness (<10% of patients)
n1=en:muscular atrophy | n2=en:mild proximal muscle weakness (<10% of patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:mildly decreased cytochrome c oxidase activity
n1=en:muscular atrophy | n2=en:mildly decreased cytochrome c oxidase activity | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:minicores (in some)
n1=en:muscular atrophy | n2=en:minicores (in some) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:minicores or core-like regions may be present
n1=en:muscular atrophy | n2=en:minicores or core-like regions may be present | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:mitochondrial myopathy
n1=en:muscular atrophy | n2=en:mitochondrial myopathy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:mitochondrial vacuolization seen on muscle biopsy
n1=en:muscular atrophy | n2=en:mitochondrial vacuolization seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:multi-core congenital myopathy
n1=en:muscular atrophy | n2=en:multi-core congenital myopathy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:multiple mitochondrial respiratory enzymes deficiencies seen on biopsy
n1=en:muscular atrophy | n2=en:multiple mitochondrial respiratory enzymes deficiencies seen on biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle aches, cramps
n1=en:muscular atrophy | n2=en:muscle aches, cramps | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle amyotrophy
n1=en:muscular atrophy | n2=en:muscle amyotrophy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle atrophy (1 patient)
n1=en:muscular atrophy | n2=en:muscle atrophy (1 patient) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle atrophy (in some patients)
n1=en:muscular atrophy | n2=en:muscle atrophy (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle atrophy, diffuse, severe
n1=en:muscular atrophy | n2=en:muscle atrophy, diffuse, severe | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle atrophy, mild
n1=en:muscular atrophy | n2=en:muscle atrophy, mild | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle atrophy, primarily in the legs
n1=en:muscular atrophy | n2=en:muscle atrophy, primarily in the legs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle atrophy, proximal and distal (predominant lower limb involvement)
n1=en:muscular atrophy | n2=en:muscle atrophy, proximal and distal (predominant lower limb involvement) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle atrophy, severe
n1=en:muscular atrophy | n2=en:muscle atrophy, severe | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy may show deficiency of multiple mitochondrial respiratory complexes
n1=en:muscular atrophy | n2=en:muscle biopsy may show deficiency of multiple mitochondrial respiratory complexes | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows 'spheroid bodies' in type 1 muscle fibers
n1=en:muscular atrophy | n2=en:muscle biopsy shows 'spheroid bodies' in type 1 muscle fibers | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows atrophic fibers
n1=en:muscular atrophy | n2=en:muscle biopsy shows atrophic fibers | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows atrophy
n1=en:muscular atrophy | n2=en:muscle biopsy shows atrophy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows cytochrome c oxidase-negative fibers
n1=en:muscular atrophy | n2=en:muscle biopsy shows cytochrome c oxidase-negative fibers | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows decreased glycosylation of alpha-dystroglycan
n1=en:muscular atrophy | n2=en:muscle biopsy shows decreased glycosylation of alpha-dystroglycan | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows dystrophic features (later in disease course)
n1=en:muscular atrophy | n2=en:muscle biopsy shows dystrophic features (later in disease course) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows fiber type variation (in some patients)
n1=en:muscular atrophy | n2=en:muscle biopsy shows fiber type variation (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows grouped atrophy
n1=en:muscular atrophy | n2=en:muscle biopsy shows grouped atrophy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows groups of small angulated fibers consistent with denervation
n1=en:muscular atrophy | n2=en:muscle biopsy shows groups of small angulated fibers consistent with denervation | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows hypoglycosylation of alpha-dystroglycan
n1=en:muscular atrophy | n2=en:muscle biopsy shows hypoglycosylation of alpha-dystroglycan | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows lipid droplets
n1=en:muscular atrophy | n2=en:muscle biopsy shows lipid droplets | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows mitochondrial aggregates
n1=en:muscular atrophy | n2=en:muscle biopsy shows mitochondrial aggregates | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows nemaline rods
n1=en:muscular atrophy | n2=en:muscle biopsy shows nemaline rods | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows neurogenic atrophy affecting both fibers types
n1=en:muscular atrophy | n2=en:muscle biopsy shows neurogenic atrophy affecting both fibers types | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows peripheral accumulation of abnormal mitochondria
n1=en:muscular atrophy | n2=en:muscle biopsy shows peripheral accumulation of abnormal mitochondria | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle biopsy shows sarcoplasmic rods in myofibers
n1=en:muscular atrophy | n2=en:muscle biopsy shows sarcoplasmic rods in myofibers | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle degeneration
n1=en:muscular atrophy | n2=en:muscle degeneration | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle fatigability
n1=en:muscular atrophy | n2=en:muscle fatigability | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle fatigue
n1=en:muscular atrophy | n2=en:muscle fatigue | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle fiber splitting (in some patients)
n1=en:muscular atrophy | n2=en:muscle fiber splitting (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle fibers contain internal nuclei
n1=en:muscular atrophy | n2=en:muscle fibers contain internal nuclei | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle hypertrophy in affected area
n1=en:muscular atrophy | n2=en:muscle hypertrophy in affected area | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle pain after exercise
n1=en:muscular atrophy | n2=en:muscle pain after exercise | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle pain and cramping on exertion
n1=en:muscular atrophy | n2=en:muscle pain and cramping on exertion | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle paralysis, episodic
n1=en:muscular atrophy | n2=en:muscle paralysis, episodic | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle strength and bulk is preserved
n1=en:muscular atrophy | n2=en:muscle strength and bulk is preserved | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle wasting (especially legs and arms)
n1=en:muscular atrophy | n2=en:muscle wasting (especially legs and arms) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle wasting, severe, primarily in the legs
n1=en:muscular atrophy | n2=en:muscle wasting, severe, primarily in the legs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness (1 patient)
n1=en:muscular atrophy | n2=en:muscle weakness (1 patient) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness (in 90% of patients)
n1=en:muscular atrophy | n2=en:muscle weakness (in 90% of patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness and atrophy
n1=en:muscular atrophy | n2=en:muscle weakness and atrophy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness and atrophy, distal
n1=en:muscular atrophy | n2=en:muscle weakness and atrophy, distal | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness and atrophy, progressive
n1=en:muscular atrophy | n2=en:muscle weakness and atrophy, progressive | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness due to peripheral neuropathy
n1=en:muscular atrophy | n2=en:muscle weakness due to peripheral neuropathy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness following prolonged exercise
n1=en:muscular atrophy | n2=en:muscle weakness following prolonged exercise | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness may affect upper limbs
n1=en:muscular atrophy | n2=en:muscle weakness may affect upper limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness of proximal and distal upper and lower limbs
n1=en:muscular atrophy | n2=en:muscle weakness of proximal and distal upper and lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, distal (in some patients)
n1=en:muscular atrophy | n2=en:muscle weakness, distal (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, distal more than proximal
n1=en:muscular atrophy | n2=en:muscle weakness, distal more than proximal | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, distal, restricted to the lower limbs
n1=en:muscular atrophy | n2=en:muscle weakness, distal, restricted to the lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, episodic
n1=en:muscular atrophy | n2=en:muscle weakness, episodic | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, hypokalemia-related
n1=en:muscular atrophy | n2=en:muscle weakness, hypokalemia-related | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, limb-girdle (lower and upper limbs may be affected)
n1=en:muscular atrophy | n2=en:muscle weakness, limb-girdle (lower and upper limbs may be affected) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, limb-girdle, mild
n1=en:muscular atrophy | n2=en:muscle weakness, limb-girdle, mild | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, mainly proximal and axial
n1=en:muscular atrophy | n2=en:muscle weakness, mainly proximal and axial | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, predominantly proximal (in some patients)
n1=en:muscular atrophy | n2=en:muscle weakness, predominantly proximal (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, primarily proximal
n1=en:muscular atrophy | n2=en:muscle weakness, primarily proximal | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, proximal and distal (predominant lower limb involvement)
n1=en:muscular atrophy | n2=en:muscle weakness, proximal and distal (predominant lower limb involvement) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, proximal and distal, affecting upper and lower limbs
n1=en:muscular atrophy | n2=en:muscle weakness, proximal and distal, affecting upper and lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, proximal, distal, and axial, severe
n1=en:muscular atrophy | n2=en:muscle weakness, proximal, distal, and axial, severe | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, proximal, lower limbs (upper limbs may become affected later)
n1=en:muscular atrophy | n2=en:muscle weakness, proximal, lower limbs (upper limbs may become affected later) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, proximal, pelvic girdle (in severe cases)
n1=en:muscular atrophy | n2=en:muscle weakness, proximal, pelvic girdle (in severe cases) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, proximal, upper and lower limbs affected
n1=en:muscular atrophy | n2=en:muscle weakness, proximal, upper and lower limbs affected | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, severe
n1=en:muscular atrophy | n2=en:muscle weakness, severe | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, severe, axial and proximal predominance
n1=en:muscular atrophy | n2=en:muscle weakness, severe, axial and proximal predominance | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, severe, proximal and distal
n1=en:muscular atrophy | n2=en:muscle weakness, severe, proximal and distal | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscle weakness, symmetric, proximal, lower limbs
n1=en:muscular atrophy | n2=en:muscle weakness, symmetric, proximal, lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscular dystrophy (in some patients)
n1=en:muscular atrophy | n2=en:muscular dystrophy (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscular dystrophy with variable age of onset (infancy to young adult)
n1=en:muscular atrophy | n2=en:muscular dystrophy with variable age of onset (infancy to young adult) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:muscular hypotonia of the trunk
n1=en:muscular atrophy | n2=en:muscular hypotonia of the trunk | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myalgia with febrile episodes (rare)
n1=en:muscular atrophy | n2=en:myalgia with febrile episodes (rare) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myoclonic spasms
n1=en:muscular atrophy | n2=en:myoclonic spasms | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myofibrillar myopathy
n1=en:muscular atrophy | n2=en:myofibrillar myopathy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myofibromatosis
n1=en:muscular atrophy | n2=en:myofibromatosis | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myofibromatosis affecting skin, muscle, bone, and viscera
n1=en:muscular atrophy | n2=en:myofibromatosis affecting skin, muscle, bone, and viscera | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myogenic profile on electromyography
n1=en:muscular atrophy | n2=en:myogenic profile on electromyography | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myopathic changes seen muscle biopsy
n1=en:muscular atrophy | n2=en:myopathic changes seen muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myopathic changes seen on biopsy
n1=en:muscular atrophy | n2=en:myopathic changes seen on biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myopathic features seen on biopsy
n1=en:muscular atrophy | n2=en:myopathic features seen on biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myopathy (in some patients)
n1=en:muscular atrophy | n2=en:myopathy (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myopathy with abnormal lipid metabolism
n1=en:muscular atrophy | n2=en:myopathy with abnormal lipid metabolism | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myopathy, mild
n1=en:muscular atrophy | n2=en:myopathy, mild | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myosin storage myopathy (in some patients)
n1=en:muscular atrophy | n2=en:myosin storage myopathy (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myositis (in some patients)
n1=en:muscular atrophy | n2=en:myositis (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myotonia
n1=en:muscular atrophy | n2=en:myotonia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:myotonia (delayed muscle relaxation after contraction)
n1=en:muscular atrophy | n2=en:myotonia (delayed muscle relaxation after contraction) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:neck muscle weakness
n1=en:muscular atrophy | n2=en:neck muscle weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:necrosis and degeneration seen on muscle biopsy
n1=en:muscular atrophy | n2=en:necrosis and degeneration seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:necrotic and atrophic fibers with centralized nuclei
n1=en:muscular atrophy | n2=en:necrotic and atrophic fibers with centralized nuclei | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:necrotic change
n1=en:muscular atrophy | n2=en:necrotic change | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:necrotic process
n1=en:muscular atrophy | n2=en:necrotic process | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:nemaline bodies
n1=en:muscular atrophy | n2=en:nemaline bodies | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:nemaline myopathy (in 1 reported male)
n1=en:muscular atrophy | n2=en:nemaline myopathy (in 1 reported male) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:nemaline rods (rare)
n1=en:muscular atrophy | n2=en:nemaline rods (rare) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:neonatal hypertonias
n1=en:muscular atrophy | n2=en:neonatal hypertonias | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:neonatal hypotonia
n1=en:muscular atrophy | n2=en:neonatal hypotonia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:neurogenic changes
n1=en:muscular atrophy | n2=en:neurogenic changes | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:neuropathic process seen on muscle biopsy
n1=en:muscular atrophy | n2=en:neuropathic process seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:no myofibrillar abnormalities or protein aggregation
n1=en:muscular atrophy | n2=en:no myofibrillar abnormalities or protein aggregation | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:noninflammatory myopathy with rimmed vacuoles and atrophic fibers seen on muscle biopsy
n1=en:muscular atrophy | n2=en:noninflammatory myopathy with rimmed vacuoles and atrophic fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:nonspecific myopathic changes
n1=en:muscular atrophy | n2=en:nonspecific myopathic changes | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:nonspecific myopathic changes seen on biopsy
n1=en:muscular atrophy | n2=en:nonspecific myopathic changes seen on biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:nonspecific myopathic changes without dystrophic or inflammatory changes seen on muscle biopsy
n1=en:muscular atrophy | n2=en:nonspecific myopathic changes without dystrophic or inflammatory changes seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:normal phosphorylase kinase activity in muscle
n1=en:muscular atrophy | n2=en:normal phosphorylase kinase activity in muscle | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:numerous vacuole-like areas
n1=en:muscular atrophy | n2=en:numerous vacuole-like areas | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:painful swelling in aponeuroses
n1=en:muscular atrophy | n2=en:painful swelling in aponeuroses | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:paracrystalline inclusions
n1=en:muscular atrophy | n2=en:paracrystalline inclusions | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:paucity or absence of lymph nodes in the axillae and above the inguinal ligaments seen on scintilymphangiography
n1=en:muscular atrophy | n2=en:paucity or absence of lymph nodes in the axillae and above the inguinal ligaments seen on scintilymphangiography | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:pelvic girdle muscle atrophy
n1=en:muscular atrophy | n2=en:pelvic girdle muscle atrophy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:pelvic girdle weakness
n1=en:muscular atrophy | n2=en:pelvic girdle weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:percussion myotonias
n1=en:muscular atrophy | n2=en:percussion myotonias | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:peroneal muscle weakness
n1=en:muscular atrophy | n2=en:peroneal muscle weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:peroneal muscle weakness and atrophy due to peripheral neuropathy
n1=en:muscular atrophy | n2=en:peroneal muscle weakness and atrophy due to peripheral neuropathy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:plantar fibromatosis
n1=en:muscular atrophy | n2=en:plantar fibromatosis | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:polyglucosan accumulation
n1=en:muscular atrophy | n2=en:polyglucosan accumulation | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:polymyositis
n1=en:muscular atrophy | n2=en:polymyositis | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:poor head control
n1=en:muscular atrophy | n2=en:poor head control | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:poor muscle mass
n1=en:muscular atrophy | n2=en:poor muscle mass | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:poor sarcomeric structure (in some patients)
n1=en:muscular atrophy | n2=en:poor sarcomeric structure (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:predominance of oxidative fibers
n1=en:muscular atrophy | n2=en:predominance of oxidative fibers | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:predominantly lower limb lymphedema
n1=en:muscular atrophy | n2=en:predominantly lower limb lymphedema | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:preservation of visceral, neck, and axillary fat pads
n1=en:muscular atrophy | n2=en:preservation of visceral, neck, and axillary fat pads | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:presynaptic defect at the neuromuscular junction
n1=en:muscular atrophy | n2=en:presynaptic defect at the neuromuscular junction | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:progressive muscle weakness
n1=en:muscular atrophy | n2=en:progressive muscle weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:progressive proximal muscle involvement
n1=en:muscular atrophy | n2=en:progressive proximal muscle involvement | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:prominent veins, lower limbs
n1=en:muscular atrophy | n2=en:prominent veins, lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:protein aggregates immunopositive for actin and desmin
n1=en:muscular atrophy | n2=en:protein aggregates immunopositive for actin and desmin | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:protein aggregates resembling myofibrillar myopathy may be present
n1=en:muscular atrophy | n2=en:protein aggregates resembling myofibrillar myopathy may be present | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:proximal lower limb muscle weakness, later (in some patients)
n1=en:muscular atrophy | n2=en:proximal lower limb muscle weakness, later (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:proximal muscle atrophy (in some patients)
n1=en:muscular atrophy | n2=en:proximal muscle atrophy (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:proximal muscle weakness
n1=en:muscular atrophy | n2=en:proximal muscle weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:proximal muscle weakness (120270.0002)
n1=en:muscular atrophy | n2=en:proximal muscle weakness (120270.0002) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:proximal muscle weakness (in some patients)
n1=en:muscular atrophy | n2=en:proximal muscle weakness (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:proximal muscle weakness and atrophy (may occur later)
n1=en:muscular atrophy | n2=en:proximal muscle weakness and atrophy (may occur later) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:proximal muscle weakness, less severe
n1=en:muscular atrophy | n2=en:proximal muscle weakness, less severe | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:proximal muscle weakness, limb-girdle distribution
n1=en:muscular atrophy | n2=en:proximal muscle weakness, limb-girdle distribution | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:proximal muscle weakness, lower limbs, mild
n1=en:muscular atrophy | n2=en:proximal muscle weakness, lower limbs, mild | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:proximal muscle weakness, mild (in some patients)
n1=en:muscular atrophy | n2=en:proximal muscle weakness, mild (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:proximal muscle weakness, mild, of shoulder and hip girdle muscles (in some patients)
n1=en:muscular atrophy | n2=en:proximal muscle weakness, mild, of shoulder and hip girdle muscles (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:proximal muscles may be mildly affected
n1=en:muscular atrophy | n2=en:proximal muscles may be mildly affected | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:proximal muscles more often affected
n1=en:muscular atrophy | n2=en:proximal muscles more often affected | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:quadriceps aplasia
n1=en:muscular atrophy | n2=en:quadriceps aplasia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:ragged red fibers (in some patients)
n1=en:muscular atrophy | n2=en:ragged red fibers (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:ragged red fibers seen on biopsy
n1=en:muscular atrophy | n2=en:ragged red fibers seen on biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:rare necrotic fibers
n1=en:muscular atrophy | n2=en:rare necrotic fibers | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:recovery between attacks
n1=en:muscular atrophy | n2=en:recovery between attacks | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:reduced activity of mitochondrial respiratory chains (1 family)
n1=en:muscular atrophy | n2=en:reduced activity of mitochondrial respiratory chains (1 family) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:reduced lower limb subcutaneous fat
n1=en:muscular atrophy | n2=en:reduced lower limb subcutaneous fat | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:reduced subcutaneous adipose tissue
n1=en:muscular atrophy | n2=en:reduced subcutaneous adipose tissue | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:redundancy of basal lamina with accumulated debris
n1=en:muscular atrophy | n2=en:redundancy of basal lamina with accumulated debris | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:relative muscle weakness, especially in pelvic girdle
n1=en:muscular atrophy | n2=en:relative muscle weakness, especially in pelvic girdle | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:relative sparing of the rectus femoris
n1=en:muscular atrophy | n2=en:relative sparing of the rectus femoris | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:relative sparing of the tibialis anterior
n1=en:muscular atrophy | n2=en:relative sparing of the tibialis anterior | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:replacement of myofibers with connective tissue
n1=en:muscular atrophy | n2=en:replacement of myofibers with connective tissue | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:rhabdomyolysis (in some patients)
n1=en:muscular atrophy | n2=en:rhabdomyolysis (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:rigidity (uncommon)
n1=en:muscular atrophy | n2=en:rigidity (uncommon) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:rimmed vacuoles
n1=en:muscular atrophy | n2=en:rimmed vacuoles | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:ring fibers
n1=en:muscular atrophy | n2=en:ring fibers | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:roussy-levy syndrome (disorder)
n1=en:muscular atrophy | n2=en:roussy-levy syndrome (disorder) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:sarcomere disappearance seen on muscle biopsy
n1=en:muscular atrophy | n2=en:sarcomere disappearance seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:sarcoplasmic accumulation of electron-dense granulofilamentous material
n1=en:muscular atrophy | n2=en:sarcoplasmic accumulation of electron-dense granulofilamentous material | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:scapular muscle atrophy
n1=en:muscular atrophy | n2=en:scapular muscle atrophy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:scapuloperoneal weakness
n1=en:muscular atrophy | n2=en:scapuloperoneal weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:secondary hypertrophy
n1=en:muscular atrophy | n2=en:secondary hypertrophy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:secondary loss of merosin and desmin
n1=en:muscular atrophy | n2=en:secondary loss of merosin and desmin | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:secondary myopathic changes
n1=en:muscular atrophy | n2=en:secondary myopathic changes | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:severe muscle wasting and atrophy, primarily in the legs
n1=en:muscular atrophy | n2=en:severe muscle wasting and atrophy, primarily in the legs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:severe muscular hypotonia
n1=en:muscular atrophy | n2=en:severe muscular hypotonia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:shoulder girdle muscle weakness and atrophy, progressive
n1=en:muscular atrophy | n2=en:shoulder girdle muscle weakness and atrophy, progressive | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:signs of denervation seen on biopsy
n1=en:muscular atrophy | n2=en:signs of denervation seen on biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:skeletal muscle atrophy
n1=en:muscular atrophy | n2=en:skeletal muscle atrophy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:skeletal muscle damage
n1=en:muscular atrophy | n2=en:skeletal muscle damage | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:skeletal muscle weakness
n1=en:muscular atrophy | n2=en:skeletal muscle weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:slim, muscular build (in some patients)
n1=en:muscular atrophy | n2=en:slim, muscular build (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:slowly-progressive muscle wasting and weakness with humeroperoneal and scapuloperoneal distribution
n1=en:muscular atrophy | n2=en:slowly-progressive muscle wasting and weakness with humeroperoneal and scapuloperoneal distribution | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:small endplate
n1=en:muscular atrophy | n2=en:small endplate | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:small or absent axon terminals
n1=en:muscular atrophy | n2=en:small or absent axon terminals | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:small rounded fibers
n1=en:muscular atrophy | n2=en:small rounded fibers | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:small, angulated muscle fibers seen on muscle biopsy
n1=en:muscular atrophy | n2=en:small, angulated muscle fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:small, firm, rubbery, flesh-colored nodules most commonly found on the head, neck, and trunk
n1=en:muscular atrophy | n2=en:small, firm, rubbery, flesh-colored nodules most commonly found on the head, neck, and trunk | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:spheroid bodies are composed of fine filamentous (myofibrillar) material
n1=en:muscular atrophy | n2=en:spheroid bodies are composed of fine filamentous (myofibrillar) material | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:stiffness (uncommon)
n1=en:muscular atrophy | n2=en:stiffness (uncommon) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:structurally abnormal mitochondria
n1=en:muscular atrophy | n2=en:structurally abnormal mitochondria | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:subcutaneous edema
n1=en:muscular atrophy | n2=en:subcutaneous edema | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:subcutaneous fat markedly reduced
n1=en:muscular atrophy | n2=en:subcutaneous fat markedly reduced | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:subsarcolemmal accumulation of normal mitochondria (in some patients)
n1=en:muscular atrophy | n2=en:subsarcolemmal accumulation of normal mitochondria (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:subsarcolemmal lipofuscin-positive deposits
n1=en:muscular atrophy | n2=en:subsarcolemmal lipofuscin-positive deposits | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:subsarcolemmal mitochondrial aggregates
n1=en:muscular atrophy | n2=en:subsarcolemmal mitochondrial aggregates | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:swelling of the hands and feet (in 1 patient)
n1=en:muscular atrophy | n2=en:swelling of the hands and feet (in 1 patient) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:swelling of the hands and feet, episodic
n1=en:muscular atrophy | n2=en:swelling of the hands and feet, episodic | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:symmetrical muscle wasting
n1=en:muscular atrophy | n2=en:symmetrical muscle wasting | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:symmetrical, proximal limb muscle atrophy (pelvic, scapular, trunk muscles)
n1=en:muscular atrophy | n2=en:symmetrical, proximal limb muscle atrophy (pelvic, scapular, trunk muscles) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:thenar eminence hypoplasia
n1=en:muscular atrophy | n2=en:thenar eminence hypoplasia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:thick palmar fascia
n1=en:muscular atrophy | n2=en:thick palmar fascia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:thickening of fascia of forearm
n1=en:muscular atrophy | n2=en:thickening of fascia of forearm | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:thin filament shortening and disorganization (in some patients)
n1=en:muscular atrophy | n2=en:thin filament shortening and disorganization (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:toe and foot dorsiflexor weakness
n1=en:muscular atrophy | n2=en:toe and foot dorsiflexor weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:toe-walking gait
n1=en:muscular atrophy | n2=en:toe-walking gait | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:tortuous lymphatic tracts
n1=en:muscular atrophy | n2=en:tortuous lymphatic tracts | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:transient eosinophilic myositis (seen on muscle biopsy) in the first decade
n1=en:muscular atrophy | n2=en:transient eosinophilic myositis (seen on muscle biopsy) in the first decade | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:tremor of the upper limb
n1=en:muscular atrophy | n2=en:tremor of the upper limb | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:triceps aplasia
n1=en:muscular atrophy | n2=en:triceps aplasia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:tubular aggregates (in some patients)
n1=en:muscular atrophy | n2=en:tubular aggregates (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:tubular aggregates mainly in type 1 fibers
n1=en:muscular atrophy | n2=en:tubular aggregates mainly in type 1 fibers | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:tubular aggregates seen on biopsy
n1=en:muscular atrophy | n2=en:tubular aggregates seen on biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:tubular aggregates seen on muscle biopsy
n1=en:muscular atrophy | n2=en:tubular aggregates seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:type 1 fiber atrophy seen on muscle biopsy
n1=en:muscular atrophy | n2=en:type 1 fiber atrophy seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:type 1 fiber predominance seen on muscle biopsy
n1=en:muscular atrophy | n2=en:type 1 fiber predominance seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:type 2 fiber atrophy see on biopsy
n1=en:muscular atrophy | n2=en:type 2 fiber atrophy see on biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:type 2 fiber predominance
n1=en:muscular atrophy | n2=en:type 2 fiber predominance | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:ubiquinone decreased
n1=en:muscular atrophy | n2=en:ubiquinone decreased | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:umbilical hernia
n1=en:muscular atrophy | n2=en:umbilical hernia | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:unable to walk
n1=en:muscular atrophy | n2=en:unable to walk | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:upper and/or lower limbs may be affected
n1=en:muscular atrophy | n2=en:upper and/or lower limbs may be affected | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:upper limb muscle weakness may be more severe than lower limb weakness
n1=en:muscular atrophy | n2=en:upper limb muscle weakness may be more severe than lower limb weakness | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:vacuoles containing neutral lipids seen on muscle biopsy
n1=en:muscular atrophy | n2=en:vacuoles containing neutral lipids seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:vacuoles predominantly in type 2 fibers seen on muscle biopsy
n1=en:muscular atrophy | n2=en:vacuoles predominantly in type 2 fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:variability in fiber size
n1=en:muscular atrophy | n2=en:variability in fiber size | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:variable deficiencies of mitochondrial respiratory chain enzymes
n1=en:muscular atrophy | n2=en:variable deficiencies of mitochondrial respiratory chain enzymes | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:wasted lower leg muscles
n1=en:muscular atrophy | n2=en:wasted lower leg muscles | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:weak extraocular muscles
n1=en:muscular atrophy | n2=en:weak extraocular muscles | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:weakness of all intrinsic hand muscles (later)
n1=en:muscular atrophy | n2=en:weakness of all intrinsic hand muscles (later) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:weakness of neck extensors (rare)
n1=en:muscular atrophy | n2=en:weakness of neck extensors (rare) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:weakness of the anterior tibial muscle and toe extensors
n1=en:muscular atrophy | n2=en:weakness of the anterior tibial muscle and toe extensors | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:weakness of the extensor muscles of the hands (initially)
n1=en:muscular atrophy | n2=en:weakness of the extensor muscles of the hands (initially) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:weakness of the intrinsic hand muscles (in some patients)
n1=en:muscular atrophy | n2=en:weakness of the intrinsic hand muscles (in some patients) | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:weakness, axial and limb muscles, upper limb muscles more affected than lower limbs
n1=en:muscular atrophy | n2=en:weakness, axial and limb muscles, upper limb muscles more affected than lower limbs | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:wide variation in fiber size
n1=en:muscular atrophy | n2=en:wide variation in fiber size | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
en:wrist swelling
n1=en:muscular atrophy | n2=en:wrist swelling | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
Maladies
n1=en:muscular atrophy | n2=Maladies | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 15 / 0.041 ->
neuropathie
n1=en:muscular atrophy | n2=neuropathie | rel=r_associated | relid=0 | w=15
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
a-
n1=en:muscular atrophy | n2=a- | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ABCA4 gene
n1=en:muscular atrophy | n2=ABCA4 gene | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
abêtalipoprotéinémie
n1=en:muscular atrophy | n2=abêtalipoprotéinémie | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
albinisme oculaire
n1=en:muscular atrophy | n2=albinisme oculaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
altération de l'état général
n1=en:muscular atrophy | n2=altération de l'état général | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amaigrissement pathologique
n1=en:muscular atrophy | n2=amaigrissement pathologique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie à forme werdnig-hoffmann
n1=en:muscular atrophy | n2=amyotrophie à forme werdnig-hoffmann | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie bulbo-spinale héréditaire liée à l'x
n1=en:muscular atrophy | n2=amyotrophie bulbo-spinale héréditaire liée à l'x | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie bulbospinale héréditaire liée à l'x
n1=en:muscular atrophy | n2=amyotrophie bulbospinale héréditaire liée à l'x | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie d'aran duchenne
n1=en:muscular atrophy | n2=amyotrophie d'aran duchenne | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie de charcot-marie-tooth
n1=en:muscular atrophy | n2=amyotrophie de charcot-marie-tooth | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie de Charcot-Marie-Tooth
n1=en:muscular atrophy | n2=amyotrophie de Charcot-Marie-Tooth | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie de charcot-marie-tooth, forme hypertrophique
n1=en:muscular atrophy | n2=amyotrophie de charcot-marie-tooth, forme hypertrophique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie de charcot-marie-tooth, forme neuronale
n1=en:muscular atrophy | n2=amyotrophie de charcot-marie-tooth, forme neuronale | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie myogène
n1=en:muscular atrophy | n2=amyotrophie myogène | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie neurale
n1=en:muscular atrophy | n2=amyotrophie neurale | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie neurogène familiale pseudo-myopathique de la seconde enfance
n1=en:muscular atrophy | n2=amyotrophie neurogène familiale pseudo-myopathique de la seconde enfance | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie neurogène juvénile précoce pseudo-myopathique
n1=en:muscular atrophy | n2=amyotrophie neurogène juvénile précoce pseudo-myopathique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie péronière de Charcot-Marie-Tooth combinée ? l'ataxie de Friedreich
n1=en:muscular atrophy | n2=amyotrophie péronière de Charcot-Marie-Tooth combinée ? l'ataxie de Friedreich | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie post-asthmatique aiguë
n1=en:muscular atrophy | n2=amyotrophie post-asthmatique aiguë | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinale
n1=en:muscular atrophy | n2=amyotrophie spinale | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinale antérieure de type III
n1=en:muscular atrophy | n2=amyotrophie spinale antérieure de type III | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinale antérieure dégénérative de type III
n1=en:muscular atrophy | n2=amyotrophie spinale antérieure dégénérative de type III | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinale de forme scapulo-péronière
n1=en:muscular atrophy | n2=amyotrophie spinale de forme scapulo-péronière | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinale infantile
n1=en:muscular atrophy | n2=amyotrophie spinale infantile | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinale juvénile
n1=en:muscular atrophy | n2=amyotrophie spinale juvénile | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinale juvénile pseudomyopathique
n1=en:muscular atrophy | n2=amyotrophie spinale juvénile pseudomyopathique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinale juvénile pseudomyopathique amyotrophie spinale proximale amyotrophies spinales progressives
n1=en:muscular atrophy | n2=amyotrophie spinale juvénile pseudomyopathique amyotrophie spinale proximale amyotrophies spinales progressives | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinale oculo-pharyngée
n1=en:muscular atrophy | n2=amyotrophie spinale oculo-pharyngée | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinale proximale
n1=en:muscular atrophy | n2=amyotrophie spinale proximale | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinale proximale liée au gène SMN1
n1=en:muscular atrophy | n2=amyotrophie spinale proximale liée au gène SMN1 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinale scapulo-péronière
n1=en:muscular atrophy | n2=amyotrophie spinale scapulo-péronière | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spino-bulbaire
n1=en:muscular atrophy | n2=amyotrophie spino-bulbaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spino-bulbaire liée à l'x
n1=en:muscular atrophy | n2=amyotrophie spino-bulbaire liée à l'x | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinobulbaire
n1=en:muscular atrophy | n2=amyotrophie spinobulbaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie spinobulbaire liée à l'x
n1=en:muscular atrophy | n2=amyotrophie spinobulbaire liée à l'x | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
amyotrophie type aran-duchenne
n1=en:muscular atrophy | n2=amyotrophie type aran-duchenne | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
anomalie de la coordination
n1=en:muscular atrophy | n2=anomalie de la coordination | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
anomalies de la démarche et de la motilité
n1=en:muscular atrophy | n2=anomalies de la démarche et de la motilité | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
aplasie rétinienne congénitale
n1=en:muscular atrophy | n2=aplasie rétinienne congénitale | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
apparition
n1=en:muscular atrophy | n2=apparition | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
Atad (sonde cervico-utérine d')
n1=en:muscular atrophy | n2=Atad (sonde cervico-utérine d') | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie aigüe de Leyden-Westphal
n1=en:muscular atrophy | n2=ataxie aigüe de Leyden-Westphal | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie appendiculaire
n1=en:muscular atrophy | n2=ataxie appendiculaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie avec déficit isolé en vitamine E
n1=en:muscular atrophy | n2=ataxie avec déficit isolé en vitamine E | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie cérébelleuse cataracte
n1=en:muscular atrophy | n2=ataxie cérébelleuse cataracte | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie cérébelleuse cataracte, surdité et démence ou psychose
n1=en:muscular atrophy | n2=ataxie cérébelleuse cataracte, surdité et démence ou psychose | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie cérébelleuse pure autosomique dominante
n1=en:muscular atrophy | n2=ataxie cérébelleuse pure autosomique dominante | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie cérebelleuse-dégénérescence choriorétinienne
n1=en:muscular atrophy | n2=ataxie cérebelleuse-dégénérescence choriorétinienne | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie cinétique
n1=en:muscular atrophy | n2=ataxie cinétique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie d'un membre
n1=en:muscular atrophy | n2=ataxie d'un membre | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie de Charlevoix-Saguenay
n1=en:muscular atrophy | n2=ataxie de Charlevoix-Saguenay | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie de Friedreich
n1=en:muscular atrophy | n2=ataxie de Friedreich | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie de Pierre-Marie
n1=en:muscular atrophy | n2=ataxie de Pierre-Marie | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie dynamique
n1=en:muscular atrophy | n2=ataxie dynamique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie enzootique de l'agneau
n1=en:muscular atrophy | n2=ataxie enzootique de l'agneau | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie idéo-motrice gauche
n1=en:muscular atrophy | n2=ataxie idéo-motrice gauche | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie létale liée au sexe avec surdité et malvoyance
n1=en:muscular atrophy | n2=ataxie létale liée au sexe avec surdité et malvoyance | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie locomotrice
n1=en:muscular atrophy | n2=ataxie locomotrice | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie motrice
n1=en:muscular atrophy | n2=ataxie motrice | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie sensitive
n1=en:muscular atrophy | n2=ataxie sensitive | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie spastique avec myosis congénital
n1=en:muscular atrophy | n2=ataxie spastique avec myosis congénital | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie spastique de type Charlevoix-Saguenay
n1=en:muscular atrophy | n2=ataxie spastique de type Charlevoix-Saguenay | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie spinocérébelleuse type 1
n1=en:muscular atrophy | n2=ataxie spinocérébelleuse type 1 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie tronculaire
n1=en:muscular atrophy | n2=ataxie tronculaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie visuomotrice
n1=en:muscular atrophy | n2=ataxie visuomotrice | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxie-télangiectasie héréditaire
n1=en:muscular atrophy | n2=ataxie-télangiectasie héréditaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxies
n1=en:muscular atrophy | n2=ataxies | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ataxique
n1=en:muscular atrophy | n2=ataxique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie généralisée
n1=en:muscular atrophy | n2=atrophie généralisée | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie hépatique
n1=en:muscular atrophy | n2=atrophie hépatique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire bulbo-spinale congénitale
n1=en:muscular atrophy | n2=atrophie musculaire bulbo-spinale congénitale | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire juvénile
n1=en:muscular atrophy | n2=atrophie musculaire juvénile | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire juvénile hérédo-familiale simulant une dystrophie musculaire
n1=en:muscular atrophy | n2=atrophie musculaire juvénile hérédo-familiale simulant une dystrophie musculaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire post-polio
n1=en:muscular atrophy | n2=atrophie musculaire post-polio | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire post-poliomyélitique
n1=en:muscular atrophy | n2=atrophie musculaire post-poliomyélitique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire postpoliomyélitique
n1=en:muscular atrophy | n2=atrophie musculaire postpoliomyélitique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire primitive spinale type aran-duchenne
n1=en:muscular atrophy | n2=atrophie musculaire primitive spinale type aran-duchenne | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire progressive spinale type Aran-Duchenne
n1=en:muscular atrophy | n2=atrophie musculaire progressive spinale type Aran-Duchenne | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire progressive type Aran-Duchenne
n1=en:muscular atrophy | n2=atrophie musculaire progressive type Aran-Duchenne | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire progressive type Vulpian
n1=en:muscular atrophy | n2=atrophie musculaire progressive type Vulpian | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire progressive type vulpian
n1=en:muscular atrophy | n2=atrophie musculaire progressive type vulpian | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire rachidienne non précisée
n1=en:muscular atrophy | n2=atrophie musculaire rachidienne non précisée | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire spinale infantile
n1=en:muscular atrophy | n2=atrophie musculaire spinale infantile | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire spino-bulbaire
n1=en:muscular atrophy | n2=atrophie musculaire spino-bulbaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie musculaire spinobulbaire
n1=en:muscular atrophy | n2=atrophie musculaire spinobulbaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie myotonique
n1=en:muscular atrophy | n2=atrophie myotonique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie olivoponto-cérébelleuse de type I
n1=en:muscular atrophy | n2=atrophie olivoponto-cérébelleuse de type I | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie olivoponto-cérébelleuse de type II
n1=en:muscular atrophy | n2=atrophie olivoponto-cérébelleuse de type II | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie olivoponto-cérébelleuse de type III
n1=en:muscular atrophy | n2=atrophie olivoponto-cérébelleuse de type III | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie olivoponto-cérébelleuse et dégénérescence rétinienne
n1=en:muscular atrophy | n2=atrophie olivoponto-cérébelleuse et dégénérescence rétinienne | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
atrophie olivopontocérébelleuse
n1=en:muscular atrophy | n2=atrophie olivopontocérébelleuse | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
autres malformations congénitales de l'oeil
n1=en:muscular atrophy | n2=autres malformations congénitales de l'oeil | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
aveugle
n1=en:muscular atrophy | n2=aveugle | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
Bassen-Kornzweig (maladie de)
n1=en:muscular atrophy | n2=Bassen-Kornzweig (maladie de) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
BBS2 gene
n1=en:muscular atrophy | n2=BBS2 gene | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
BEST1 gene
n1=en:muscular atrophy | n2=BEST1 gene | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
cachexie
n1=en:muscular atrophy | n2=cachexie | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
cachexie maligne
n1=en:muscular atrophy | n2=cachexie maligne | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
cataracte
n1=en:muscular atrophy | n2=cataracte | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
cataracte-ataxie-surdité
n1=en:muscular atrophy | n2=cataracte-ataxie-surdité | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
cataracte-ataxie-surdité et retard mental (syndrome)
n1=en:muscular atrophy | n2=cataracte-ataxie-surdité et retard mental (syndrome) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
cécité
n1=en:muscular atrophy | n2=cécité | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
cérébelleuse
n1=en:muscular atrophy | n2=cérébelleuse | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
cervelet
n1=en:muscular atrophy | n2=cervelet | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
colobome de l'iris avec ptosis, hypertélorisme et retard mental
n1=en:muscular atrophy | n2=colobome de l'iris avec ptosis, hypertélorisme et retard mental | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
coordination
n1=en:muscular atrophy | n2=coordination | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
coordination anormale
n1=en:muscular atrophy | n2=coordination anormale | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
craw-craw
n1=en:muscular atrophy | n2=craw-craw | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
CRB1 gene
n1=en:muscular atrophy | n2=CRB1 gene | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
danse des tendons
n1=en:muscular atrophy | n2=danse des tendons | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
dégénérescence tapétorétinienne
n1=en:muscular atrophy | n2=dégénérescence tapétorétinienne | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
déséquilibre
n1=en:muscular atrophy | n2=déséquilibre | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
désordre morbide
n1=en:muscular atrophy | n2=désordre morbide | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
désorganiser
n1=en:muscular atrophy | n2=désorganiser | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
désorganisés
n1=en:muscular atrophy | n2=désorganisés | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
dysplasie ectodermique-fente labiopalatine-déformation des mains et des pieds avec retard mental
n1=en:muscular atrophy | n2=dysplasie ectodermique-fente labiopalatine-déformation des mains et des pieds avec retard mental | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
dyssynergie
n1=en:muscular atrophy | n2=dyssynergie | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
dystrophie des cônes et des bâtonnets
n1=en:muscular atrophy | n2=dystrophie des cônes et des bâtonnets | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
dystrophie rétinienne héréditaire
n1=en:muscular atrophy | n2=dystrophie rétinienne héréditaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
dystrophie rétinienne mixte
n1=en:muscular atrophy | n2=dystrophie rétinienne mixte | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
dystrophie rétinienne périphérique
n1=en:muscular atrophy | n2=dystrophie rétinienne périphérique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
dystrophie vitréo-rétinienne
n1=en:muscular atrophy | n2=dystrophie vitréo-rétinienne | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
dystrophies rétiniennes héréditaires
n1=en:muscular atrophy | n2=dystrophies rétiniennes héréditaires | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ectodermique-fente labiopalatine-déformation des mains et des pieds avec retard mental (dysplasie)
n1=en:muscular atrophy | n2=ectodermique-fente labiopalatine-déformation des mains et des pieds avec retard mental (dysplasie) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
effet Antabuse
n1=en:muscular atrophy | n2=effet Antabuse | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
électrorétinogramme
n1=en:muscular atrophy | n2=électrorétinogramme | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:abnormal coordination
n1=en:muscular atrophy | n2=en:abnormal coordination | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:abnormalities of gait and mobility
n1=en:muscular atrophy | n2=en:abnormalities of gait and mobility | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:and mental retardation
n1=en:muscular atrophy | n2=en:and mental retardation | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:anterior spinal degenerative muscular atrophy type III
n1=en:muscular atrophy | n2=en:anterior spinal degenerative muscular atrophy type III | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:Aran-Duchenne disease
n1=en:muscular atrophy | n2=en:Aran-Duchenne disease | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:Aran-Duchenne type progressive spinal muscular atrophy
n1=en:muscular atrophy | n2=en:Aran-Duchenne type progressive spinal muscular atrophy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:ataxias, appendicular
n1=en:muscular atrophy | n2=en:ataxias, appendicular | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:ataxias, sensory
n1=en:muscular atrophy | n2=en:ataxias, sensory | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:ataxias, truncal
n1=en:muscular atrophy | n2=en:ataxias, truncal | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:ataxic
n1=en:muscular atrophy | n2=en:ataxic | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:ataxy
n1=en:muscular atrophy | n2=en:ataxy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:cachexia
n1=en:muscular atrophy | n2=en:cachexia | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:carpal syndrome channel
n1=en:muscular atrophy | n2=en:carpal syndrome channel | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:carpal tunnel syndrome
n1=en:muscular atrophy | n2=en:carpal tunnel syndrome | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:cataract
n1=en:muscular atrophy | n2=en:cataract | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:Charcot-Marie-Tooth's peroneal muscular atrophy and Friedreich's ataxia combined
n1=en:muscular atrophy | n2=en:Charcot-Marie-Tooth's peroneal muscular atrophy and Friedreich's ataxia combined | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:childhood spinal muscular atrophies
n1=en:muscular atrophy | n2=en:childhood spinal muscular atrophies | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:diabetic neuropathies
n1=en:muscular atrophy | n2=en:diabetic neuropathies | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:distal hereditary motor neuropathy
n1=en:muscular atrophy | n2=en:distal hereditary motor neuropathy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:dyssynergia
n1=en:muscular atrophy | n2=en:dyssynergia | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:hereditary retinal dystrophy
n1=en:muscular atrophy | n2=en:hereditary retinal dystrophy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:infantile muscular atrophy
n1=en:muscular atrophy | n2=en:infantile muscular atrophy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:late-adult onset
n1=en:muscular atrophy | n2=en:late-adult onset | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of ability to walk later
n1=en:muscular atrophy | n2=en:loss of ability to walk later | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of ankle reflexes
n1=en:muscular atrophy | n2=en:loss of ankle reflexes | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of any acquired abilities in early childhood
n1=en:muscular atrophy | n2=en:loss of any acquired abilities in early childhood | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of balance may occur
n1=en:muscular atrophy | n2=en:loss of balance may occur | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of cerebellar purkinje cells
n1=en:muscular atrophy | n2=en:loss of cerebellar purkinje cells | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of coordination
n1=en:muscular atrophy | n2=en:loss of coordination | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of developmental milestones
n1=en:muscular atrophy | n2=en:loss of developmental milestones | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of dopaminergic neurons in the substantia nigra
n1=en:muscular atrophy | n2=en:loss of dopaminergic neurons in the substantia nigra | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of executive functions
n1=en:muscular atrophy | n2=en:loss of executive functions | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of gait (in some)
n1=en:muscular atrophy | n2=en:loss of gait (in some) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of independent ambulation
n1=en:muscular atrophy | n2=en:loss of independent ambulation | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of independent ambulation approximately 30 years after onset
n1=en:muscular atrophy | n2=en:loss of independent ambulation approximately 30 years after onset | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of independent ambulation within a few years
n1=en:muscular atrophy | n2=en:loss of independent ambulation within a few years | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of language ability
n1=en:muscular atrophy | n2=en:loss of language ability | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of motor functions
n1=en:muscular atrophy | n2=en:loss of motor functions | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of motor neurons in the anterior horn of the spinal cord
n1=en:muscular atrophy | n2=en:loss of motor neurons in the anterior horn of the spinal cord | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of motor skills
n1=en:muscular atrophy | n2=en:loss of motor skills | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of myelin and oligodendroglia
n1=en:muscular atrophy | n2=en:loss of myelin and oligodendroglia | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of myelin in the descending lateral spinal cord tracts
n1=en:muscular atrophy | n2=en:loss of myelin in the descending lateral spinal cord tracts | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of myelinated fibers in spinal cord roots
n1=en:muscular atrophy | n2=en:loss of myelinated fibers in spinal cord roots | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of neurons affecting all cortical layers
n1=en:muscular atrophy | n2=en:loss of neurons affecting all cortical layers | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of pain and temperature in a cape-like distribution
n1=en:muscular atrophy | n2=en:loss of pain and temperature in a cape-like distribution | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of postural tone
n1=en:muscular atrophy | n2=en:loss of postural tone | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of purkinje cells
n1=en:muscular atrophy | n2=en:loss of purkinje cells | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of purkinje cells in the cerebellum
n1=en:muscular atrophy | n2=en:loss of purkinje cells in the cerebellum | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of reflexes due to myopathy
n1=en:muscular atrophy | n2=en:loss of reflexes due to myopathy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of speech (1 patient)
n1=en:muscular atrophy | n2=en:loss of speech (1 patient) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of spontaneous movements
n1=en:muscular atrophy | n2=en:loss of spontaneous movements | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:loss of white matter
n1=en:muscular atrophy | n2=en:loss of white matter | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:low densities in the basal ganglia similar to leigh syndrome (256000)
n1=en:muscular atrophy | n2=en:low densities in the basal ganglia similar to leigh syndrome (256000) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:low-normal intelligence
n1=en:muscular atrophy | n2=en:low-normal intelligence | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lower extremity weakness with febrile episodes (rare)
n1=en:muscular atrophy | n2=en:lower extremity weakness with febrile episodes (rare) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lower limb dystonia
n1=en:muscular atrophy | n2=en:lower limb dystonia | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lower limb hyperreflexia (reported in 1 patient)
n1=en:muscular atrophy | n2=en:lower limb hyperreflexia (reported in 1 patient) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lower limb hypotrophy
n1=en:muscular atrophy | n2=en:lower limb hypotrophy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lower limb muscle weakness (occurs later)
n1=en:muscular atrophy | n2=en:lower limb muscle weakness (occurs later) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lower limb spasticity, mild
n1=en:muscular atrophy | n2=en:lower limb spasticity, mild | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lower limbs weakness and atrophy, distal
n1=en:muscular atrophy | n2=en:lower limbs weakness and atrophy, distal | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lower motor neuron degeneration
n1=en:muscular atrophy | n2=en:lower motor neuron degeneration | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lower motor neuron dysfunction
n1=en:muscular atrophy | n2=en:lower motor neuron dysfunction | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lower motor neuron involvement, mild, seen on emg (in some patients)
n1=en:muscular atrophy | n2=en:lower motor neuron involvement, mild, seen on emg (in some patients) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lower motor neuron signs, later
n1=en:muscular atrophy | n2=en:lower motor neuron signs, later | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lower motor signs
n1=en:muscular atrophy | n2=en:lower motor signs | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lumbar paraspinal rigidity causes exaggerated lumbar lordosis
n1=en:muscular atrophy | n2=en:lumbar paraspinal rigidity causes exaggerated lumbar lordosis | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:lymphocytic infiltration of the brain
n1=en:muscular atrophy | n2=en:lymphocytic infiltration of the brain | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:magnetic resonance spectroscopy (mrs) shows increased lactate in the central nervous system
n1=en:muscular atrophy | n2=en:magnetic resonance spectroscopy (mrs) shows increased lactate in the central nervous system | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:major developmental milestones are not attained
n1=en:muscular atrophy | n2=en:major developmental milestones are not attained | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:malformations of the mid- and hindbrain
n1=en:muscular atrophy | n2=en:malformations of the mid- and hindbrain | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:markedly delayed nerve conduction velocities
n1=en:muscular atrophy | n2=en:markedly delayed nerve conduction velocities | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:mean sleep latency is less than 5 to 8 minutes
n1=en:muscular atrophy | n2=en:mean sleep latency is less than 5 to 8 minutes | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:mental delay syndrome
n1=en:muscular atrophy | n2=en:mental delay syndrome | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:mental retardation and hypogonadisme
n1=en:muscular atrophy | n2=en:mental retardation and hypogonadisme | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:motor ataxia
n1=en:muscular atrophy | n2=en:motor ataxia | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:musculature
n1=en:muscular atrophy | n2=en:musculature | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:musculus quadriceps femoris
n1=en:muscular atrophy | n2=en:musculus quadriceps femoris | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:myopathic muscular atrophy
n1=en:muscular atrophy | n2=en:myopathic muscular atrophy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:neurologic manifestations
n1=en:muscular atrophy | n2=en:neurologic manifestations | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:other congenital malformations of eye
n1=en:muscular atrophy | n2=en:other congenital malformations of eye | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:PDEB-related autosomique recessive
n1=en:muscular atrophy | n2=en:PDEB-related autosomique recessive | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:peripherin-related
n1=en:muscular atrophy | n2=en:peripherin-related | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:pigment retinopathy
n1=en:muscular atrophy | n2=en:pigment retinopathy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:prominent cortical sulci
n1=en:muscular atrophy | n2=en:prominent cortical sulci | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:prominent perivascular spaces
n1=en:muscular atrophy | n2=en:prominent perivascular spaces | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:prominent sulci
n1=en:muscular atrophy | n2=en:prominent sulci | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:prominent ventricles (in some patients)
n1=en:muscular atrophy | n2=en:prominent ventricles (in some patients) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:proximal limb muscle stiffness
n1=en:muscular atrophy | n2=en:proximal limb muscle stiffness | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:proximal spinal muscular atrophy
n1=en:muscular atrophy | n2=en:proximal spinal muscular atrophy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:proximal weakness occurs later
n1=en:muscular atrophy | n2=en:proximal weakness occurs later | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:prp immunoreactivity limited to cerebellum and putamen
n1=en:muscular atrophy | n2=en:prp immunoreactivity limited to cerebellum and putamen | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:pseudobulbar palsy (e.g. involuntary weeping or laughter)
n1=en:muscular atrophy | n2=en:pseudobulbar palsy (e.g. involuntary weeping or laughter) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:pseudobulbar symptoms (uncontrolled laughter, weeping)
n1=en:muscular atrophy | n2=en:pseudobulbar symptoms (uncontrolled laughter, weeping) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:quadriceps
n1=en:muscular atrophy | n2=en:quadriceps | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:quadriceps muscle of the thigh
n1=en:muscular atrophy | n2=en:quadriceps muscle of the thigh | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:quads
n1=en:muscular atrophy | n2=en:quads | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:reduced concentration span
n1=en:muscular atrophy | n2=en:reduced concentration span | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:retinal degeneration
n1=en:muscular atrophy | n2=en:retinal degeneration | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:rhodopsin-related
n1=en:muscular atrophy | n2=en:rhodopsin-related | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:senile
n1=en:muscular atrophy | n2=en:senile | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:SMA
n1=en:muscular atrophy | n2=en:SMA | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:social communication disorder
n1=en:muscular atrophy | n2=en:social communication disorder | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:spastic quadriplegia
n1=en:muscular atrophy | n2=en:spastic quadriplegia | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:spinal muscle atrophy
n1=en:muscular atrophy | n2=en:spinal muscle atrophy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:thews
n1=en:muscular atrophy | n2=en:thews | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:tremors, rubral
n1=en:muscular atrophy | n2=en:tremors, rubral | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:vulpian' atrophy
n1=en:muscular atrophy | n2=en:vulpian' atrophy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:wasting palsy
n1=en:muscular atrophy | n2=en:wasting palsy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:wasting syndrome
n1=en:muscular atrophy | n2=en:wasting syndrome | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:X-linked recessive 3 or retinitis pigmentosa-6
n1=en:muscular atrophy | n2=en:X-linked recessive 3 or retinitis pigmentosa-6 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:young spinal muscular atrophy
n1=en:muscular atrophy | n2=en:young spinal muscular atrophy | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
en:young spinal muscular atrophy pseudomyopathique
n1=en:muscular atrophy | n2=en:young spinal muscular atrophy pseudomyopathique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
encéphalomyopathie, acidose lactique et accidents vasculaires cérébraux
n1=en:muscular atrophy | n2=encéphalomyopathie, acidose lactique et accidents vasculaires cérébraux | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
épilepsie myoclonique à fibres rouges en lambeau
n1=en:muscular atrophy | n2=épilepsie myoclonique à fibres rouges en lambeau | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
épilepsie myoclonique sévère du nourrisson
n1=en:muscular atrophy | n2=épilepsie myoclonique sévère du nourrisson | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ERG
n1=en:muscular atrophy | n2=ERG | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
FACES syndrome
n1=en:muscular atrophy | n2=FACES syndrome | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
fatigue musculaire
n1=en:muscular atrophy | n2=fatigue musculaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
génétique
n1=en:muscular atrophy | n2=génétique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
handicap
n1=en:muscular atrophy | n2=handicap | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
héméralopie
n1=en:muscular atrophy | n2=héméralopie | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
hémiataxie
n1=en:muscular atrophy | n2=hémiataxie | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
hypoacousie
n1=en:muscular atrophy | n2=hypoacousie | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
hypoesthésie cornéenne, anomalie rétinienne, surdité neurosensorielle, anomalie du faciès, persistance du canal artériel et retard mental
n1=en:muscular atrophy | n2=hypoesthésie cornéenne, anomalie rétinienne, surdité neurosensorielle, anomalie du faciès, persistance du canal artériel et retard mental | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
hypogonadisme
n1=en:muscular atrophy | n2=hypogonadisme | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
I-II
n1=en:muscular atrophy | n2=I-II | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
III
n1=en:muscular atrophy | n2=III | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
incoordination
n1=en:muscular atrophy | n2=incoordination | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
incoordination motrice
n1=en:muscular atrophy | n2=incoordination motrice | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
incoordination musculaire
n1=en:muscular atrophy | n2=incoordination musculaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
inflammation
(médecine)
n1=en:muscular atrophy | n2=inflammation (médecine) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
liée
n1=en:muscular atrophy | n2=liée | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maculopathie pigmentaire
n1=en:muscular atrophy | n2=maculopathie pigmentaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maladie de Bernheimer-Seitelberger
n1=en:muscular atrophy | n2=maladie de Bernheimer-Seitelberger | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maladie de Förster
n1=en:muscular atrophy | n2=maladie de Förster | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maladie de Kufs
n1=en:muscular atrophy | n2=maladie de Kufs | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maladie de l'oeil
n1=en:muscular atrophy | n2=maladie de l'oeil | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maladie de Pelizaeus-Merzbacher
n1=en:muscular atrophy | n2=maladie de Pelizaeus-Merzbacher | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maladie de Stargardt
n1=en:muscular atrophy | n2=maladie de Stargardt | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maladie du segment postérieur
n1=en:muscular atrophy | n2=maladie du segment postérieur | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maladie génétique
n1=en:muscular atrophy | n2=maladie génétique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maladie génétique de l'oeil
n1=en:muscular atrophy | n2=maladie génétique de l'oeil | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maladie kystique de la médullaire rénale
n1=en:muscular atrophy | n2=maladie kystique de la médullaire rénale | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maladie neuromusculaire
n1=en:muscular atrophy | n2=maladie neuromusculaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maladie oculaire héréditaire
n1=en:muscular atrophy | n2=maladie oculaire héréditaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
maladies génétiques
n1=en:muscular atrophy | n2=maladies génétiques | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
malvoyant
n1=en:muscular atrophy | n2=malvoyant | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
manque de coordination
n1=en:muscular atrophy | n2=manque de coordination | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
marasme nutritionnel
n1=en:muscular atrophy | n2=marasme nutritionnel | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
Mirhosseini-Holmes-Walton (syndrome de)
n1=en:muscular atrophy | n2=Mirhosseini-Holmes-Walton (syndrome de) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
mouvement
n1=en:muscular atrophy | n2=mouvement | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
mouvements anormaux
n1=en:muscular atrophy | n2=mouvements anormaux | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
muscle quadriceps fémoral
n1=en:muscular atrophy | n2=muscle quadriceps fémoral | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
National Aeronautics and Space Administration
n1=en:muscular atrophy | n2=National Aeronautics and Space Administration | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
nausée
n1=en:muscular atrophy | n2=nausée | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
neurologie
n1=en:muscular atrophy | n2=neurologie | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
neuropathie ataxiante
n1=en:muscular atrophy | n2=neuropathie ataxiante | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
neuropathie ataxie et rétinite pigmentaire
n1=en:muscular atrophy | n2=neuropathie ataxie et rétinite pigmentaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
non coordonné
n1=en:muscular atrophy | n2=non coordonné | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
non précisée, dystrophie rétinienne héréditaire
n1=en:muscular atrophy | n2=non précisée, dystrophie rétinienne héréditaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
nosologie
n1=en:muscular atrophy | n2=nosologie | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
nystagmus congénital
n1=en:muscular atrophy | n2=nystagmus congénital | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
oeil
n1=en:muscular atrophy | n2=oeil | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
OHAHA (syndrome)
n1=en:muscular atrophy | n2=OHAHA (syndrome) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
olivoponto
n1=en:muscular atrophy | n2=olivoponto | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
olivoponto-cérébelleuse
n1=en:muscular atrophy | n2=olivoponto-cérébelleuse | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
ophtalmoplégie, hypotonie, ataxie, hypoacousie et athétose
n1=en:muscular atrophy | n2=ophtalmoplégie, hypotonie, ataxie, hypoacousie et athétose | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
optogénétique
n1=en:muscular atrophy | n2=optogénétique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
PDC gene
n1=en:muscular atrophy | n2=PDC gene | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
PDE6A gene
n1=en:muscular atrophy | n2=PDE6A gene | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
PDE6B gene
n1=en:muscular atrophy | n2=PDE6B gene | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
PDE6G gene
n1=en:muscular atrophy | n2=PDE6G gene | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
périphérine-RDS
n1=en:muscular atrophy | n2=périphérine-RDS | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
perte de la coordination
n1=en:muscular atrophy | n2=perte de la coordination | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
phosphodiestérase du GMP cyclique des photorécepteurs
n1=en:muscular atrophy | n2=phosphodiestérase du GMP cyclique des photorécepteurs | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
polyneuropathie-cataracte-surdité (syndrome de)
n1=en:muscular atrophy | n2=polyneuropathie-cataracte-surdité (syndrome de) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
POMGNT1 gene s
n1=en:muscular atrophy | n2=POMGNT1 gene s | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
quadriceps
n1=en:muscular atrophy | n2=quadriceps | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
quadriceps (hypoplasie du)
n1=en:muscular atrophy | n2=quadriceps (hypoplasie du) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
quadriplégie spastique, rétinite pigmentaire et retard mental
n1=en:muscular atrophy | n2=quadriplégie spastique, rétinite pigmentaire et retard mental | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
RDH12 gene
n1=en:muscular atrophy | n2=RDH12 gene | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
récessive
n1=en:muscular atrophy | n2=récessive | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
Rétinite
n1=en:muscular atrophy | n2=Rétinite | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire
n1=en:muscular atrophy | n2=rétinite pigmentaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire (classification de Fishman)
n1=en:muscular atrophy | n2=rétinite pigmentaire (classification de Fishman) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire 6
n1=en:muscular atrophy | n2=rétinite pigmentaire 6 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire autosomique récessive liée à la rhodopsine
n1=en:muscular atrophy | n2=rétinite pigmentaire autosomique récessive liée à la rhodopsine | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire avec préservation para-artérielle de l'épithélium pigmenté rétinien
n1=en:muscular atrophy | n2=rétinite pigmentaire avec préservation para-artérielle de l'épithélium pigmenté rétinien | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire centrale
n1=en:muscular atrophy | n2=rétinite pigmentaire centrale | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire d'apparition tardive
n1=en:muscular atrophy | n2=rétinite pigmentaire d'apparition tardive | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire en secteur ou unilatérale
n1=en:muscular atrophy | n2=rétinite pigmentaire en secteur ou unilatérale | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire et retard mental
n1=en:muscular atrophy | n2=rétinite pigmentaire et retard mental | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire et surdité congénitale
n1=en:muscular atrophy | n2=rétinite pigmentaire et surdité congénitale | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire in utero
n1=en:muscular atrophy | n2=rétinite pigmentaire in utero | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire inverse
n1=en:muscular atrophy | n2=rétinite pigmentaire inverse | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire liée à la PDEB (1-bp del, his557-to-tyr)
n1=en:muscular atrophy | n2=rétinite pigmentaire liée à la PDEB (1-bp del, his557-to-tyr) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire liée à la PDEB (gln298ter, arg531ter)
n1=en:muscular atrophy | n2=rétinite pigmentaire liée à la PDEB (gln298ter, arg531ter) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire liée à la périphérine
n1=en:muscular atrophy | n2=rétinite pigmentaire liée à la périphérine | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire liée à la périphérine (pro219leu)
n1=en:muscular atrophy | n2=rétinite pigmentaire liée à la périphérine (pro219leu) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire liée à la rhodopsine
n1=en:muscular atrophy | n2=rétinite pigmentaire liée à la rhodopsine | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire liée au sexe récessive 3
n1=en:muscular atrophy | n2=rétinite pigmentaire liée au sexe récessive 3 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire paraveineuse
n1=en:muscular atrophy | n2=rétinite pigmentaire paraveineuse | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire péricentrale dominante
n1=en:muscular atrophy | n2=rétinite pigmentaire péricentrale dominante | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire péricentrale récessive
n1=en:muscular atrophy | n2=rétinite pigmentaire péricentrale récessive | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire sénile
n1=en:muscular atrophy | n2=rétinite pigmentaire sénile | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire-10
n1=en:muscular atrophy | n2=rétinite pigmentaire-10 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire-2
n1=en:muscular atrophy | n2=rétinite pigmentaire-2 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire-3
n1=en:muscular atrophy | n2=rétinite pigmentaire-3 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire-4
n1=en:muscular atrophy | n2=rétinite pigmentaire-4 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire-5
n1=en:muscular atrophy | n2=rétinite pigmentaire-5 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire-6
n1=en:muscular atrophy | n2=rétinite pigmentaire-6 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire-7
n1=en:muscular atrophy | n2=rétinite pigmentaire-7 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire-8
n1=en:muscular atrophy | n2=rétinite pigmentaire-8 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire-9
n1=en:muscular atrophy | n2=rétinite pigmentaire-9 | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinite pigmentaire, surdité, retard mental, et hypogonadisme
n1=en:muscular atrophy | n2=rétinite pigmentaire, surdité, retard mental, et hypogonadisme | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinites pigmentaires
n1=en:muscular atrophy | n2=rétinites pigmentaires | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinopathie
n1=en:muscular atrophy | n2=rétinopathie | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinopathie pigmentaire
n1=en:muscular atrophy | n2=rétinopathie pigmentaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rétinopathie poivre et sel
n1=en:muscular atrophy | n2=rétinopathie poivre et sel | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rhétinite
n1=en:muscular atrophy | n2=rhétinite | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
rhodopsine
n1=en:muscular atrophy | n2=rhodopsine | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
RPE
n1=en:muscular atrophy | n2=RPE | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
RTPG gene
n1=en:muscular atrophy | n2=RTPG gene | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
Ryukyu (amyotrophie spinale de type)
n1=en:muscular atrophy | n2=Ryukyu (amyotrophie spinale de type) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
scotopique
n1=en:muscular atrophy | n2=scotopique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
sénile
n1=en:muscular atrophy | n2=sénile | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
sexe
n1=en:muscular atrophy | n2=sexe | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
signe de Lhermitte
n1=en:muscular atrophy | n2=signe de Lhermitte | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
signe de Romberg
n1=en:muscular atrophy | n2=signe de Romberg | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
Silver (amyotrophie spinale distale de)
n1=en:muscular atrophy | n2=Silver (amyotrophie spinale distale de) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
sous-alimentation
n1=en:muscular atrophy | n2=sous-alimentation | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
Spielmeyer-Vogt (maladie de)
n1=en:muscular atrophy | n2=Spielmeyer-Vogt (maladie de) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
spinale
n1=en:muscular atrophy | n2=spinale | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
surdité et démence ou psychose
n1=en:muscular atrophy | n2=surdité et démence ou psychose | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome
n1=en:muscular atrophy | n2=syndrome | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome cachectique
n1=en:muscular atrophy | n2=syndrome cachectique | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome cachectique dû au vih
n1=en:muscular atrophy | n2=syndrome cachectique dû au vih | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome cataracte-ataxie-surdité et retard mental
n1=en:muscular atrophy | n2=syndrome cataracte-ataxie-surdité et retard mental | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome d'Allan-Herndon-Dudley
n1=en:muscular atrophy | n2=syndrome d'Allan-Herndon-Dudley | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome d'Angelman
n1=en:muscular atrophy | n2=syndrome d'Angelman | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome de Boor
n1=en:muscular atrophy | n2=syndrome de Boor | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome de cachexie
n1=en:muscular atrophy | n2=syndrome de cachexie | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome de cachexie progressive
n1=en:muscular atrophy | n2=syndrome de cachexie progressive | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome de Cockayne
n1=en:muscular atrophy | n2=syndrome de Cockayne | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome de dépérissement
n1=en:muscular atrophy | n2=syndrome de dépérissement | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome de Joubert
n1=en:muscular atrophy | n2=syndrome de Joubert | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome de Kugelberg-Welander
n1=en:muscular atrophy | n2=syndrome de Kugelberg-Welander | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome de Mirhosseini-Holmes-Walton
n1=en:muscular atrophy | n2=syndrome de Mirhosseini-Holmes-Walton | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome de Rett
n1=en:muscular atrophy | n2=syndrome de Rett | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome de Sensenbrenner
n1=en:muscular atrophy | n2=syndrome de Sensenbrenner | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome de Sylvester
n1=en:muscular atrophy | n2=syndrome de Sylvester | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome de Wadia-Swami
n1=en:muscular atrophy | n2=syndrome de Wadia-Swami | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
Syndrome du canal carpien
n1=en:muscular atrophy | n2=Syndrome du canal carpien | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome du canal carpien
n1=en:muscular atrophy | n2=syndrome du canal carpien | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome lacunaire
n1=en:muscular atrophy | n2=syndrome lacunaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
syndrome neuropathie, ataxie, rétinite pigmentaire
n1=en:muscular atrophy | n2=syndrome neuropathie, ataxie, rétinite pigmentaire | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
tabès
n1=en:muscular atrophy | n2=tabès | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
tardive
n1=en:muscular atrophy | n2=tardive | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
tremblement de holmes
n1=en:muscular atrophy | n2=tremblement de holmes | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
tremblement rubral
n1=en:muscular atrophy | n2=tremblement rubral | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
trouble de l'équilibre
n1=en:muscular atrophy | n2=trouble de l'équilibre | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
trouble de la coordination
n1=en:muscular atrophy | n2=trouble de la coordination | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
trouble de la vision
n1=en:muscular atrophy | n2=trouble de la vision | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
trouble de la vue
n1=en:muscular atrophy | n2=trouble de la vue | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
troubles de l'équilibre
n1=en:muscular atrophy | n2=troubles de l'équilibre | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
troubles de la coordination
n1=en:muscular atrophy | n2=troubles de la coordination | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
type
n1=en:muscular atrophy | n2=type | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 10 / 0.028 ->
Usher (syndrome de)
n1=en:muscular atrophy | n2=Usher (syndrome de) | rel=r_associated | relid=0 | w=10
- en:muscular atrophy --
r_associated #0: 5 / 0.014 ->
en:amyotrophia
n1=en:muscular atrophy | n2=en:amyotrophia | rel=r_associated | relid=0 | w=5
- en:muscular atrophy --
r_associated #0: 5 / 0.014 ->
Médecine
n1=en:muscular atrophy | n2=Médecine | rel=r_associated | relid=0 | w=5
- en:muscular atrophy --
r_associated #0: 2 / 0.006 ->
diminution
n1=en:muscular atrophy | n2=diminution | rel=r_associated | relid=0 | w=2
- en:muscular atrophy --
r_associated #0: 2 / 0.006 ->
en:neurodegenerative disorders
n1=en:muscular atrophy | n2=en:neurodegenerative disorders | rel=r_associated | relid=0 | w=2
- en:muscular atrophy --
r_associated #0: 2 / 0.006 ->
pathologie du muscle strié
n1=en:muscular atrophy | n2=pathologie du muscle strié | rel=r_associated | relid=0 | w=2
- en:muscular atrophy --
r_associated #0: 2 / 0.006 ->
pathologie
(maladie)
n1=en:muscular atrophy | n2=pathologie (maladie) | rel=r_associated | relid=0 | w=2
- en:muscular atrophy --
r_associated #0: 2 / 0.006 ->
signe clinique
n1=en:muscular atrophy | n2=signe clinique | rel=r_associated | relid=0 | w=2
- en:muscular atrophy --
r_associated #0: 2 / 0.006 ->
signe clinique en neurologie
n1=en:muscular atrophy | n2=signe clinique en neurologie | rel=r_associated | relid=0 | w=2
- en:muscular atrophy --
r_associated #0: 1 / 0.003 ->
affections neurodégénératives
n1=en:muscular atrophy | n2=affections neurodégénératives | rel=r_associated | relid=0 | w=1
- en:muscular atrophy --
r_associated #0: 1 / 0.003 ->
atteintes neurodégénératives
n1=en:muscular atrophy | n2=atteintes neurodégénératives | rel=r_associated | relid=0 | w=1
- en:muscular atrophy --
r_associated #0: 1 / 0.003 ->
en:neurodegenerative disorder
n1=en:muscular atrophy | n2=en:neurodegenerative disorder | rel=r_associated | relid=0 | w=1
- en:muscular atrophy --
r_associated #0: 1 / 0.003 ->
processus
n1=en:muscular atrophy | n2=processus | rel=r_associated | relid=0 | w=1
- en:muscular atrophy --
r_associated #0: 1 / 0.003 ->
Signe clinique
n1=en:muscular atrophy | n2=Signe clinique | rel=r_associated | relid=0 | w=1
- en:muscular atrophy --
r_associated #0: 1 / 0.003 ->
trouble neurodégénératif
n1=en:muscular atrophy | n2=trouble neurodégénératif | rel=r_associated | relid=0 | w=1
| ≈ 1213 relations entrantes
- médecine ---
r_associated #0: 177 -->
en:muscular atrophy
n1=médecine | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=177
- atrophie musculaire ---
r_associated #0: 149 -->
en:muscular atrophy
n1=atrophie musculaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=149
- atrophie des muscles ---
r_associated #0: 146 -->
en:muscular atrophy
n1=atrophie des muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=146
- en:muscle atrophy ---
r_associated #0: 146 -->
en:muscular atrophy
n1=en:muscle atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=146
- fonte musculaire ---
r_associated #0: 146 -->
en:muscular atrophy
n1=fonte musculaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=146
- amyotrophie ---
r_associated #0: 144 -->
en:muscular atrophy
n1=amyotrophie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=144
- myatrophie ---
r_associated #0: 143 -->
en:muscular atrophy
n1=myatrophie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=143
- en:muscle wasting ---
r_associated #0: 130 -->
en:muscular atrophy
n1=en:muscle wasting | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=130
- en:atrophy ---
r_associated #0: 60 -->
en:muscular atrophy
n1=en:atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=60
- atrophie ---
r_associated #0: 52 -->
en:muscular atrophy
n1=atrophie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=52
- gaspi ---
r_associated #0: 49 -->
en:muscular atrophy
n1=gaspi | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=49
- en:feebleness ---
r_associated #0: 47 -->
en:muscular atrophy
n1=en:feebleness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=47
- gaspillage ---
r_associated #0: 46 -->
en:muscular atrophy
n1=gaspillage | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=46
- en:distal muscle atrophy (lower limbs more affected than upper limbs) ---
r_associated #0: 43 -->
en:muscular atrophy
n1=en:distal muscle atrophy (lower limbs more affected than upper limbs) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=43
- en:finger and wrist extensor weakness ---
r_associated #0: 43 -->
en:muscular atrophy
n1=en:finger and wrist extensor weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=43
- en:generalized amyoplasia ---
r_associated #0: 43 -->
en:muscular atrophy
n1=en:generalized amyoplasia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=43
- en:lipoatrophy, generalized ---
r_associated #0: 43 -->
en:muscular atrophy
n1=en:lipoatrophy, generalized | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=43
- en:muscle biopsy shows decreased activity of cytochrome c oxidase ---
r_associated #0: 43 -->
en:muscular atrophy
n1=en:muscle biopsy shows decreased activity of cytochrome c oxidase | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=43
- en:myotonia is usually not seen ---
r_associated #0: 43 -->
en:muscular atrophy
n1=en:myotonia is usually not seen | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=43
- en:quadriceps atrophy ---
r_associated #0: 43 -->
en:muscular atrophy
n1=en:quadriceps atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=43
- en:skeletal muscle shows dystrophic changes ---
r_associated #0: 43 -->
en:muscular atrophy
n1=en:skeletal muscle shows dystrophic changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=43
- hypoplasie glutéale ---
r_associated #0: 43 -->
en:muscular atrophy
n1=hypoplasie glutéale | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=43
- en:absent moro response ---
r_associated #0: 42 -->
en:muscular atrophy
n1=en:absent moro response | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=42
- en:decreased activities of mitochondrial-encoded respiratory chain complexes ---
r_associated #0: 42 -->
en:muscular atrophy
n1=en:decreased activities of mitochondrial-encoded respiratory chain complexes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=42
- en:hypoglycosylation of alpha-dystroglycan seen on muscle biopsy ---
r_associated #0: 42 -->
en:muscular atrophy
n1=en:hypoglycosylation of alpha-dystroglycan seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=42
- en:lipohypoplasia, regional ---
r_associated #0: 42 -->
en:muscular atrophy
n1=en:lipohypoplasia, regional | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=42
- en:nemaline rod formation ---
r_associated #0: 42 -->
en:muscular atrophy
n1=en:nemaline rod formation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=42
- en:plasma membrane discontinuities ---
r_associated #0: 42 -->
en:muscular atrophy
n1=en:plasma membrane discontinuities | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=42
- en:poor head control in infancy ---
r_associated #0: 42 -->
en:muscular atrophy
n1=en:poor head control in infancy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=42
- en:small nerve terminals ---
r_associated #0: 42 -->
en:muscular atrophy
n1=en:small nerve terminals | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=42
- en:superior rectus atrophy ---
r_associated #0: 42 -->
en:muscular atrophy
n1=en:superior rectus atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=42
- en:vacuoles in the myofiber cytoplasm ---
r_associated #0: 42 -->
en:muscular atrophy
n1=en:vacuoles in the myofiber cytoplasm | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=42
- en:weakness of neck muscles may occur later ---
r_associated #0: 42 -->
en:muscular atrophy
n1=en:weakness of neck muscles may occur later | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=42
- en:distal muscle weakness, mild ---
r_associated #0: 41 -->
en:muscular atrophy
n1=en:distal muscle weakness, mild | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=41
- en:hypotonia, profound ---
r_associated #0: 41 -->
en:muscular atrophy
n1=en:hypotonia, profound | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=41
- en:progression to wheelchair in fourth decade ---
r_associated #0: 41 -->
en:muscular atrophy
n1=en:progression to wheelchair in fourth decade | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=41
- en:proximal weakness ---
r_associated #0: 41 -->
en:muscular atrophy
n1=en:proximal weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=41
- en:skeletal muscle biopsy shows hypertrophy of type 1 and 2 muscle fibers ---
r_associated #0: 41 -->
en:muscular atrophy
n1=en:skeletal muscle biopsy shows hypertrophy of type 1 and 2 muscle fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=41
- en:wasting ---
r_associated #0: 41 -->
en:muscular atrophy
n1=en:wasting | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=41
- en:decreased cytochrome c oxidase activity ---
r_associated #0: 40 -->
en:muscular atrophy
n1=en:decreased cytochrome c oxidase activity | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=40
- en:distal limb muscle atrophy (less common) ---
r_associated #0: 40 -->
en:muscular atrophy
n1=en:distal limb muscle atrophy (less common) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=40
- en:loss of independent ambulation around age 12 years ---
r_associated #0: 40 -->
en:muscular atrophy
n1=en:loss of independent ambulation around age 12 years | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=40
- en:mild kinetic abnormalities of the achr (in some patients) ---
r_associated #0: 40 -->
en:muscular atrophy
n1=en:mild kinetic abnormalities of the achr (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=40
- en:skeletal muscle biopsy shows impaired respiratory oxidation ---
r_associated #0: 40 -->
en:muscular atrophy
n1=en:skeletal muscle biopsy shows impaired respiratory oxidation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=40
- en:z-band streaming ---
r_associated #0: 40 -->
en:muscular atrophy
n1=en:z-band streaming | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=40
- en:decreased caveolae in muscle tissue ---
r_associated #0: 39 -->
en:muscular atrophy
n1=en:decreased caveolae in muscle tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=39
- en:degenerating nerve terminals ---
r_associated #0: 39 -->
en:muscular atrophy
n1=en:degenerating nerve terminals | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=39
- en:distal weakness, upper and lower limbs (variable) ---
r_associated #0: 39 -->
en:muscular atrophy
n1=en:distal weakness, upper and lower limbs (variable) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=39
- en:excess fat, symmetrically located in buttocks and lower extremities to ankles ---
r_associated #0: 39 -->
en:muscular atrophy
n1=en:excess fat, symmetrically located in buttocks and lower extremities to ankles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=39
- en:gluteal hypoplasia ---
r_associated #0: 39 -->
en:muscular atrophy
n1=en:gluteal hypoplasia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=39
- en:muscle weakness, mild, proximal and distal ---
r_associated #0: 39 -->
en:muscular atrophy
n1=en:muscle weakness, mild, proximal and distal | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=39
- en:normal mitochondrial morphology (1 patient) ---
r_associated #0: 39 -->
en:muscular atrophy
n1=en:normal mitochondrial morphology (1 patient) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=39
- en:thickened subcutaneous tissue ---
r_associated #0: 39 -->
en:muscular atrophy
n1=en:thickened subcutaneous tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=39
- en:type 1 fiber predominance ---
r_associated #0: 39 -->
en:muscular atrophy
n1=en:type 1 fiber predominance | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=39
- en:upper limb weakness ---
r_associated #0: 39 -->
en:muscular atrophy
n1=en:upper limb weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=39
- en:a subset of patients develop bilateral weakness ---
r_associated #0: 38 -->
en:muscular atrophy
n1=en:a subset of patients develop bilateral weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=38
- en:deep finger muscle weakness ---
r_associated #0: 38 -->
en:muscular atrophy
n1=en:deep finger muscle weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=38
- en:exercise intolerance (less common) ---
r_associated #0: 38 -->
en:muscular atrophy
n1=en:exercise intolerance (less common) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=38
- en:motor disability ---
r_associated #0: 38 -->
en:muscular atrophy
n1=en:motor disability | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=38
- en:muscle biopsy shows decrease or absence of cytochrome c oxidase ---
r_associated #0: 38 -->
en:muscular atrophy
n1=en:muscle biopsy shows decrease or absence of cytochrome c oxidase | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=38
- en:muscle cramps during exercise ---
r_associated #0: 38 -->
en:muscular atrophy
n1=en:muscle cramps during exercise | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=38
- en:poor musculature ---
r_associated #0: 38 -->
en:muscular atrophy
n1=en:poor musculature | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=38
- en:shoulder weakness ---
r_associated #0: 38 -->
en:muscular atrophy
n1=en:shoulder weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=38
- en:speech disability ---
r_associated #0: 38 -->
en:muscular atrophy
n1=en:speech disability | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=38
- en:atrophia ---
r_associated #0: 37 -->
en:muscular atrophy
n1=en:atrophia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=37
- en:biceps brachii atrophy ---
r_associated #0: 37 -->
en:muscular atrophy
n1=en:biceps brachii atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=37
- en:hypoplasia of the hand muscles (29%) ---
r_associated #0: 37 -->
en:muscular atrophy
n1=en:hypoplasia of the hand muscles (29%) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=37
- en:interfibrillar and subsarcolemmal vacuoles ---
r_associated #0: 37 -->
en:muscular atrophy
n1=en:interfibrillar and subsarcolemmal vacuoles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=37
- en:mental retardation, mild to severe (iq <35 in some patients) ---
r_associated #0: 37 -->
en:muscular atrophy
n1=en:mental retardation, mild to severe (iq <35 in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=37
- en:primarily affects lower limbs ---
r_associated #0: 37 -->
en:muscular atrophy
n1=en:primarily affects lower limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=37
- en:smooth muscle adaptation ---
r_associated #0: 37 -->
en:muscular atrophy
n1=en:smooth muscle adaptation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=37
- en:calf hypertrophy (early in the disease) ---
r_associated #0: 36 -->
en:muscular atrophy
n1=en:calf hypertrophy (early in the disease) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=36
- en:decreased activity of multiple mitochondrial respiratory complex enzymes ---
r_associated #0: 36 -->
en:muscular atrophy
n1=en:decreased activity of multiple mitochondrial respiratory complex enzymes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=36
- en:eosinophilic inclusions ---
r_associated #0: 36 -->
en:muscular atrophy
n1=en:eosinophilic inclusions | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=36
- en:levator palpebrae superioris atrophy ---
r_associated #0: 36 -->
en:muscular atrophy
n1=en:levator palpebrae superioris atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=36
- en:muscle shows lipid accumulation ---
r_associated #0: 36 -->
en:muscular atrophy
n1=en:muscle shows lipid accumulation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=36
- en:muscle weakness in forearm muscles ---
r_associated #0: 36 -->
en:muscular atrophy
n1=en:muscle weakness in forearm muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=36
- en:myotonia (usually occurs during rapid voluntary muscle movements after a period of rest) ---
r_associated #0: 36 -->
en:muscular atrophy
n1=en:myotonia (usually occurs during rapid voluntary muscle movements after a period of rest) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=36
- en:nearly complete absence of metabolically active adipose tissue (subcutaneous, intraabdominal, intrathoracic) ---
r_associated #0: 36 -->
en:muscular atrophy
n1=en:nearly complete absence of metabolically active adipose tissue (subcutaneous, intraabdominal, intrathoracic) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=36
- en:abnormal mitochondria in skeletal muscle biopsy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:abnormal mitochondria in skeletal muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:abnormal mitochondria with loss of cristae ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:abnormal mitochondria with loss of cristae | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:absence of merosin in muscle ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:absence of merosin in muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:amyloid deposition in muscle fibers occurs rarely ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:amyloid deposition in muscle fibers occurs rarely | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:atrophy of anterior compartment tibial muscles ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:atrophy of anterior compartment tibial muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:attacks precipitated by potassium ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:attacks precipitated by potassium | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:auditory auras ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:auditory auras | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:autophagic rimmed vacuoles ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:autophagic rimmed vacuoles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:centralized nuclei, rare ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:centralized nuclei, rare | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:cerebellar tonsilar ectopia (in some patients) ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:cerebellar tonsilar ectopia (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:congophilic amyloid material ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:congophilic amyloid material | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:cores have abrupt borders within normal regions of the muscle fiber ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:cores have abrupt borders within normal regions of the muscle fiber | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:cytochrome c oxidase-negative fibers ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:cytochrome c oxidase-negative fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:cytoplasmic inclusion bodies (finding) ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:cytoplasmic inclusion bodies (finding) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:decreased caveolin-3 expression seen on muscle biopsy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:decreased caveolin-3 expression seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:defective mitochondrial oxidative phosphorylation of multiple enzymes ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:defective mitochondrial oxidative phosphorylation of multiple enzymes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:dense membranous structure surrounding nuclei on electron microscopy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:dense membranous structure surrounding nuclei on electron microscopy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:difficulty running or inability to run ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:difficulty running or inability to run | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:difficulty walking, running, climbing stairs ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:difficulty walking, running, climbing stairs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:distal limb muscle weakness and atrophy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:distal limb muscle weakness and atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:distal lower limb muscle weakness and atrophy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:distal lower limb muscle weakness and atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:distal muscle weakness due to neuropathy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:distal muscle weakness due to neuropathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:distal muscle weakness may occur ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:distal muscle weakness may occur | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:distal muscle weakness, occurs initially ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:distal muscle weakness, occurs initially | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:electron microscopy shows abnormal mitochondria with disorganized and vacuolated cristae ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:electron microscopy shows abnormal mitochondria with disorganized and vacuolated cristae | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:episodic weakness may or may not occur independent of myotonia ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:episodic weakness may or may not occur independent of myotonia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:episodic, nonpruritic, nonurticarial, nonpitting edema ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:episodic, nonpruritic, nonurticarial, nonpitting edema | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:exercise-induced muscle stiffness ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:exercise-induced muscle stiffness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:facial muscle weakness and atrophy, progressive ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:facial muscle weakness and atrophy, progressive | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:fiber necrosis ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:fiber necrosis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:fiber type grouping ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:fiber type grouping | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:generalized muscle weakness, proximal and distal ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:generalized muscle weakness, proximal and distal | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:handgrip myotonia ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:handgrip myotonia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:hypothenar muscle atrophy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:hypothenar muscle atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:hypotonia (45%) ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:hypotonia (45%) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:hypotonia, generalized, severe ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:hypotonia, generalized, severe | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:imaging shows muscle atrophy and fatty replacement ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:imaging shows muscle atrophy and fatty replacement | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:increased endo- and perimysial connective tissue ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:increased endo- and perimysial connective tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:increased endomysial connective tissue around muscle fibers ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:increased endomysial connective tissue around muscle fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:increased fibrosis (family a) ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:increased fibrosis (family a) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:increased lipid droplets and abnormal mitochondria ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:increased lipid droplets and abnormal mitochondria | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:interosseus muscles involved ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:interosseus muscles involved | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:large lipid droplets ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:large lipid droplets | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:limb weakness and atrophy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:limb weakness and atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:lymphedema (primarily in lower limbs, but also arms in some patients) ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:lymphedema (primarily in lower limbs, but also arms in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:lymphography shows hypoplasia of lymphatic vessels ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:lymphography shows hypoplasia of lymphatic vessels | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:marked loss of subcutaneous fat in the limbs, face, and sometimes chest ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:marked loss of subcutaneous fat in the limbs, face, and sometimes chest | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:marked predominance of slow-twitch, oxidative (type 1) muscle fibers ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:marked predominance of slow-twitch, oxidative (type 1) muscle fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:merosin-positive biopsy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:merosin-positive biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:mild muscle atrophy in forearm muscles ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:mild muscle atrophy in forearm muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:mitochondria show paracrystalline inclusions ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:mitochondria show paracrystalline inclusions | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:miyoshi myopathy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:miyoshi myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle atrophy restricted to the upper limb ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle atrophy restricted to the upper limb | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle atrophy, progressive ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle atrophy, progressive | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle biopsy shows hypotrophy of type 1 muscle fibers ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle biopsy shows hypotrophy of type 1 muscle fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle biopsy shows increased subsarcolemmal vacuolar glycogen accumulation ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle biopsy shows increased subsarcolemmal vacuolar glycogen accumulation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle biopsy shows mitochondrial paracrystalline inclusions ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle biopsy shows mitochondrial paracrystalline inclusions | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle biopsy shows myodegenerative changes with beta-amyloid and phosphorylated tau deposits ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle biopsy shows myodegenerative changes with beta-amyloid and phosphorylated tau deposits | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle biopsy shows myofibrillar myopathy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle biopsy shows myofibrillar myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle biopsy shows no dystrophic changes ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle biopsy shows no dystrophic changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle biopsy shows type 2 fiber atrophy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle biopsy shows type 2 fiber atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle hyperirritability ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle hyperirritability | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle mitochondria normal by histochemical analysis ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle mitochondria normal by histochemical analysis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle mounding ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle mounding | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle pain (less common) ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle pain (less common) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle wasting in lower limbs ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle wasting in lower limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle weakness (hcs) ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle weakness (hcs) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:muscle weakness is predominantly of extremities and tongue ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:muscle weakness is predominantly of extremities and tongue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:myofibril destruction (in some patients) ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:myofibril destruction (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:neurogenic atrophy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:neurogenic atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:no facial muscle involvement ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:no facial muscle involvement | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:normal dystrophin immunostaining ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:normal dystrophin immunostaining | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:normal neonatal period may occur before weakness is apparent ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:normal neonatal period may occur before weakness is apparent | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:normal or increased adipose tissue around the neck ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:normal or increased adipose tissue around the neck | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:onset of weakness in hands and feet ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:onset of weakness in hands and feet | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:other mitochondrial complex enzyme activities may also be decreased ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:other mitochondrial complex enzyme activities may also be decreased | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:painful muscle cramps ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:painful muscle cramps | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:positive staining for slow myosin heavy chain ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:positive staining for slow myosin heavy chain | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:progressive distal muscle weakness ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:progressive distal muscle weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:pseudoathletic appearance with prominent muscles before disease onset ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:pseudoathletic appearance with prominent muscles before disease onset | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:repetitive response to single nerve stimulus ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:repetitive response to single nerve stimulus | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:rhabdomyolysis, episodic and recurrent ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:rhabdomyolysis, episodic and recurrent | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:rimmed vacuoles on biopsy ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:rimmed vacuoles on biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:severe disability within 20 years of onset ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:severe disability within 20 years of onset | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:severe form shows absence of spontaneous activity at birth ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:severe form shows absence of spontaneous activity at birth | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:shortened open channel duration ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:shortened open channel duration | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:some patients become wheelchair-dependent ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:some patients become wheelchair-dependent | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:some patients do not achieve ability to walk ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:some patients do not achieve ability to walk | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:spastic-ataxic tetraparesis ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:spastic-ataxic tetraparesis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:spasticity (reported in 1 patient) ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:spasticity (reported in 1 patient) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:spasticity of lower and upper limbs ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:spasticity of lower and upper limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:spasticity, mainly in the lower limbs ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:spasticity, mainly in the lower limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:speech absent or delayed ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:speech absent or delayed | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:speech delay (1 patient) ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:speech delay (1 patient) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:subsarcolemmal aggregates of abnormal mitochondria with concentric lamellar membranes ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:subsarcolemmal aggregates of abnormal mitochondria with concentric lamellar membranes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:swelling of the extremities, episodic ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:swelling of the extremities, episodic | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:tendinous and tuberous xanthoma ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:tendinous and tuberous xanthoma | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:triceps weakness ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:triceps weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:upper limb involvement occurs later or not at all ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:upper limb involvement occurs later or not at all | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:upper limb muscle hypoplasia ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:upper limb muscle hypoplasia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:variable decreases in mitochondrial respiratory complex enzyme activities ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:variable decreases in mitochondrial respiratory complex enzyme activities | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- en:white matter rarefaction ---
r_associated #0: 35 -->
en:muscular atrophy
n1=en:white matter rarefaction | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=35
- amyotrophies ---
r_associated #0: 34 -->
en:muscular atrophy
n1=amyotrophies | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- consomption ---
r_associated #0: 34 -->
en:muscular atrophy
n1=consomption | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:a subset of patients have aggravation on cold exposure ('cold paresis') ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:a subset of patients have aggravation on cold exposure ('cold paresis') | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:abnormal fat pad, buttocks and upper thighs (in some patients) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:abnormal fat pad, buttocks and upper thighs (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:abnormal irregular myofibrillar network ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:abnormal irregular myofibrillar network | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:abnormal mitochondria ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:abnormal mitochondria | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:abnormal variation in fiber type seen on muscle biopsy ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:abnormal variation in fiber type seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:absence of gamma-sarcoglycan protein ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:absence of gamma-sarcoglycan protein | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:absence of spontaneous activity at birth (severe form) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:absence of spontaneous activity at birth (severe form) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:accumulation of intrasarcoplasmic granulofilamentous aggregates that are immunoreactive to desmin and alpha-beta-crystallin ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:accumulation of intrasarcoplasmic granulofilamentous aggregates that are immunoreactive to desmin and alpha-beta-crystallin | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:acetazolamide may worsen symptoms ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:acetazolamide may worsen symptoms | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:angulated atrophic muscle fibers ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:angulated atrophic muscle fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:anterior tibial muscles first involved ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:anterior tibial muscles first involved | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:areflexia due to muscle weakness ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:areflexia due to muscle weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:asymmetric muscle involvement ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:asymmetric muscle involvement | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:biopsy shows nonspecific myopathy without rimmed vacuoles ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:biopsy shows nonspecific myopathy without rimmed vacuoles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:calf hypertrophy (less common) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:calf hypertrophy (less common) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:calf hypertrophy (reported in 1 family) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:calf hypertrophy (reported in 1 family) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:decreased endplate potential and amplitudes ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:decreased endplate potential and amplitudes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:decreased numbers of achr seen on muscle biopsy ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:decreased numbers of achr seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:decreased numbers of postsynaptic nerve terminals at the neuromuscular junction ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:decreased numbers of postsynaptic nerve terminals at the neuromuscular junction | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:decremental compound muscle action potential (cmap) in response to repetitive nerve stimulation seen on emg ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:decremental compound muscle action potential (cmap) in response to repetitive nerve stimulation seen on emg | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:delayed myelination (patients a and c) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:delayed myelination (patients a and c) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:diffuse signal hyperintensity of white matter seen on mri ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:diffuse signal hyperintensity of white matter seen on mri | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:disorganization of the neuromuscular junction ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:disorganization of the neuromuscular junction | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:distal muscle weakness and atrophy ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:distal muscle weakness and atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:distal muscle weakness, lower legs ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:distal muscle weakness, lower legs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:dystrophic changes on biopsy ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:dystrophic changes on biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:dystrophic features ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:dystrophic features | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:edema at birth ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:edema at birth | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:electron microscopy shows subsarcolemmal accumulations of abnormally shaped mitochondria ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:electron microscopy shows subsarcolemmal accumulations of abnormally shaped mitochondria | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:endomysial fibrosis ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:endomysial fibrosis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:enlarged mitochondria ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:enlarged mitochondria | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:exercise-induced muscle fatigue ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:exercise-induced muscle fatigue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:fat droplets in sarcoplasm and mitochondria seen on skeletal muscle biopsy ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:fat droplets in sarcoplasm and mitochondria seen on skeletal muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:gait abnormalities (occurs later) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:gait abnormalities (occurs later) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:hypertonia at birth ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:hypertonia at birth | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:hypotonia, neonatal and later ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:hypotonia, neonatal and later | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:inability to stand on tiptoes ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:inability to stand on tiptoes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:increased fatigue ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:increased fatigue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:increased glycogen ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:increased glycogen | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:increased internal nuclei (in some patients) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:increased internal nuclei (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:increased subcutaneous truncal adipose tissue ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:increased subcutaneous truncal adipose tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:increased variation in fiber size seen on muscle biopsy ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:increased variation in fiber size seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:increased white matter signal ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:increased white matter signal | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:limb-girdle muscle weakness, proximal, upper greater than lower ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:limb-girdle muscle weakness, proximal, upper greater than lower | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:lipid storage, mainly in type i fibers ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:lipid storage, mainly in type i fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:lipoatrophy (lower face, upper limb, buttock) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:lipoatrophy (lower face, upper limb, buttock) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:loss of ambulation between third and sixth decade ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:loss of ambulation between third and sixth decade | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:lymphedema of the lower limbs (swelling is confined to below the knees) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:lymphedema of the lower limbs (swelling is confined to below the knees) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:minicore-like lesions with mitochondrial depletion and sarcomeric disorganization ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:minicore-like lesions with mitochondrial depletion and sarcomeric disorganization | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:minimal subcutaneous fat ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:minimal subcutaneous fat | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:minipolymyoclonus ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:minipolymyoclonus | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:mitochondria are placed at the periphery of muscle fibers ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:mitochondria are placed at the periphery of muscle fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:mitochondrial proliferation ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:mitochondrial proliferation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:mlasa syndrome ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:mlasa syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:muscle aches, intermittent ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:muscle aches, intermittent | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:muscle atrophy (variable) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:muscle atrophy (variable) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:muscle atrophy affecting the upper back and neck muscles ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:muscle atrophy affecting the upper back and neck muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:muscle atrophy, upper and lower limbs ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:muscle atrophy, upper and lower limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:muscle biopsy shows degeneration of muscle fibers, variation in fiber size, fiber splitting, rimmed vacuoles, and central myonuclei ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:muscle biopsy shows degeneration of muscle fibers, variation in fiber size, fiber splitting, rimmed vacuoles, and central myonuclei | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:muscle biopsy shows disruption of the sarcolemmal membrane ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:muscle biopsy shows disruption of the sarcolemmal membrane | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:muscle biopsy shows fibrosis and increased connective tissue ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:muscle biopsy shows fibrosis and increased connective tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:muscle biopsy shows type 1 fiber predominance and hypertrophy ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:muscle biopsy shows type 1 fiber predominance and hypertrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:muscle fiber necrosis ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:muscle fiber necrosis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:muscle fiber splitting ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:muscle fiber splitting | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:myalgia, episodic ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:myalgia, episodic | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:myopathic episodes triggered by exercise, fasting, infection, cold temperatures ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:myopathic episodes triggered by exercise, fasting, infection, cold temperatures | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:myopathic features seen on emg ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:myopathic features seen on emg | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:myopathic findings on biopsy have been occasionally reported ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:myopathic findings on biopsy have been occasionally reported | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:myopathy, nonprogressive ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:myopathy, nonprogressive | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:myotonia improves with continued activity ('warm-up phenomenon') ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:myotonia improves with continued activity ('warm-up phenomenon') | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:nearly complete absence of mechanical adipose tissue (joints, orbits, palms, soles) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:nearly complete absence of mechanical adipose tissue (joints, orbits, palms, soles) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:no dystrophic changes ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:no dystrophic changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:no muscle weakness ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:no muscle weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:no ragged-red fibers ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:no ragged-red fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:nuclear clumps ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:nuclear clumps | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:onset of lymphedema around puberty ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:onset of lymphedema around puberty | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:patchy muscle fiber degeneration ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:patchy muscle fiber degeneration | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:patients may have distal or proximal muscle weakness, or both ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:patients may have distal or proximal muscle weakness, or both | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:pectoralis major hypoplasia ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:pectoralis major hypoplasia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:poor muscle build ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:poor muscle build | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:potassium sensitivity has been reported ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:potassium sensitivity has been reported | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:progressive proximal muscle weakness ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:progressive proximal muscle weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:proximal lower limb amyotrophy ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:proximal lower limb amyotrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:respiratory distress (congenital form) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:respiratory distress (congenital form) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:retroperitoneal fibrosis (rare) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:retroperitoneal fibrosis (rare) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:sarcoplasmic inclusions ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:sarcoplasmic inclusions | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:shortening of various muscle-tendon groups in feet ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:shortening of various muscle-tendon groups in feet | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:smooth muscle may also become involved ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:smooth muscle may also become involved | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:soft tissue vascular malformations ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:soft tissue vascular malformations | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:sparing of anterior tibialis muscle ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:sparing of anterior tibialis muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:specific visual spatial processing defect ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:specific visual spatial processing defect | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:subsarcolemmal accumulations of abnormally shaped mitochondria (on electron microscopy) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:subsarcolemmal accumulations of abnormally shaped mitochondria (on electron microscopy) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:thenar amyotrophy (rare) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:thenar amyotrophy (rare) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:tubulofilamentous inclusions ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:tubulofilamentous inclusions | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:type 2 muscle fiber atrophy ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:type 2 muscle fiber atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:usually no myopathic changes on biopsy ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:usually no myopathic changes on biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:vacuolar degeneration ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:vacuolar degeneration | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:variation of myofiber diameter ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:variation of myofiber diameter | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:weakness of ankle plantar flexion ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:weakness of ankle plantar flexion | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle) ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:wheelchair dependency in 20% of patients by age 40 ---
r_associated #0: 34 -->
en:muscular atrophy
n1=en:wheelchair dependency in 20% of patients by age 40 | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=34
- en:abnormal changes in the organization of the sarcolemma and the subsarcolemmal membrane cytoskeleton ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:abnormal changes in the organization of the sarcolemma and the subsarcolemmal membrane cytoskeleton | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:abnormal fiber size variation ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:abnormal fiber size variation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:accelerated decay of the synaptic current ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:accelerated decay of the synaptic current | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:angular fibers (in some patients) ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:angular fibers (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:arnold stickler bourne syndrome ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:arnold stickler bourne syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:atrophic fibers ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:atrophic fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:attacks precipitated by rest after exercise ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:attacks precipitated by rest after exercise | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:attacks usually decrease or disappear after age 40 years ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:attacks usually decrease or disappear after age 40 years | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:autophagic vacuoles with multilamellar structures seen on electron microscopy ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:autophagic vacuoles with multilamellar structures seen on electron microscopy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:biopsy shows defects in pyruvate oxidation ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:biopsy shows defects in pyruvate oxidation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:by fourth decade, many patients need help with ambulation ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:by fourth decade, many patients need help with ambulation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:calf muscle discomfort ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:calf muscle discomfort | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:decreased caveolin-3 expression on muscle biopsy ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:decreased caveolin-3 expression on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:decreased immunostaining for alpha-sarcoglycan ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:decreased immunostaining for alpha-sarcoglycan | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:decreased muscle mitochondrial aconitase ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:decreased muscle mitochondrial aconitase | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:decreased muscle succinate dehydrogenase ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:decreased muscle succinate dehydrogenase | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:degenerating fibers ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:degenerating fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:degenerative changes with increased connective tissue ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:degenerative changes with increased connective tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:delayed myelination (patient c) ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:delayed myelination (patient c) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:deposits immunoreactive to beta-amyloid protein ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:deposits immunoreactive to beta-amyloid protein | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:difficulty rising from chair ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:difficulty rising from chair | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:disarray of mitochondrial cristae seen on muscle biopsy ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:disarray of mitochondrial cristae seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:dystrophic changes ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:dystrophic changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:edema, subcutaneous, generalized ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:edema, subcutaneous, generalized | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:fibrillations in affected muscles ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:fibrillations in affected muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:furukawa takagi nakao syndrome ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:furukawa takagi nakao syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:generalized muscle weakness (less common) ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:generalized muscle weakness (less common) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:glycogenosis of skeletal muscle, mild (in some patients) ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:glycogenosis of skeletal muscle, mild (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:inclusion body myopathy ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:inclusion body myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:increased adipose fibrosis ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:increased adipose fibrosis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:increased length of endplate regions seen on muscle biopsy ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:increased length of endplate regions seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:increased lysosomal glycogen ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:increased lysosomal glycogen | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:increased muscle glycogen content ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:increased muscle glycogen content | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:limb-girdle muscle atrophy ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:limb-girdle muscle atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:loss of ability to walk in early childhood ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:loss of ability to walk in early childhood | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:loss of adipose tissue occurs around puberty ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:loss of adipose tissue occurs around puberty | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:loss of antigravity strength ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:loss of antigravity strength | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:lymphedema, hands (rare) ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:lymphedema, hands (rare) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:minicores extend full fiber diameter ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:minicores extend full fiber diameter | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscle atrophy, especially quadriceps and forearm muscles ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscle atrophy, especially quadriceps and forearm muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscle biopsy in acute stage shows increased numbers of abnormal mitochondria ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscle biopsy in acute stage shows increased numbers of abnormal mitochondria | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscle biopsy shows fiber type disproportion ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscle biopsy shows fiber type disproportion | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscle biopsy shows increased variation in fiber size ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscle biopsy shows increased variation in fiber size | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscle biopsy shows intranuclear tubulofilamentous inclusions ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscle biopsy shows intranuclear tubulofilamentous inclusions | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscle biopsy shows nonspecific myopathic changes without dystrophic or inflammatory changes ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscle biopsy shows nonspecific myopathic changes without dystrophic or inflammatory changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscle biopsy shows small fibers with central nuclei and accumulation of mitochondria in the central part of the fibers ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscle biopsy shows small fibers with central nuclei and accumulation of mitochondria in the central part of the fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscle biopsy shows small, membrane-bound vacuoles predominantly in type 2 fibers ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscle biopsy shows small, membrane-bound vacuoles predominantly in type 2 fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscle cramps affect the upper and lower limbs ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscle cramps affect the upper and lower limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscle cramps, painful, recurrent ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscle cramps, painful, recurrent | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscle fiber splitting and fibrosis seen on muscle biopsy ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscle fiber splitting and fibrosis seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscle wasting due to chronic denervation ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscle wasting due to chronic denervation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscle weakness and atrophy may be asymmetric ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscle weakness and atrophy may be asymmetric | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscles become hard and tender during exercise ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscles become hard and tender during exercise | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscular appearance ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscular appearance | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:muscular dystrophy (in 1 of 3 patients) ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:muscular dystrophy (in 1 of 3 patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:myopathy (rare) ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:myopathy (rare) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:myopathy due to magnesium deficiency ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:myopathy due to magnesium deficiency | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:myopathy, mild to severe ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:myopathy, mild to severe | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:myotonia, cold-sensitive, predominantly of face, tongue, forearm, and hand precipitated by muscle cooling or cold exposure or rest after exercise ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:myotonia, cold-sensitive, predominantly of face, tongue, forearm, and hand precipitated by muscle cooling or cold exposure or rest after exercise | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:neck flexor weakness ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:neck flexor weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:nemaline myopathy 8 ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:nemaline myopathy 8 | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:nonspecific muscle fiber atrophy ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:nonspecific muscle fiber atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:paralysis of the lower limbs (later) ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:paralysis of the lower limbs (later) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:partial lipodystrophy (abnormal distribution of subcutaneous adipose tissue) ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:partial lipodystrophy (abnormal distribution of subcutaneous adipose tissue) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:patients achieve independent ambulation, but may lose it ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:patients achieve independent ambulation, but may lose it | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:peroneal muscle atrophy ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:peroneal muscle atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:phagocytic vacuoles with degraded membranous material ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:phagocytic vacuoles with degraded membranous material | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:progression to proximal muscle weakness ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:progression to proximal muscle weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:prominent involvement of the biceps brachii muscles ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:prominent involvement of the biceps brachii muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:prominent involvement of the quadriceps femoris muscles ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:prominent involvement of the quadriceps femoris muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:proximal and distal muscle atrophy ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:proximal and distal muscle atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:proximal muscle weakness more severe than distal muscle weakness ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:proximal muscle weakness more severe than distal muscle weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:proximal muscle weakness occurs later ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:proximal muscle weakness occurs later | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:proximal muscle weakness, upper and lower limbs, due to peripheral neuropathy, later in disease course ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:proximal muscle weakness, upper and lower limbs, due to peripheral neuropathy, later in disease course | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:red-ragged fibers (2p21del) ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:red-ragged fibers (2p21del) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:reduced ankle dorsiflexion ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:reduced ankle dorsiflexion | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:severe muscle hypotonia at birth ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:severe muscle hypotonia at birth | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:shoulder weakness and atrophy ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:shoulder weakness and atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:skeletal muscle biopsy shows dystrophic changes ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:skeletal muscle biopsy shows dystrophic changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:somatosensory evoked potentials show prolonged latency ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:somatosensory evoked potentials show prolonged latency | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:some patients have neurologic involvement ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:some patients have neurologic involvement | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:spastic paraplegia, slowly progressive ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:spastic paraplegia, slowly progressive | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:stoke-like lesions ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:stoke-like lesions | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:structural brain abnormalities ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:structural brain abnormalities | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:symptoms may be induced by heat ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:symptoms may be induced by heat | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:tetanus-like muscle contractions ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:tetanus-like muscle contractions | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:transient neonatal hypotonia (less common) ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:transient neonatal hypotonia (less common) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:upper limb involvement and distal muscle involvement may occur later in disease course (often by second decade) ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:upper limb involvement and distal muscle involvement may occur later in disease course (often by second decade) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:usually a unilateral disorder ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:usually a unilateral disorder | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:vacuolar membranes immunostain with sarcolemmal proteins ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:vacuolar membranes immunostain with sarcolemmal proteins | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:variation in fibrodiameter seen on muscle biopsy ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:variation in fibrodiameter seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:wasting of calf muscles (rare) ---
r_associated #0: 32 -->
en:muscular atrophy
n1=en:wasting of calf muscles (rare) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=32
- en:abnormal aggregation of mitochondria ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:abnormal aggregation of mitochondria | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:abnormal muscle fibers with amorphous, granular, or hyaline deposits ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:abnormal muscle fibers with amorphous, granular, or hyaline deposits | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:absence of laminin alpha-2 chain in muscle ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:absence of laminin alpha-2 chain in muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:absence of myotonia in infancy (congenital form) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:absence of myotonia in infancy (congenital form) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:angulated atrophic fibers ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:angulated atrophic fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:attacks last 4 to 24 hours ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:attacks last 4 to 24 hours | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:attacks relieved by potassium administration ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:attacks relieved by potassium administration | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:biopsy of adipose tissue shows reduced adipocyte size ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:biopsy of adipose tissue shows reduced adipocyte size | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:calf muscle hypertrophy ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:calf muscle hypertrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:cores extend along length of muscle fiber ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:cores extend along length of muscle fiber | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:decreased achr ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:decreased achr | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:decreased hand grip strength ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:decreased hand grip strength | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:decreased miniature endplate potential (mepp) and current (mepc) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:decreased miniature endplate potential (mepp) and current (mepc) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:decreased spontaneous miniature endplate potentials (mepp) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:decreased spontaneous miniature endplate potentials (mepp) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:decremental cmap response to repetitive nerve stimulation ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:decremental cmap response to repetitive nerve stimulation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:decremental response to repetitive stimulation at neuromuscular junction ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:decremental response to repetitive stimulation at neuromuscular junction | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:distal muscle atrophy due to denervation ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:distal muscle atrophy due to denervation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:distal muscle weakness in lower limbs, severe ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:distal muscle weakness in lower limbs, severe | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:dystonic movements (in some patients) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:dystonic movements (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:easy bruisability of lower extremities ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:easy bruisability of lower extremities | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:edema (hands and feet) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:edema (hands and feet) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:extensor muscle weakness more severe than flexor muscle weakness ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:extensor muscle weakness more severe than flexor muscle weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:fasciculations (less common) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:fasciculations (less common) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:firm muscles ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:firm muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:foot extensor muscle weakness (later onset) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:foot extensor muscle weakness (later onset) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:generalized muscle wasting ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:generalized muscle wasting | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:generalized neonatal hypotonia ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:generalized neonatal hypotonia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:granular deposits in the sarcomeres ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:granular deposits in the sarcomeres | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:humeroperoneal weakness and atrophy ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:humeroperoneal weakness and atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:hyporeflexia in affected muscles ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:hyporeflexia in affected muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:hypotonia, truncal and appendicular ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:hypotonia, truncal and appendicular | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:inability to walk (in some patients) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:inability to walk (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:increased central nucleation ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:increased central nucleation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:increased fatty and connective tissue in skeletal muscle ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:increased fatty and connective tissue in skeletal muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:increased glycogen in muscle (but to a lesser extent than in the heart) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:increased glycogen in muscle (but to a lesser extent than in the heart) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:inflammatory cells absent ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:inflammatory cells absent | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:loss of ambulation ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:loss of ambulation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:lymphedema (lower limb) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:lymphedema (lower limb) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:lymphedema, of upper and/or lower extremity (rare) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:lymphedema, of upper and/or lower extremity (rare) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:macies ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:macies | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:mild variability in muscle fiber size ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:mild variability in muscle fiber size | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle biopsy may show inflammatory changes ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle biopsy may show inflammatory changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle biopsy shows chronic and active denervation ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle biopsy shows chronic and active denervation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle biopsy shows decreased or absent dysferlin staining ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle biopsy shows decreased or absent dysferlin staining | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle biopsy shows degenerating endplates and junctional folds ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle biopsy shows degenerating endplates and junctional folds | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle biopsy shows glycogen storage ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle biopsy shows glycogen storage | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle biopsy shows loss of type 2a fibers ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle biopsy shows loss of type 2a fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle biopsy shows myopathic changes ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle biopsy shows myopathic changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle biopsy shows neurogenic atrophy ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle biopsy shows neurogenic atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle biopsy shows rimmed vacuoles ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle biopsy shows rimmed vacuoles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle cramps may affect jaw muscles ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle cramps may affect jaw muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle hyperplasia ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle hyperplasia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle weakness (in some patients) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle weakness (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle weakness after cooling or on warming affected muscle ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle weakness after cooling or on warming affected muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle weakness and atrophy, proximal ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle weakness and atrophy, proximal | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle weakness, distal, particularly affecting the hands ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle weakness, distal, particularly affecting the hands | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:muscle weakness, proximal and distal ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:muscle weakness, proximal and distal | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:myofibrillar disintegration ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:myofibrillar disintegration | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:nemaline bodies occur in type 1 fibers ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:nemaline bodies occur in type 1 fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:neurogenic atrophy seen on muscle biopsy ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:neurogenic atrophy seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:no lipodystrophy in face and neck ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:no lipodystrophy in face and neck | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:pain or cramping during sustained manual activity ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:pain or cramping during sustained manual activity | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:prominent muscular appearance ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:prominent muscular appearance | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:proximal muscle weakness (occasional) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:proximal muscle weakness (occasional) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:proximal muscle weakness in upper limbs ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:proximal muscle weakness in upper limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:ragged-red fibers seen on muscle biopsy ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:ragged-red fibers seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:secondary loss of sarcolemmal caveolin-3 ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:secondary loss of sarcolemmal caveolin-3 | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:secondary myopathic features ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:secondary myopathic features | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:shortening of flexor profundus muscle-tendon unit ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:shortening of flexor profundus muscle-tendon unit | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:soft fleshy palms (50%) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:soft fleshy palms (50%) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:sporadic adult-onset ataxia of unknown etiology ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:sporadic adult-onset ataxia of unknown etiology | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:stimulation sensitive generalized myoclonus (stage 3) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:stimulation sensitive generalized myoclonus (stage 3) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:type 1 muscle fiber predominance ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:type 1 muscle fiber predominance | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:type 1 muscle fibers with clearly demarcated central 'core' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:type 1 muscle fibers with clearly demarcated central 'core' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:type 2 muscle fiber predominance ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:type 2 muscle fiber predominance | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:upper arm and pelvic muscle weakness and atrophy (later onset) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:upper arm and pelvic muscle weakness and atrophy (later onset) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:uterine muscle may be stiff during pregnancy ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:uterine muscle may be stiff during pregnancy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:vacuoles are autophagocytic ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:vacuoles are autophagocytic | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:vacuoles are autophagocytic and contain granular and membranous cellular debris ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:vacuoles are autophagocytic and contain granular and membranous cellular debris | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:walking may be limited ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:walking may be limited | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:wasting, especially temporal, neck, and facial muscles ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:wasting, especially temporal, neck, and facial muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:weakness of long finger extensor muscles (occurs later) ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:weakness of long finger extensor muscles (occurs later) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:weakness worsened by activity ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:weakness worsened by activity | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:z-disk degeneration ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:z-disk degeneration | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:z-line streaming see on electron microscopy ---
r_associated #0: 31 -->
en:muscular atrophy
n1=en:z-line streaming see on electron microscopy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=31
- en:abdominal muscle hypoplasia ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:abdominal muscle hypoplasia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:abdominal wall muscle weakness (later onset) ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:abdominal wall muscle weakness (later onset) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:abnormal size and shape of synaptic endplates ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:abnormal size and shape of synaptic endplates | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:amyotrophy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:amyotrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:angina co-occurrent and due to arteriosclerosis of coronary artery bypass graft ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:angina co-occurrent and due to arteriosclerosis of coronary artery bypass graft | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:apoptotic nuclei ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:apoptotic nuclei | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:atrophy of the muscles in the anterior compartment of the lower leg ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:atrophy of the muscles in the anterior compartment of the lower leg | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:calf muscle pseudohypertrophy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:calf muscle pseudohypertrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:chronic neurogenic changes seen on emg ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:chronic neurogenic changes seen on emg | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:congenital, nonprogressive myopathy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:congenital, nonprogressive myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:decreased adipose tissue around neck ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:decreased adipose tissue around neck | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:decreased mitochondria ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:decreased mitochondria | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:decreased muscle mass (especially in lower limbs) ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:decreased muscle mass (especially in lower limbs) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:decreased quantal release ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:decreased quantal release | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:decremental cmap response to repetitive nerve stimulation seen on emg ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:decremental cmap response to repetitive nerve stimulation seen on emg | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:deltoid muscle hypoplasia ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:deltoid muscle hypoplasia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:dependent edema after excess fat has been present for several years ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:dependent edema after excess fat has been present for several years | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:distal atrophy of the legs ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:distal atrophy of the legs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:distal limb muscle weakness occurs later ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:distal limb muscle weakness occurs later | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:distal lower limb amyotrophy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:distal lower limb amyotrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:distal muscle atrophy, affecting the lower limbs ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:distal muscle atrophy, affecting the lower limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:distal muscle weakness, affecting the lower limbs ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:distal muscle weakness, affecting the lower limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:dystrophic changes seen on muscle biopsy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:dystrophic changes seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:electromyographic decrements in some muscles ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:electromyographic decrements in some muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:endplate myopathy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:endplate myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:gastrocnemius and soleus muscles most affected ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:gastrocnemius and soleus muscles most affected | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:hamstring muscle affected ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:hamstring muscle affected | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:hip flexor weakness ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:hip flexor weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:hip girdle muscle weakness (usually presenting symptom) ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:hip girdle muscle weakness (usually presenting symptom) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:hypertrophy of the extensor digitorum brevis muscles ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:hypertrophy of the extensor digitorum brevis muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:hypoplasia of supraspinatus muscle ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:hypoplasia of supraspinatus muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:hypotonia (2 patients) ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:hypotonia (2 patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:hypotonia (families a and b) ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:hypotonia (families a and b) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:inability to jump or squat ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:inability to jump or squat | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:increased connective tissue and fat in muscles ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:increased connective tissue and fat in muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:independent walking may not be achieved ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:independent walking may not be achieved | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:lafora bodies (accumulation of polyglucosan) seen on skeletal muscle biopsy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:lafora bodies (accumulation of polyglucosan) seen on skeletal muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:limb-girdle myopathy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:limb-girdle myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:lipid droplet accumulation ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:lipid droplet accumulation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:loss of subcutaneous adipose tissue primarily in gluteal region and lower limbs ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:loss of subcutaneous adipose tissue primarily in gluteal region and lower limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:lymphedema of the extremities ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:lymphedema of the extremities | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:lymphedema of the hands (in some patients) ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:lymphedema of the hands (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:marked lack of adipose tissue ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:marked lack of adipose tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:marked muscular hypertrophy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:marked muscular hypertrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:mild endplate myopathy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:mild endplate myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:minimal muscle mass ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:minimal muscle mass | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:mitochondrial paracrystalline inclusion bodies ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:mitochondrial paracrystalline inclusion bodies | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:muscle biopsy shows dystrophic pattern ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:muscle biopsy shows dystrophic pattern | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:muscle biopsy shows loss of myofibrillar organization ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:muscle biopsy shows loss of myofibrillar organization | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:muscle biopsy shows mild dystrophic changes ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:muscle biopsy shows mild dystrophic changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:muscle biopsy shows necrotic and atrophic fibers with centralized nuclei ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:muscle biopsy shows necrotic and atrophic fibers with centralized nuclei | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:muscle pain with exercise (in older patients) ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:muscle pain with exercise (in older patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:muscle weakness of the face and neck, mild to moderate ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:muscle weakness of the face and neck, mild to moderate | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:muscle weakness, proximal, slowly progressive ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:muscle weakness, proximal, slowly progressive | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:muscle weakness, upper and lower limbs ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:muscle weakness, upper and lower limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:muscles do not contract upon electrical stimulation ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:muscles do not contract upon electrical stimulation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:myofibrillar lesions ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:myofibrillar lesions | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:myopathic changes on pathology ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:myopathic changes on pathology | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:myotonia is present in majority of cases ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:myotonia is present in majority of cases | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:myxedematous appearance ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:myxedematous appearance | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:nonspecific myopathy seen on biopsy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:nonspecific myopathy seen on biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:paradoxical myotonia (myotonia increases with exercise) ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:paradoxical myotonia (myotonia increases with exercise) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:positive regulation of muscle atrophy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:positive regulation of muscle atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:primrose syndrome ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:primrose syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:progressive distal and proximal symmetric limb weakness ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:progressive distal and proximal symmetric limb weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:prolonged endplate potentials ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:prolonged endplate potentials | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:prominent musculature ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:prominent musculature | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:proximal limb muscle weakness (occurs later) ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:proximal limb muscle weakness (occurs later) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:proximal lower limb muscle weakness, upper and lower (later onset) ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:proximal lower limb muscle weakness, upper and lower (later onset) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:proximal muscle weakness, mild ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:proximal muscle weakness, mild | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:ragged-red muscle fibers ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:ragged-red muscle fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:reduced muscle bulk ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:reduced muscle bulk | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:retain some mechanical adipose tissue (joints, orbits, palms, soles) ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:retain some mechanical adipose tissue (joints, orbits, palms, soles) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:scapuloperoneal muscular atrophy due to denervation ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:scapuloperoneal muscular atrophy due to denervation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:shoulder girdle muscle atrophy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:shoulder girdle muscle atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:skeletal muscle shows decreased sarcoglycan proteins ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:skeletal muscle shows decreased sarcoglycan proteins | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:smooth brain surface ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:smooth brain surface | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:some patients may develop afebrile seizures later in life ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:some patients may develop afebrile seizures later in life | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:some patients never achieve ambulation ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:some patients never achieve ambulation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:spasticity may be present ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:spasticity may be present | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:subsarcolemmal accumulation of enlarged mitochondria with variably sized rectangular or elongated rhomboidal paracrystalline inclusions ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:subsarcolemmal accumulation of enlarged mitochondria with variably sized rectangular or elongated rhomboidal paracrystalline inclusions | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:subsarcolemmal accumulations of abnormally shaped mitochondria seen on electron microscopy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:subsarcolemmal accumulations of abnormally shaped mitochondria seen on electron microscopy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:subsarcolemmal accumulations of abnormally shaped mitochondria seen with electronmicroscopy ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:subsarcolemmal accumulations of abnormally shaped mitochondria seen with electronmicroscopy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:tendon tears ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:tendon tears | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:thickening of the fascial structures of the palm and fingers ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:thickening of the fascial structures of the palm and fingers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:tubular aggregates in muscle fibers may occur ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:tubular aggregates in muscle fibers may occur | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- en:weakness of ankle and toe extensor (dorsiflexor) muscles ---
r_associated #0: 30 -->
en:muscular atrophy
n1=en:weakness of ankle and toe extensor (dorsiflexor) muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=30
- dégénérescence vacuolaire ---
r_associated #0: 29 -->
en:muscular atrophy
n1=dégénérescence vacuolaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:affected muscles show atrophy ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:affected muscles show atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:and diabetes mellitus ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:and diabetes mellitus | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:atrophic muscle fiber on biopsy ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:atrophic muscle fiber on biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:biopsy shows dystrophic changes ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:biopsy shows dystrophic changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:calf atrophy (later onset) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:calf atrophy (later onset) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:cellulitis or infection may occur ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:cellulitis or infection may occur | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:centralized nuclei may be seen ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:centralized nuclei may be seen | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:congophilic staining ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:congophilic staining | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:cores or minicores ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:cores or minicores | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:cores with lack of oxidative activity and mitochondrial depletion may also be found and extend along length of fiber ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:cores with lack of oxidative activity and mitochondrial depletion may also be found and extend along length of fiber | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:decreased distal strength (in some patients) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:decreased distal strength (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:decreased glycosylation of alpha-dystroglycan ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:decreased glycosylation of alpha-dystroglycan | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:decreased lactate clearance from muscle after exercise (reported in 1 patient) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:decreased lactate clearance from muscle after exercise (reported in 1 patient) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:decreased muscle density on imaging ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:decreased muscle density on imaging | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:decreased numbers of acetylcholine receptors (achr) in the postsynaptic membrane (less than 50% of normal) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:decreased numbers of acetylcholine receptors (achr) in the postsynaptic membrane (less than 50% of normal) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:decreased or patchy amounts of alpha-dystrobrevin and beta-2-syntrophin at the sarcolemma ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:decreased or patchy amounts of alpha-dystrobrevin and beta-2-syntrophin at the sarcolemma | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:decreased postsynaptic length ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:decreased postsynaptic length | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:delayed myelination endocrine : gonadotropin-dependent precocious puberty (1 patient) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:delayed myelination endocrine : gonadotropin-dependent precocious puberty (1 patient) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:disorganization of the myofibrillar pattern ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:disorganization of the myofibrillar pattern | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:distal leg muscle atrophy ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:distal leg muscle atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:distal muscle atrophy due to neuropathy ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:distal muscle atrophy due to neuropathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:distal muscle weakness and atrophy may occur, upper and lower limbs affected ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:distal muscle weakness and atrophy may occur, upper and lower limbs affected | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:edema is present at birth and then slowly decreases ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:edema is present at birth and then slowly decreases | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:exertional fatigue ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:exertional fatigue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:fatty infiltration of affected muscles ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:fatty infiltration of affected muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:few spontaneous movements ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:few spontaneous movements | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:fiber type variation ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:fiber type variation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:focal loss of cross striations seen on muscle biopsy ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:focal loss of cross striations seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:generalized muscular appearance from birth ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:generalized muscular appearance from birth | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:heterotopic bone formation in subcutaneous fat ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:heterotopic bone formation in subcutaneous fat | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:hip girdle muscle atrophy ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:hip girdle muscle atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:hypoplasia of cervical paravertebral muscles ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:hypoplasia of cervical paravertebral muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:increased internal nuclei ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:increased internal nuclei | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:increased intraabdominal fat ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:increased intraabdominal fat | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:increased variation in muscle fiber diameter ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:increased variation in muscle fiber diameter | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:indentations or folds of the sarcolemma are connected to the membranes enclosing the vacuoles ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:indentations or folds of the sarcolemma are connected to the membranes enclosing the vacuoles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:leg cramps may occur with exercise ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:leg cramps may occur with exercise | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:lipodystrophy (in some patients) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:lipodystrophy (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:lipodystrophy, generalized, panniculitis-induced (in some) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:lipodystrophy, generalized, panniculitis-induced (in some) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:loss of gluteal adipose tissue ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:loss of gluteal adipose tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:loss of subcutaneous fat, generalized ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:loss of subcutaneous fat, generalized | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:lymphedema, dorsa of feet ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:lymphedema, dorsa of feet | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:lymphography shows increased number of dilated lymphatic vessels (hyperplasia) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:lymphography shows increased number of dilated lymphatic vessels (hyperplasia) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:mallory-like bodies ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:mallory-like bodies | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:mild weakness ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:mild weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle atrophy appears later in disease course ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle atrophy appears later in disease course | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle biopsy shows 60-80-nm tubular aggregates arranged in hexagonal arrays in type 2 fibers ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle biopsy shows 60-80-nm tubular aggregates arranged in hexagonal arrays in type 2 fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle biopsy shows dystrophic features ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle biopsy shows dystrophic features | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle biopsy shows merosin (156225)-positive muscle fibers ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle biopsy shows merosin (156225)-positive muscle fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle biopsy shows myofiber degeneration ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle biopsy shows myofiber degeneration | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle biopsy shows necrotic and regenerating fibers ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle biopsy shows necrotic and regenerating fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle biopsy shows neurogenic atrophy (1 patient) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle biopsy shows neurogenic atrophy (1 patient) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle biopsy shows nonspecific myopathic changes ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle biopsy shows nonspecific myopathic changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle biopsy shows small rounded fibers ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle biopsy shows small rounded fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle cramps (also seen in some heterozygotes) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle cramps (also seen in some heterozygotes) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle fibers appear as fetal myotubules ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle fibers appear as fetal myotubules | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle stiffness (in older patients) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle stiffness (in older patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle weakness, proximal greater than distal ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle weakness, proximal greater than distal | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle weakness, proximal limb muscle, mild to moderate ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle weakness, proximal limb muscle, mild to moderate | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscle weakness, proximal, limb-girdle ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscle weakness, proximal, limb-girdle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:muscular atrophy, malignant neurogenic ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:muscular atrophy, malignant neurogenic | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:myofibrillar disorganization ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:myofibrillar disorganization | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:myopathy in approximately 45% of patients ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:myopathy in approximately 45% of patients | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:myotonia, potassium-sensitive (may be responsive to acetazolamide) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:myotonia, potassium-sensitive (may be responsive to acetazolamide) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:neonatal edema (in some patients) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:neonatal edema (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:no rods ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:no rods | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:normal or decreased facial and neck adipose tissue ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:normal or decreased facial and neck adipose tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:pelvic girdle muscle weakness (occurs earlier) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:pelvic girdle muscle weakness (occurs earlier) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:pelvic muscle involvement occurs later ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:pelvic muscle involvement occurs later | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:plaques immunoreactive for desmin and alpha-beta-crystallin ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:plaques immunoreactive for desmin and alpha-beta-crystallin | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:progressive interictal weakness is common ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:progressive interictal weakness is common | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:proximal upper limb amyotrophy ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:proximal upper limb amyotrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:quadriceps atrophy (later onset) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:quadriceps atrophy (later onset) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:ragged red fibers seen on skeletal muscle biopsy ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:ragged red fibers seen on skeletal muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:ragged-red fibers on muscle biopsy ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:ragged-red fibers on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:replacement of affected muscle tissue with fatty tissue ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:replacement of affected muscle tissue with fatty tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:rimmed vacuoles with basophilic granular material ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:rimmed vacuoles with basophilic granular material | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:scattered necrotic fibers ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:scattered necrotic fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:shoulder muscle hypoplasia ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:shoulder muscle hypoplasia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:small rotary component may be present ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:small rotary component may be present | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:sparing of the anterior tibial compartment ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:sparing of the anterior tibial compartment | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:spasticity may occur ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:spasticity may occur | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:speech never acquired ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:speech never acquired | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:spinal neurofibromas (64%) ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:spinal neurofibromas (64%) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:subsarcolemmal mitochondrial accumulation ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:subsarcolemmal mitochondrial accumulation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:swelling of the affected areas ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:swelling of the affected areas | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:tremor at birth, involving most skeletal muscle groups, especially jaw muscles and lower limb muscles ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:tremor at birth, involving most skeletal muscle groups, especially jaw muscles and lower limb muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:tubular aggregates in type 2 skeletal muscle fibers ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:tubular aggregates in type 2 skeletal muscle fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:type 1 fibers are at least 12% smaller than type 2 fibers ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:type 1 fibers are at least 12% smaller than type 2 fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:type 2 fiber hypertrophy ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:type 2 fiber hypertrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:vacuolar myopathy ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:vacuolar myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:widening of the synaptic cleft ---
r_associated #0: 29 -->
en:muscular atrophy
n1=en:widening of the synaptic cleft | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- handicap moteur ---
r_associated #0: 29 -->
en:muscular atrophy
n1=handicap moteur | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=29
- en:abnormal distribution of subcutaneous fat ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:abnormal distribution of subcutaneous fat | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:absence of telethonin protein ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:absence of telethonin protein | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:amyotrophy, distal, upper and lower limbs ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:amyotrophy, distal, upper and lower limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:atrophy of neck muscles may occur later ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:atrophy of neck muscles may occur later | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:atrophy of the lower leg muscles ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:atrophy of the lower leg muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:atrophy of the thenar and hypothenar muscles ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:atrophy of the thenar and hypothenar muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:axial hypertonia ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:axial hypertonia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:bifrontal subdural hygroma ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:bifrontal subdural hygroma | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:both type 1 and type 2 fiber predominance has been reported ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:both type 1 and type 2 fiber predominance has been reported | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:calf hypertrophy (uncommon) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:calf hypertrophy (uncommon) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:changes in sarcoplasmic reticulum and t-tubules ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:changes in sarcoplasmic reticulum and t-tubules | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:congenital myasthenic syndrome (reported in 1 patient who survived to age 20 years) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:congenital myasthenic syndrome (reported in 1 patient who survived to age 20 years) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:congophilic deposits ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:congophilic deposits | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:congophilic inclusions ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:congophilic inclusions | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:cores contain densely packed myofilaments ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:cores contain densely packed myofilaments | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:decreased ability to run ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:decreased ability to run | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:decreased activity of cytochrome c oxidase in most cases seen on muscle biopsy ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:decreased activity of cytochrome c oxidase in most cases seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:decreased distal reflexes ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:decreased distal reflexes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:decreased lipoic acid ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:decreased lipoic acid | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:difficulty walking and climbing stairs (patient a) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:difficulty walking and climbing stairs (patient a) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:distal limb muscle weakness (less common) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:distal limb muscle weakness (less common) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:distal muscle weakness due to peripheral neuropathy, lower limbs more affected than upper limbs ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:distal muscle weakness due to peripheral neuropathy, lower limbs more affected than upper limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:distal muscles may be affected ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:distal muscles may be affected | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:dystrophic changes may be present ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:dystrophic changes may be present | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:exercise intolerance (also seen in some heterozygotes) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:exercise intolerance (also seen in some heterozygotes) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:fat pad anterior to malleolus ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:fat pad anterior to malleolus | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:hamstring and quadriceps muscles mildly affected ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:hamstring and quadriceps muscles mildly affected | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:hyaline inclusion ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:hyaline inclusion | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:hyaline plaques with absent oxidative activity ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:hyaline plaques with absent oxidative activity | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:hypertrophy of calves (in 3 of 6 patients) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:hypertrophy of calves (in 3 of 6 patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:hypoplasia of serratus anterior muscle ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:hypoplasia of serratus anterior muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:increased connective tissue ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:increased connective tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:increased connective tissue and fat ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:increased connective tissue and fat | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:increased fatty infiltration ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:increased fatty infiltration | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:increased fibrosis (in some patients) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:increased fibrosis (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:increased intramuscular fat ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:increased intramuscular fat | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:increased variation in fiber size (in some patients) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:increased variation in fiber size (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:internal nuclei ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:internal nuclei | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:internal nuclei (in some patients) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:internal nuclei (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:limb muscle weakness, proximal, upper and lower ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:limb muscle weakness, proximal, upper and lower | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:lipomas or lipomatous masses (most cases) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:lipomas or lipomatous masses (most cases) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:loss of subcutaneous adipose tissue from gluteal region ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:loss of subcutaneous adipose tissue from gluteal region | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:loss of truncal subcutaneous adipose tissue ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:loss of truncal subcutaneous adipose tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:mild weakness of the small hand muscles ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:mild weakness of the small hand muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:mildly increased mtdna ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:mildly increased mtdna | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:minicore regions are poorly defined and do not extend through entire fiber length ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:minicore regions are poorly defined and do not extend through entire fiber length | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:miyoshi muscular dystrophy 2 (disorder) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:miyoshi muscular dystrophy 2 (disorder) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:muscle biopsy is immunopositive for merosin (156225) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:muscle biopsy is immunopositive for merosin (156225) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:muscle biopsy shows abnormal fiber size and variation ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:muscle biopsy shows abnormal fiber size and variation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:muscle biopsy shows decreased muscle-specific phosphorylase kinase activity ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:muscle biopsy shows decreased muscle-specific phosphorylase kinase activity | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:muscle biopsy shows dystrophic changes ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:muscle biopsy shows dystrophic changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:muscle biopsy shows ragged red fibers ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:muscle biopsy shows ragged red fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:muscle biopsy shows type 1 fiber predominance ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:muscle biopsy shows type 1 fiber predominance | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:muscle fiber atrophy, profound (rare) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:muscle fiber atrophy, profound (rare) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:muscle fiber regeneration ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:muscle fiber regeneration | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:muscle weakness associated with fasting or infection ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:muscle weakness associated with fasting or infection | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:muscle weakness, particularly of the lower limbs ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:muscle weakness, particularly of the lower limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:muscle weakness, severe, diffuse ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:muscle weakness, severe, diffuse | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:muscles have a woody consistency on palpation ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:muscles have a woody consistency on palpation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:myalgia (in some patients) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:myalgia (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:myotonic discharges ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:myotonic discharges | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:necrotic and atrophic fibers with centralized nuclei seen on muscle biopsy ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:necrotic and atrophic fibers with centralized nuclei seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:nonspecific myopathy ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:nonspecific myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:partial lipodystrophy (abnormal distribution of adipose tissue) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:partial lipodystrophy (abnormal distribution of adipose tissue) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:pectoralis hypoplasia ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:pectoralis hypoplasia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:periventricular calcifications (patient c) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:periventricular calcifications (patient c) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:progressive loss of facial adipose tissue ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:progressive loss of facial adipose tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:proximal muscle weakness (85% of patients) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:proximal muscle weakness (85% of patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:rectus abdominis muscle separation ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:rectus abdominis muscle separation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:reduced muscle tone ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:reduced muscle tone | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:repetitive action potentials in response to single nerve stimulation ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:repetitive action potentials in response to single nerve stimulation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:repetitive compound muscle action potentials (cmap) in response to single stimulus ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:repetitive compound muscle action potentials (cmap) in response to single stimulus | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:repetitive response to single nerve stimulation ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:repetitive response to single nerve stimulation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:retinitis pigmentosa ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:retinitis pigmentosa | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:rhabdomyolysis may occur ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:rhabdomyolysis may occur | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:skeletal muscle biopsy shows minor variation in fiber size ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:skeletal muscle biopsy shows minor variation in fiber size | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:small but structurally normal cerebral cortex ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:small but structurally normal cerebral cortex | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:sparing of the brachioradialis muscle (gives appearance of 'oblique amyotrophy') ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:sparing of the brachioradialis muscle (gives appearance of 'oblique amyotrophy') | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:spastic-ataxic gait ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:spastic-ataxic gait | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:spinocerebellar tract disease in lower limbs (in adulthood) ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:spinocerebellar tract disease in lower limbs (in adulthood) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:symptoms are progressive for a few years, and then become stationary ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:symptoms are progressive for a few years, and then become stationary | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:tenderness of lower extremities ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:tenderness of lower extremities | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:transient muscle weakness occur in 75% of patients, particularly in the arms and hands ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:transient muscle weakness occur in 75% of patients, particularly in the arms and hands | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:type 1 fiber atrophy ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:type 1 fiber atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- en:vacuolar myopathy may occur ---
r_associated #0: 28 -->
en:muscular atrophy
n1=en:vacuolar myopathy may occur | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=28
- amyotrophique ---
r_associated #0: 27 -->
en:muscular atrophy
n1=amyotrophique | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:Primrose syndrome ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:Primrose syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:abnormal fatigue ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:abnormal fatigue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:abnormal iron deposition in mitochondria ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:abnormal iron deposition in mitochondria | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:abnormalities in myofibril organization ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:abnormalities in myofibril organization | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:absence of immunostaining for alpha- and beta-dystroglycan (family b) ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:absence of immunostaining for alpha- and beta-dystroglycan (family b) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:acquire ability to walk and jump in childhood, but motor regression occurs later ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:acquire ability to walk and jump in childhood, but motor regression occurs later | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:angulated fibers ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:angulated fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:atrophy of ankle and toe extensor (dorsiflexor) muscles ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:atrophy of ankle and toe extensor (dorsiflexor) muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:bethlem myopathy 1 ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:bethlem myopathy 1 | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:calf pseudohypertrophy rare ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:calf pseudohypertrophy rare | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:centralized myonuclei ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:centralized myonuclei | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:decreased glutamate oxidation (about 63% of normal) ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:decreased glutamate oxidation (about 63% of normal) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:decreased shank muscle mass ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:decreased shank muscle mass | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:decreased thiamine pyrophosphate ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:decreased thiamine pyrophosphate | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:decremental compound muscle action potential on repetitive stimulation ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:decremental compound muscle action potential on repetitive stimulation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:difficulty in toe walking ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:difficulty in toe walking | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:distal muscle atrophy due to neurologic disease ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:distal muscle atrophy due to neurologic disease | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:distal muscle weakness occurs later ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:distal muscle weakness occurs later | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:distal muscle weakness of the lower limbs secondary to peripheral neuropathy ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:distal muscle weakness of the lower limbs secondary to peripheral neuropathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:electromyography shows myotonic discharges ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:electromyography shows myotonic discharges | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:exercise-induced weakness ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:exercise-induced weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:extrapyramidal symptoms (patient a) ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:extrapyramidal symptoms (patient a) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:fatty replacement ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:fatty replacement | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:fiber size variation ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:fiber size variation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:foot dorsiflexor weakness ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:foot dorsiflexor weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:frittering ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:frittering | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:generalized limb muscle atrophy ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:generalized limb muscle atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:glycogen depletion in skeletal muscle ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:glycogen depletion in skeletal muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:hand and foot weakness ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:hand and foot weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:hypotrophy of type 1 fibers ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:hypotrophy of type 1 fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:increased muscle lipid content ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:increased muscle lipid content | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:increased perisarcolemmal calcium deposition ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:increased perisarcolemmal calcium deposition | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:increased staining for myotilin, dystrophin, desmin ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:increased staining for myotilin, dystrophin, desmin | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:increased variability in muscle fiber diameter ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:increased variability in muscle fiber diameter | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:intrasarcoplasmic dense granulofilamentous aggregates that are immunoreactive with desmin ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:intrasarcoplasmic dense granulofilamentous aggregates that are immunoreactive with desmin | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:involves upper and lower proximal muscles ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:involves upper and lower proximal muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:lack of antigravity movements (patient b) ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:lack of antigravity movements (patient b) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:large hypertrophied fibers ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:large hypertrophied fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:lipoatrophy of trunk ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:lipoatrophy of trunk | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:low muscle mass ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:low muscle mass | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:lymphangitis, episodic ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:lymphangitis, episodic | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:molar tooth sign seen on brain imaging ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:molar tooth sign seen on brain imaging | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:motor deficits (in some patients) ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:motor deficits (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:motor handicap ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:motor handicap | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle atrophy in the limbs ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle atrophy in the limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle atrophy later in the disease ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle atrophy later in the disease | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle atrophy, lower limbs more affected than upper limbs ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle atrophy, lower limbs more affected than upper limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle atrophy, mild, more proximal than distal ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle atrophy, mild, more proximal than distal | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle biopsy shows lipid deposition ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle biopsy shows lipid deposition | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle biopsy shows myofibrillar disruption ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle biopsy shows myofibrillar disruption | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle biopsy shows myopathic or dystrophic changes ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle biopsy shows myopathic or dystrophic changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle biopsy shows variation in fiber size ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle biopsy shows variation in fiber size | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle hypertrophy of the lower extremities ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle hypertrophy of the lower extremities | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle pain and cramps following exercise ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle pain and cramps following exercise | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle stiffness or aching ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle stiffness or aching | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle weakness is not a feature ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle weakness is not a feature | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle weakness restricted to the upper limb ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle weakness restricted to the upper limb | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle weakness usually does not occur ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle weakness usually does not occur | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle weakness, congenital ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle weakness, congenital | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle weakness, lower limbs (patient a) ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle weakness, lower limbs (patient a) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:muscle weakness, predominantly proximal ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:muscle weakness, predominantly proximal | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:myotonia is most pronounced in the extremities ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:myotonia is most pronounced in the extremities | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:necrotic and regenerating muscle fibers ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:necrotic and regenerating muscle fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:nemaline bodies are usually subsarcolemmal or sarcoplasmic ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:nemaline bodies are usually subsarcolemmal or sarcoplasmic | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:neurogenic atrophy of muscle fibers seen on biopsy (in some patients) ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:neurogenic atrophy of muscle fibers seen on biopsy (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:no muscle fiber necrosis ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:no muscle fiber necrosis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:preserved junctional structure seen on muscle biopsy ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:preserved junctional structure seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:proximal and distal muscle atrophy in lower limbs ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:proximal and distal muscle atrophy in lower limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:quadriceps muscle spared ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:quadriceps muscle spared | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:rectus fascia separation ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:rectus fascia separation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:respiratory muscles may be involved (more common in juvenile-onset) ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:respiratory muscles may be involved (more common in juvenile-onset) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:rhabdomyolysis with exercise (in older patients) ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:rhabdomyolysis with exercise (in older patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:rhabdomyolysis, episodic ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:rhabdomyolysis, episodic | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:scapuloperoneal amyotrophy ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:scapuloperoneal amyotrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:slow motor responses to sudden events (i.e., falling) ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:slow motor responses to sudden events (i.e., falling) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:small cerebellum (especially vermis) ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:small cerebellum (especially vermis) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:sparing of small hand and finger muscles ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:sparing of small hand and finger muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:spastic diplegia, symmetric ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:spastic diplegia, symmetric | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:spasticity (later onset) ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:spasticity (later onset) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:spike-wave discharges ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:spike-wave discharges | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:spongiform degeneration ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:spongiform degeneration | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:strokes due to coagulopathy ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:strokes due to coagulopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:subsarcolemmal hyaline bodies in type 1 fibers only ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:subsarcolemmal hyaline bodies in type 1 fibers only | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:thakker donnai syndrome ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:thakker donnai syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:vacuolated muscle fibers show reduplication of the basement membrane ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:vacuolated muscle fibers show reduplication of the basement membrane | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:variable fiber size ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:variable fiber size | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:velopharyngeal muscle weakness ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:velopharyngeal muscle weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:weakness and wasting of the lower limbs ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:weakness and wasting of the lower limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:weakness of anterior compartment tibial muscles ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:weakness of anterior compartment tibial muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:z-disk streaming ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:z-disk streaming | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- en:z-disks with abnormal homogeneous material ---
r_associated #0: 27 -->
en:muscular atrophy
n1=en:z-disks with abnormal homogeneous material | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=27
- altération cavitaire ---
r_associated #0: 26 -->
en:muscular atrophy
n1=altération cavitaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- atrophie musculaire, ataxie, rétinite pigmentaire et diabète sucré ---
r_associated #0: 26 -->
en:muscular atrophy
n1=atrophie musculaire, ataxie, rétinite pigmentaire et diabète sucré | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- dégénérescence cavitaire ---
r_associated #0: 26 -->
en:muscular atrophy
n1=dégénérescence cavitaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:absence of necrosis ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:absence of necrosis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:atrophic calf muscles ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:atrophic calf muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:atrophy of soft tissue of orbit ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:atrophy of soft tissue of orbit | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:atrophy of the intrinsic foot and hand muscles ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:atrophy of the intrinsic foot and hand muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:attacks precipitated by cold temperature ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:attacks precipitated by cold temperature | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:bilateral facial weakness (congenital form) ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:bilateral facial weakness (congenital form) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:congenital absence of gluteal muscles ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:congenital absence of gluteal muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:cranial muscles spared ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:cranial muscles spared | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:decreased activity of cytochrome c oxidase seen on muscle biopsy ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:decreased activity of cytochrome c oxidase seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:decreased atp production ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:decreased atp production | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:decreased cytochrome c oxidase staining ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:decreased cytochrome c oxidase staining | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:decreased muscle action potential after warming affected muscle ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:decreased muscle action potential after warming affected muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:decreased muscle bulk ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:decreased muscle bulk | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:decreased muscle bulk (in one patient) ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:decreased muscle bulk (in one patient) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:decreased muscle mass ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:decreased muscle mass | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:degenerating junctional folds ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:degenerating junctional folds | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:degeneration of junctional folds ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:degeneration of junctional folds | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:denuded postsynaptic regions ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:denuded postsynaptic regions | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:difficulty climbing stairs, jumping, running ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:difficulty climbing stairs, jumping, running | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:difficulty rising from a squatting position ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:difficulty rising from a squatting position | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:difficulty walking on heels occurs prior to difficulty walking on toes ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:difficulty walking on heels occurs prior to difficulty walking on toes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:diffuse slow background activity seen on eeg ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:diffuse slow background activity seen on eeg | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:distal muscle weakness (first affects anterior leg muscles, then posterior leg muscles) ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:distal muscle weakness (first affects anterior leg muscles, then posterior leg muscles) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:dorsal and flexor muscles of the forearm are involved ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:dorsal and flexor muscles of the forearm are involved | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:dystrophic changes occur later ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:dystrophic changes occur later | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:dystrophic changes seen on skeletal muscle biopsy ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:dystrophic changes seen on skeletal muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:edema reoccurs with infections ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:edema reoccurs with infections | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:fiber size variation seen on muscle biopsy ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:fiber size variation seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:flaccid weakness or paralysis, episodic attacks ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:flaccid weakness or paralysis, episodic attacks | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:generalized lack of subcutaneous fat ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:generalized lack of subcutaneous fat | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:generalized muscle weakness, severe ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:generalized muscle weakness, severe | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:gluteus maximus and thigh adductors most affected ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:gluteus maximus and thigh adductors most affected | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:hangrip myotonia ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:hangrip myotonia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:hip abductor weakness and atrophy ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:hip abductor weakness and atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:hypertrophy of orbicularis oculi muscle ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:hypertrophy of orbicularis oculi muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:hypotonia (patients a and c) ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:hypotonia (patients a and c) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:hypotonia (untreated hypothyroidism) ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:hypotonia (untreated hypothyroidism) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:hypotonia, neonatal, severe (hcs) ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:hypotonia, neonatal, severe (hcs) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:imaging shows progressive fatty infiltration of muscle ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:imaging shows progressive fatty infiltration of muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:inability to stand or walk (in severe cases) ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:inability to stand or walk (in severe cases) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:increased centralized internal nuclei ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:increased centralized internal nuclei | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:increased internal nuclei in skeletal muscle fibers ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:increased internal nuclei in skeletal muscle fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:increased numbers of type 1 fibers ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:increased numbers of type 1 fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:intermyofibrillar and subsarcolemmal granulofilamentous protein aggregates ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:intermyofibrillar and subsarcolemmal granulofilamentous protein aggregates | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:limited walking ability ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:limited walking ability | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:loss of subcutaneous adipose tissue from upper limbs and trunk ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:loss of subcutaneous adipose tissue from upper limbs and trunk | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:loss of subcutaneous adipose tissue in limbs ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:loss of subcutaneous adipose tissue in limbs | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:motor clumsiness ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:motor clumsiness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:muscle atrophy, limb-girdle and proximal ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:muscle atrophy, limb-girdle and proximal | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:muscle biopsy shows abnormal mitochondria ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:muscle biopsy shows abnormal mitochondria | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:muscle biopsy shows centralized nuclei ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:muscle biopsy shows centralized nuclei | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:muscle biopsy shows core-like regions devoid of oxidative activity ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:muscle biopsy shows core-like regions devoid of oxidative activity | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:muscle biopsy shows glycogen accumulation in myofibrils and lysosomes ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:muscle biopsy shows glycogen accumulation in myofibrils and lysosomes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:muscle biopsy shows myofibrillar changes ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:muscle biopsy shows myofibrillar changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:muscle fibers are immunoreactive for desmin and vimentin ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:muscle fibers are immunoreactive for desmin and vimentin | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:muscle fibers may contain abnormal polysaccharide ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:muscle fibers may contain abnormal polysaccharide | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:muscle weakness, lower limbs, during exercise ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:muscle weakness, lower limbs, during exercise | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:neck and proximal limb muscle myopathy ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:neck and proximal limb muscle myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:necrotic fibers ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:necrotic fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:nemaline bodies are rarely intranuclear ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:nemaline bodies are rarely intranuclear | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:no staining for oxidative enzymes ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:no staining for oxidative enzymes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:non-pitting edema ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:non-pitting edema | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:normal or increased abdominal adipose tissue ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:normal or increased abdominal adipose tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:normal or increased facial and neck adipose tissue ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:normal or increased facial and neck adipose tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:normal or increased truncal adipose tissue ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:normal or increased truncal adipose tissue | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:opisthotonus (patient b) ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:opisthotonus (patient b) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:painful swelling in fasciae ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:painful swelling in fasciae | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:pectoralis muscles may be less involved, leading to inward shrugging posture ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:pectoralis muscles may be less involved, leading to inward shrugging posture | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:pelvic girdle weakness and atrophy ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:pelvic girdle weakness and atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:percussion-induced muscle mounding (muscle rippling) ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:percussion-induced muscle mounding (muscle rippling) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:poor exercise tolerance ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:poor exercise tolerance | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:poor muscle bulk ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:poor muscle bulk | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:premature exertional muscle weakness ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:premature exertional muscle weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:preserved junctional folds ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:preserved junctional folds | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:progressive ectopic ossification (neck, dorsal trunk, proximal limbs, sternocleidomastoid, masseters) ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:progressive ectopic ossification (neck, dorsal trunk, proximal limbs, sternocleidomastoid, masseters) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:proliferation of fatty tissue in muscle (in some patients) ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:proliferation of fatty tissue in muscle (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:proximal limb muscle weakness initially ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:proximal limb muscle weakness initially | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:proximal weakness of the lower limbs with longer disease duration ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:proximal weakness of the lower limbs with longer disease duration | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:pyruvate oxidation defect ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:pyruvate oxidation defect | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:ragged red fibers, mainly in type i fibers seen on skeletal muscle biopsy ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:ragged red fibers, mainly in type i fibers seen on skeletal muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:rectus medial atrophy ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:rectus medial atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:reduced muscle mass ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:reduced muscle mass | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:reduced postsynaptic cleft area ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:reduced postsynaptic cleft area | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:rounded, atrophic fibers (family a) ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:rounded, atrophic fibers (family a) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:secondarily decreased activities of mitochondrial respiratory enzymes (in some patients) ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:secondarily decreased activities of mitochondrial respiratory enzymes (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:slowly progressive limb-girdle myopathy ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:slowly progressive limb-girdle myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:small and incompletely fused muscle fibers seen on biopsy ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:small and incompletely fused muscle fibers seen on biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:soft tissue or tendinous calcinosis may occur ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:soft tissue or tendinous calcinosis may occur | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:some patients have no structural brain abnormalities ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:some patients have no structural brain abnormalities | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:some subcutaneous adipose tissue may remain on upper arms ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:some subcutaneous adipose tissue may remain on upper arms | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:superficial rerouting of lymph through the skin ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:superficial rerouting of lymph through the skin | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:tremors subside over the first 2 to 3 months of life ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:tremors subside over the first 2 to 3 months of life | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:tubulofilamentous nuclear or cytoplasmic inclusions on biopsy ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:tubulofilamentous nuclear or cytoplasmic inclusions on biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:type 1 and type 2 muscle fibers with 'minicore' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:type 1 and type 2 muscle fibers with 'minicore' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:vacuoles appear to be exocytosing material at the cell surface ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:vacuoles appear to be exocytosing material at the cell surface | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:variation in skeletal muscle fiber diameter ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:variation in skeletal muscle fiber diameter | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:variation of fiber size and shape ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:variation of fiber size and shape | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:wastefulness ---
r_associated #0: 26 -->
en:muscular atrophy
n1=en:wastefulness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=26
- en:waste of money ---
r_associated #0: 25 -->
en:muscular atrophy
n1=en:waste of money | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=25
- en:ataxia ---
r_associated #0: 22 -->
en:muscular atrophy
n1=en:ataxia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=22
- en:physical disability ---
r_associated #0: 22 -->
en:muscular atrophy
n1=en:physical disability | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=22
- en:lavishing ---
r_associated #0: 21 -->
en:muscular atrophy
n1=en:lavishing | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=21
- amyotrophie de dénervation ---
r_associated #0: 20 -->
en:muscular atrophy
n1=amyotrophie de dénervation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- amyotrophie neurogénique ---
r_associated #0: 20 -->
en:muscular atrophy
n1=amyotrophie neurogénique | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- amyotrophie péronière de Charcot-Marie-Tooth combinée à l'ataxie de Friedreich ---
r_associated #0: 20 -->
en:muscular atrophy
n1=amyotrophie péronière de Charcot-Marie-Tooth combinée à l'ataxie de Friedreich | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- ataxie ---
r_associated #0: 20 -->
en:muscular atrophy
n1=ataxie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- atrophie d'un groupe de fibres musculaires ---
r_associated #0: 20 -->
en:muscular atrophy
n1=atrophie d'un groupe de fibres musculaires | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- atrophie musculaire de la sénescence ---
r_associated #0: 20 -->
en:muscular atrophy
n1=atrophie musculaire de la sénescence | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- atrophie musculaire neurogène ---
r_associated #0: 20 -->
en:muscular atrophy
n1=atrophie musculaire neurogène | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- atrophie musculaire neurogénique ---
r_associated #0: 20 -->
en:muscular atrophy
n1=atrophie musculaire neurogénique | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- diabète sucré ---
r_associated #0: 20 -->
en:muscular atrophy
n1=diabète sucré | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- dystrophie musculaire oculopharyngée récessive ---
r_associated #0: 20 -->
en:muscular atrophy
n1=dystrophie musculaire oculopharyngée récessive | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:3-hydroxyacetyl-coenzyme a dehydrogenase deficiency ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:3-hydroxyacetyl-coenzyme a dehydrogenase deficiency | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:acute post asthmatic amyotrophy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:acute post asthmatic amyotrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:age-related atrophy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:age-related atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:alcoholic brain atrophy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:alcoholic brain atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:amyotrophy (1 patient) ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:amyotrophy (1 patient) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:amyotrophy of the upper limbs (in some patients) ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:amyotrophy of the upper limbs (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:amyotrophy, monomelic ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:amyotrophy, monomelic | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:angioedema ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:angioedema | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:ankle edema (finding) ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:ankle edema (finding) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:arm/shoulder muscle hypoplasia ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:arm/shoulder muscle hypoplasia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:arthrogryposis ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:arthrogryposis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:ascites (in some patients) ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:ascites (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:athetosis ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:athetosis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:atrophic muscle fibers ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:atrophic muscle fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:atrophy of the small muscles in the hands and feet ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:atrophy of the small muscles in the hands and feet | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:atrophy of type 1 and type 2 fibers ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:atrophy of type 1 and type 2 fibers | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:atrophy, neurogenic muscular ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:atrophy, neurogenic muscular | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:attacks of weakness ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:attacks of weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:autoimmune necrotizing myopathy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:autoimmune necrotizing myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:autophagic vacuoles seen on biopsy (in some patients) ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:autophagic vacuoles seen on biopsy (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:autophagosome ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:autophagosome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:axial muscle hyperextension, episodic ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:axial muscle hyperextension, episodic | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:axial weakness ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:axial weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:berardinelli-seip congenital lipodystrophy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:berardinelli-seip congenital lipodystrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:bilateral foot drop ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:bilateral foot drop | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:biopsy shows degenerative changes consistent with myopathy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:biopsy shows degenerative changes consistent with myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:biopsy shows deposition of complement proteins c5b-9 of the membrane attack complex on muscle fibers or in vacuoles ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:biopsy shows deposition of complement proteins c5b-9 of the membrane attack complex on muscle fibers or in vacuoles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:biopsy shows myopathic and dystrophic changes ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:biopsy shows myopathic and dystrophic changes | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:bone mineral density ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:bone mineral density | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:bradykinesia ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:bradykinesia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:brain ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:brain | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:brain stem ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:brain stem | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:buffalo hump ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:buffalo hump | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:bulbar weakness ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:bulbar weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:calcific tendinopathy, early-onset (in some patients) ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:calcific tendinopathy, early-onset (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:calf hypertrophy (in some patients) ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:calf hypertrophy (in some patients) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:cardiomyopathy is not a feature ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:cardiomyopathy is not a feature | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:casq1-immunopositive inclusions ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:casq1-immunopositive inclusions | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:centrally located nuclei seen on muscle biopsy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:centrally located nuclei seen on muscle biopsy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:cerebral atrophy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:cerebral atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:cerebrospinal fluid ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:cerebrospinal fluid | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:chills ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:chills | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:chronic fatigue syndrome ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:chronic fatigue syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:cns component ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:cns component | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:compartment syndrome ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:compartment syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:congenital fiber-type disproportion ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:congenital fiber-type disproportion | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:congenital structural myopathy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:congenital structural myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:cranial suture separation ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:cranial suture separation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:dermatomyositis ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:dermatomyositis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:detrusor and sphincter dyssynergia ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:detrusor and sphincter dyssynergia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:diaphragmatic paresis ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:diaphragmatic paresis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:disorder of extraocular muscle ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:disorder of extraocular muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:disorder of muscle, unspecified; ankle and foot ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:disorder of muscle, unspecified; ankle and foot | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:disorder of muscle, unspecified; hand ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:disorder of muscle, unspecified; hand | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:disorder of muscle, unspecified; multiple sites ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:disorder of muscle, unspecified; multiple sites | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:disorder of muscle, unspecified; pelvic region and thigh ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:disorder of muscle, unspecified; pelvic region and thigh | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:disorder of muscle, unspecified; site unspecified ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:disorder of muscle, unspecified; site unspecified | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:disuse atrophy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:disuse atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:endocrine myopathy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:endocrine myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:eosinophilia-myalgia syndrome ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:eosinophilia-myalgia syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:epiphysiolysis ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:epiphysiolysis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:eye ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:eye | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:facial dysmorphism with multiple malformations ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:facial dysmorphism with multiple malformations | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:fasciculation ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:fasciculation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:fibromyalgia ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:fibromyalgia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:finger ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:finger | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:foot-drop ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:foot-drop | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:frontal bossing ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:frontal bossing | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:glycogen storage disease type ii ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:glycogen storage disease type ii | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:glycogen storage disease type v ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:glycogen storage disease type v | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:gray matter ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:gray matter | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:guillain-barre syndrome ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:guillain-barre syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:hand ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:hand | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:hereditary motor neuron disease ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:hereditary motor neuron disease | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:hyperkinesia ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:hyperkinesia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:hypocalcemic tetany ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:hypocalcemic tetany | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:hypokinesia ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:hypokinesia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:hypotonia ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:hypotonia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:hypotonic-hyporesponsive episode ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:hypotonic-hyporesponsive episode | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:idiopathic inflammatory myopathy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:idiopathic inflammatory myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:increased bone density ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:increased bone density | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:involuntary muscle contraction ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:involuntary muscle contraction | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:joint immobility ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:joint immobility | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:joint swelling ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:joint swelling | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:kearns-sayre syndrome ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:kearns-sayre syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:leg cramp ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:leg cramp | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:lethal congenital contractural syndrome 3 ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:lethal congenital contractural syndrome 3 | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:long-chain acyl-coa dehydrogenase deficiency ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:long-chain acyl-coa dehydrogenase deficiency | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:malunion of bone ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:malunion of bone | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:medial tibial stress syndrome ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:medial tibial stress syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:medium-chain acyl-coa dehydrogenase deficiency ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:medium-chain acyl-coa dehydrogenase deficiency | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:merrf syndrome ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:merrf syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:metacarpus ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:metacarpus | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:minicore (multicore) myopathy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:minicore (multicore) myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:mitochondrial encephalomyopathies ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:mitochondrial encephalomyopathies | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:mitochondrial myopathy acquired ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:mitochondrial myopathy acquired | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:motor deficit ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:motor deficit | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:motor neuron/peripheral motor ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:motor neuron/peripheral motor | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle calcification or ossification nos ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle calcification or ossification nos | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle contracture ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle contracture | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle fibrosis ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle fibrosis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle fibrosis atrophy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle fibrosis atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle hemorrhage ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle hemorrhage | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle hypertrophy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle hypertrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle hypertrophy in response to stress ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle hypertrophy in response to stress | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle infections and inflammations ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle infections and inflammations | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle necrosis ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle necrosis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle related signs and symptoms nec ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle related signs and symptoms nec | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle spasm ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle spasm | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle tightness ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle tightness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle wasting (disuse) ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle wasting (disuse) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscle weakness ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscle weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscular dystrophy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscular dystrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscular rigidity ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscular rigidity | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:muscular wasting and disuse atrophy, nec in mdr18_1 ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:muscular wasting and disuse atrophy, nec in mdr18_1 | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:musculoskeletal system disorder ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:musculoskeletal system disorder | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:myalgia ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:myalgia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:myasthenias ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:myasthenias | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:myofascial spasm ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:myofascial spasm | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:myoglobinuria ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:myoglobinuria | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:myokymia ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:myokymia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:myomatous neoplasm ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:myomatous neoplasm | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:myopathy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:myosclerosis ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:myosclerosis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:myositic disorders ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:myositic disorders | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:myositis ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:myositis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:myotonic disorder ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:myotonic disorder | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:nathalie syndrome ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:nathalie syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:neuralgia ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:neuralgia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:neuralgic amyotrophy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:neuralgic amyotrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:neuromuscular diseases ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:neuromuscular diseases | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:neuromuscular disorders nec ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:neuromuscular disorders nec | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:neuromuscular manifestations ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:neuromuscular manifestations | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:neuromuscular toxicity ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:neuromuscular toxicity | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:neuropathy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:neuropathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:nocturnal myoclonus syndrome ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:nocturnal myoclonus syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:other disorders of muscle ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:other disorders of muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:other specified disorders of muscle ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:other specified disorders of muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:pineal gland ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:pineal gland | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:proximal myopathy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:proximal myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:psoas sign ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:psoas sign | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:ptosis ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:ptosis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:respiratory muscle weakness ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:respiratory muscle weakness | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:rhabdomyolysis ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:rhabdomyolysis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:sarcopenia ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:sarcopenia | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:satoyoshi syndrome ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:satoyoshi syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:skeletal myopathy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:skeletal myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:somatic dysfunction ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:somatic dysfunction | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:spinal cord ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:spinal cord | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:strabismus ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:strabismus | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:striated muscle adaptation ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:striated muscle adaptation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:structure of right hand ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:structure of right hand | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:swelling of skeletal muscle ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:swelling of skeletal muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:symptomatic inflammatory myopathy associated with another disorder ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:symptomatic inflammatory myopathy associated with another disorder | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:temporomandibular joint dysfunction syndrome ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:temporomandibular joint dysfunction syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:tenesmus ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:tenesmus | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:tetany ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:tetany | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:toxic myopathy ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:toxic myopathy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:trendelenburg's symptom ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:trendelenburg's symptom | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:twitching ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:twitching | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:uvular spasm ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:uvular spasm | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:werner syndrome ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:werner syndrome | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:white matter ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:white matter | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- en:wristdrop ---
r_associated #0: 20 -->
en:muscular atrophy
n1=en:wristdrop | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- fonte ---
r_associated #0: 20 -->
en:muscular atrophy
n1=fonte | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- insuffisance ---
r_associated #0: 20 -->
en:muscular atrophy
n1=insuffisance | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- maladie ---
r_associated #0: 20 -->
en:muscular atrophy
n1=maladie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- maladie des muscles ---
r_associated #0: 20 -->
en:muscular atrophy
n1=maladie des muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- maladie
(médecine) ---
r_associated #0: 20 -->
en:muscular atrophy
n1=maladie (médecine) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- mental ---
r_associated #0: 20 -->
en:muscular atrophy
n1=mental | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- muscle ---
r_associated #0: 20 -->
en:muscular atrophy
n1=muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- muscles ---
r_associated #0: 20 -->
en:muscular atrophy
n1=muscles | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- musculaire ---
r_associated #0: 20 -->
en:muscular atrophy
n1=musculaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- neuropathies diabétiques ---
r_associated #0: 20 -->
en:muscular atrophy
n1=neuropathies diabétiques | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- pathologie ---
r_associated #0: 20 -->
en:muscular atrophy
n1=pathologie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- pigmentaire ---
r_associated #0: 20 -->
en:muscular atrophy
n1=pigmentaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- processus pathologique ---
r_associated #0: 20 -->
en:muscular atrophy
n1=processus pathologique | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- sarcopénie ---
r_associated #0: 20 -->
en:muscular atrophy
n1=sarcopénie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- tronc cérébral ---
r_associated #0: 20 -->
en:muscular atrophy
n1=tronc cérébral | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=20
- atrophie musculaire spinale de la mi-enfance et de l'adolescence ---
r_associated #0: 17 -->
en:muscular atrophy
n1=atrophie musculaire spinale de la mi-enfance et de l'adolescence | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=17
- atrophie musculaire spinale (I-II ou III) ---
r_associated #0: 15 -->
en:muscular atrophy
n1=atrophie musculaire spinale (I-II ou III) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=15
- contraction clonique ---
r_associated #0: 15 -->
en:muscular atrophy
n1=contraction clonique | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=15
- en:muscle twitch ---
r_associated #0: 15 -->
en:muscular atrophy
n1=en:muscle twitch | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=15
- secousse musculaire ---
r_associated #0: 15 -->
en:muscular atrophy
n1=secousse musculaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=15
- en:spinal muscular atrophy ---
r_associated #0: 13 -->
en:muscular atrophy
n1=en:spinal muscular atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=13
- Werdnig-Hoffmann (amyotrophie spinale de) ---
r_associated #0: 11 -->
en:muscular atrophy
n1=Werdnig-Hoffmann (amyotrophie spinale de) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=11
- en:infantile muscular atrophy ---
r_associated #0: 11 -->
en:muscular atrophy
n1=en:infantile muscular atrophy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=11
- syndrome de Kugelberg-Welander ---
r_associated #0: 11 -->
en:muscular atrophy
n1=syndrome de Kugelberg-Welander | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=11
- Amyotrophie ---
r_associated #0: 10 -->
en:muscular atrophy
n1=Amyotrophie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- Atrophie ---
r_associated #0: 10 -->
en:muscular atrophy
n1=Atrophie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- Gaspillage ---
r_associated #0: 10 -->
en:muscular atrophy
n1=Gaspillage | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- Handicap moteur ---
r_associated #0: 10 -->
en:muscular atrophy
n1=Handicap moteur | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- Musculaire ---
r_associated #0: 10 -->
en:muscular atrophy
n1=Musculaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- arthrogrypose ---
r_associated #0: 10 -->
en:muscular atrophy
n1=arthrogrypose | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- cataracte-ataxie-surdité et retard mental (syndrome) ---
r_associated #0: 10 -->
en:muscular atrophy
n1=cataracte-ataxie-surdité et retard mental (syndrome) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- contraction musculaire involontaire ---
r_associated #0: 10 -->
en:muscular atrophy
n1=contraction musculaire involontaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- cordon nerveux ---
r_associated #0: 10 -->
en:muscular atrophy
n1=cordon nerveux | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- dilapidation ---
r_associated #0: 10 -->
en:muscular atrophy
n1=dilapidation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- dystrophie musculaire ---
r_associated #0: 10 -->
en:muscular atrophy
n1=dystrophie musculaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- en:Kugelberg-Welander's disease ---
r_associated #0: 10 -->
en:muscular atrophy
n1=en:Kugelberg-Welander's disease | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- en:ataxy ---
r_associated #0: 10 -->
en:muscular atrophy
n1=en:ataxy | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- en:muscular fasciculation ---
r_associated #0: 10 -->
en:muscular atrophy
n1=en:muscular fasciculation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- en:paresis ---
r_associated #0: 10 -->
en:muscular atrophy
n1=en:paresis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- en:rectal tenesmus ---
r_associated #0: 10 -->
en:muscular atrophy
n1=en:rectal tenesmus | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- en:white substance ---
r_associated #0: 10 -->
en:muscular atrophy
n1=en:white substance | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- faiblesse de muscle ---
r_associated #0: 10 -->
en:muscular atrophy
n1=faiblesse de muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- faiblesse du muscle ---
r_associated #0: 10 -->
en:muscular atrophy
n1=faiblesse du muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- faiblesse musculaire ---
r_associated #0: 10 -->
en:muscular atrophy
n1=faiblesse musculaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- gonflement de l'articulation ---
r_associated #0: 10 -->
en:muscular atrophy
n1=gonflement de l'articulation | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- handicap physique ---
r_associated #0: 10 -->
en:muscular atrophy
n1=handicap physique | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- liquide céphalo-rachidien ---
r_associated #0: 10 -->
en:muscular atrophy
n1=liquide céphalo-rachidien | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- liquide céphalorachidien ---
r_associated #0: 10 -->
en:muscular atrophy
n1=liquide céphalorachidien | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- matière blanche ---
r_associated #0: 10 -->
en:muscular atrophy
n1=matière blanche | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- matière grise ---
r_associated #0: 10 -->
en:muscular atrophy
n1=matière grise | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- myopathie ---
r_associated #0: 10 -->
en:muscular atrophy
n1=myopathie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- myopathie toxique ---
r_associated #0: 10 -->
en:muscular atrophy
n1=myopathie toxique | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- méninge ---
r_associated #0: 10 -->
en:muscular atrophy
n1=méninge | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- neuropathie ---
r_associated #0: 10 -->
en:muscular atrophy
n1=neuropathie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- névralgie ---
r_associated #0: 10 -->
en:muscular atrophy
n1=névralgie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- ophtalmoplégie, hypotonie, ataxie, hypoacousie et athétose ---
r_associated #0: 10 -->
en:muscular atrophy
n1=ophtalmoplégie, hypotonie, ataxie, hypoacousie et athétose | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- paralysie générale ---
r_associated #0: 10 -->
en:muscular atrophy
n1=paralysie générale | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- parésie ---
r_associated #0: 10 -->
en:muscular atrophy
n1=parésie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- ptosis ---
r_associated #0: 10 -->
en:muscular atrophy
n1=ptosis | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- quadriplégie spastique, rétinite pigmentaire et retard mental ---
r_associated #0: 10 -->
en:muscular atrophy
n1=quadriplégie spastique, rétinite pigmentaire et retard mental | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- rétinite pigmentaire ---
r_associated #0: 10 -->
en:muscular atrophy
n1=rétinite pigmentaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- rétinite pigmentaire d'apparition tardive ---
r_associated #0: 10 -->
en:muscular atrophy
n1=rétinite pigmentaire d'apparition tardive | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- rétinite pigmentaire et retard mental ---
r_associated #0: 10 -->
en:muscular atrophy
n1=rétinite pigmentaire et retard mental | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- rétinite pigmentaire liée au sexe récessive 3 ---
r_associated #0: 10 -->
en:muscular atrophy
n1=rétinite pigmentaire liée au sexe récessive 3 | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- rétinite pigmentaire liée à la PDEB (1-bp del, his557-to-tyr) ---
r_associated #0: 10 -->
en:muscular atrophy
n1=rétinite pigmentaire liée à la PDEB (1-bp del, his557-to-tyr) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- rétinite pigmentaire liée à la périphérine ---
r_associated #0: 10 -->
en:muscular atrophy
n1=rétinite pigmentaire liée à la périphérine | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- rétinite pigmentaire liée à la périphérine (pro219leu) ---
r_associated #0: 10 -->
en:muscular atrophy
n1=rétinite pigmentaire liée à la périphérine (pro219leu) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- rétinite pigmentaire liée à la rhodopsine ---
r_associated #0: 10 -->
en:muscular atrophy
n1=rétinite pigmentaire liée à la rhodopsine | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- rétinite pigmentaire sénile ---
r_associated #0: 10 -->
en:muscular atrophy
n1=rétinite pigmentaire sénile | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- rétinite pigmentaire, surdité, retard mental, et hypogonadisme ---
r_associated #0: 10 -->
en:muscular atrophy
n1=rétinite pigmentaire, surdité, retard mental, et hypogonadisme | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- rétinopathie pigmentaire ---
r_associated #0: 10 -->
en:muscular atrophy
n1=rétinopathie pigmentaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- strabisme ---
r_associated #0: 10 -->
en:muscular atrophy
n1=strabisme | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- syndrome cataracte-ataxie-surdité et retard mental ---
r_associated #0: 10 -->
en:muscular atrophy
n1=syndrome cataracte-ataxie-surdité et retard mental | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- syndrome de Primrose ---
r_associated #0: 10 -->
en:muscular atrophy
n1=syndrome de Primrose | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- tuméfaction articulaire ---
r_associated #0: 10 -->
en:muscular atrophy
n1=tuméfaction articulaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- ténesme anal ---
r_associated #0: 10 -->
en:muscular atrophy
n1=ténesme anal | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- tétanie ---
r_associated #0: 10 -->
en:muscular atrophy
n1=tétanie | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- urgence de défécation douloureuse ---
r_associated #0: 10 -->
en:muscular atrophy
n1=urgence de défécation douloureuse | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=10
- Atrophie musculaire ---
r_associated #0: 5 -->
en:muscular atrophy
n1=Atrophie musculaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- DMO
(densité minérale osseuse) ---
r_associated #0: 5 -->
en:muscular atrophy
n1=DMO (densité minérale osseuse) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- Diabète sucré ---
r_associated #0: 5 -->
en:muscular atrophy
n1=Diabète sucré | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- Kugelberg-Welander (syndrome de) ---
r_associated #0: 5 -->
en:muscular atrophy
n1=Kugelberg-Welander (syndrome de) | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- Tronc cérébral ---
r_associated #0: 5 -->
en:muscular atrophy
n1=Tronc cérébral | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- atrophie olivoponto-cérébelleuse et dégénérescence rétinienne ---
r_associated #0: 5 -->
en:muscular atrophy
n1=atrophie olivoponto-cérébelleuse et dégénérescence rétinienne | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- atrophie olivopontocérébelleuse ---
r_associated #0: 5 -->
en:muscular atrophy
n1=atrophie olivopontocérébelleuse | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- cordon médullaire ---
r_associated #0: 5 -->
en:muscular atrophy
n1=cordon médullaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- densité minérale osseuse ---
r_associated #0: 5 -->
en:muscular atrophy
n1=densité minérale osseuse | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- efforts de défécation inefficaces ---
r_associated #0: 5 -->
en:muscular atrophy
n1=efforts de défécation inefficaces | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- en:brainstem ---
r_associated #0: 5 -->
en:muscular atrophy
n1=en:brainstem | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- fasciculation d'un muscle squelettique ---
r_associated #0: 5 -->
en:muscular atrophy
n1=fasciculation d'un muscle squelettique | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- myopathie primitive progressive ---
r_associated #0: 5 -->
en:muscular atrophy
n1=myopathie primitive progressive | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- parésie musculaire ---
r_associated #0: 5 -->
en:muscular atrophy
n1=parésie musculaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- pression rectale sévère ---
r_associated #0: 5 -->
en:muscular atrophy
n1=pression rectale sévère | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- spasme d'un muscle ---
r_associated #0: 5 -->
en:muscular atrophy
n1=spasme d'un muscle | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- spasme musculaire ---
r_associated #0: 5 -->
en:muscular atrophy
n1=spasme musculaire | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- ténesme ---
r_associated #0: 5 -->
en:muscular atrophy
n1=ténesme | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- ténesme rectal ---
r_associated #0: 5 -->
en:muscular atrophy
n1=ténesme rectal | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- wasting ---
r_associated #0: 5 -->
en:muscular atrophy
n1=wasting | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=5
- maladies ---
r_associated #0: 2 -->
en:muscular atrophy
n1=maladies | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=2
- amyotrophie primitive progressive ---
r_associated #0: 1 -->
en:muscular atrophy
n1=amyotrophie primitive progressive | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=1
- amyotrophie spinale ---
r_associated #0: 1 -->
en:muscular atrophy
n1=amyotrophie spinale | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=1
- amyotrophie spinale de Werdnig-Hoffmann ---
r_associated #0: 1 -->
en:muscular atrophy
n1=amyotrophie spinale de Werdnig-Hoffmann | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=1
- amyotrophie spinale de type 2 ---
r_associated #0: 1 -->
en:muscular atrophy
n1=amyotrophie spinale de type 2 | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=1
- amyotrophie spinale oculo-pharyngée ---
r_associated #0: 1 -->
en:muscular atrophy
n1=amyotrophie spinale oculo-pharyngée | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=1
- amyotrophie spinale oculopharyngée ---
r_associated #0: 1 -->
en:muscular atrophy
n1=amyotrophie spinale oculopharyngée | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=1
- amyotrophie spinale proximale progressive ---
r_associated #0: 1 -->
en:muscular atrophy
n1=amyotrophie spinale proximale progressive | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=1
- amyotrophie spinale proximale type i ---
r_associated #0: 1 -->
en:muscular atrophy
n1=amyotrophie spinale proximale type i | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=1
- amyotrophie spinobulbaire liée à l'x ---
r_associated #0: 1 -->
en:muscular atrophy
n1=amyotrophie spinobulbaire liée à l'x | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=1
- atrophie musculaire due à l'inactivité ---
r_associated #0: 1 -->
en:muscular atrophy
n1=atrophie musculaire due à l'inactivité | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=1
- atrophie musculaire postpoliomyélitique ---
r_associated #0: 1 -->
en:muscular atrophy
n1=atrophie musculaire postpoliomyélitique | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=1
- % production ---
r_associated #0: -5 -->
en:muscular atrophy
n1=% production | n2=en:muscular atrophy | rel=r_associated | relid=0 | w=-5
|